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Summary 
High blood pressure (defined as > 140/90 mmHg) is the biggest contributor to 
heart disease-related death in the world. According to WHO World Heath Report 
2002, globally 62% of cerebrovascular disease and 49% of ischemic heart disease 
were attributable to elevated blood pressure. A multifaceted strategy to reduce 
the risks associated with high BP includes healthy lifestyle changes, with 
reduction in dietary salt intake being the most cost-effective intervention.  
 
Multiple lines of investigation including genetic, epidemiological and 
interventional studies have demonstrated consistently a positive relationship 
between salt intake, blood pressure increment and cardiovascular consequences. 
In addition, it has been documented that excessive salt intake can be attributed 
to other health complications such as asthma, osteoporosis, obesity and gastric 
cancer. On the contrary, reduction in salt intake has been shown to reduce 
blood pressure and improve health outcomes, although the evidence is not 
completely unequivocal. Despite this discrepancy, low-sodium diet is widely 
being recommended to all hypertensive patients in particular, as evidence 
against its efficacy in conjunction with optimum hypertensive treatment is well 
established.  
 
The work contained in this thesis describes a study which was designated to 
assess sodium and its clinical outcomes among hypertensive patients. All 
patients attending follow-up care at Glasgow Blood Pressure Clinic (GBPC), 
Western Infirmary were invited to participate in the first part of the study by 
completing two separate questionnaires; first containing food frequency 
questionnaire (FFQ) to estimate salt intake and the other involves knowledge, 
attitude and perception (KAP) towards dietary salt consumption. In the second 
part of the study, data obtained from the FFQ for sodium estimation and spot 
urine analysis were merged to the corresponding dataset from GBPC database to 
study blood pressure outcomes, and finally the effects of serum sodium and 
mortality were investigated in an uncontrolled hypertensive cohort of GBPC. 
 
To determine salt intake status among the patients, a modified FFQ was 
constructed and validated against corrected spot urine samples and 24-hour 
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urine collections in sub-samples. On average, FFQ provided higher estimates of 
sodium consumption compared to estimation based on corrected spot urine 
sodium. The FFQ demonstrated a strong sensitivity (80.2%), high negative 
predictive value (61.1%) and significant moderate strength of reproducibility (r = 
0.619, k = 0.505). The application of this modified version of sodium FFQ in an 
out-patient clinic setting is acceptable provided that it is used in conjunction 
with other monitoring parameter such as serial spot urine measurements. 
 
Assessment on current level of awareness and practise regarding healthy salt 
intake is important as this will encourage patients to take active control over 
their own BP management.  In this study, patients’ knowledge, awareness, 
attitude and perception (KAP) towards salt intake were examined based on KAP 
questionnaire. Overall, majority of patients recognized the harmful effects of 
too much salt in their diet although very few knew that salt can contribute to 
various health complications other than increased in blood pressure. Knowledge 
regarding salt intake limit and sodium to salt conversion need to be improved. 
Further education is suggested to improve patients’ attitude regarding food-
label utilisation and salt-sensory adaptation. 
 
The association between daily sodium consumption and related clinical outcomes 
were studied in a cohort of treated hypertensive patients attending the 
specialist Glasgow Blood Pressure Clinic. Complete data for all covariates were 
available for 439 patients. Analysing longitudinal SBP and DBP change over time, 
subjects in the highest tertile of salt intake based on FFQ showed the greatest 
and sustained drop in SBP in contrast to those in the lowest tertile of salt intake. 
Whilst this is counter-intuitive, the association can be explained by the higher 
prevalence of cardiovascular disease and LVH in the highest tertile. It is likely 
that these individuals were subject of aggressive BP management because of 
their co-morbidities. This highlights the major drawback of observational studies 
which is confounding and this can be addressed through randomised control 
studies.  
 
Serum sodium is homeostatically maintained within a narrow range through 
multiple mechanisms. Previous studies have shown that hyponatremia is a poor 
prognostic sign in hospitalised patients, patients with heart failure and liver 
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disease. In a large cohort of 13380 treated hypertensive patients followed up for 
35 years, I have shown that low serum sodium is associated with increased 
mortality when adjusted for all the conventional covariates. However this 
relationship disappears when the additional electrolytes are included in the 
model (chloride, bicarbonate and potassium). This novel finding raises the 
prospect that other electrolytes may have a bigger impact on blood pressure and 
cardiovascular risk – not sodium in isolation. 
 
In summary, FFQ can be a useful tool for assessing sodium compliance in 
hypertensive patients, provided that it’s being used in conjunction with other 
robust dietary measure such as 24-hour urine collection. Health care 
professionals and public agencies need to contribute actively to improve patients 
overall knowledge, awareness, attitude and perception towards healthy salt 
intake. The observational nature of the hypertensive cohort in this study limits 
the generalisability of the findings to the population though it may be relevant 
to similar treated hypertensive cohorts. The role of other electrolytes on blood 
pressure control and cardiovascular outcomes deserve further investigations.  
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1.1 History of salt intake 
Sodium, the cation of salt was first discovered in 1807 by the English chemist Sir 
Humphrey Davy through the electrolysis of sodium hydroxide. The symbol of the 
element is ‘Na’ originating from the Latin name for a common sodium compound 
known as natrium (from the Greek ‘nitron’ refers to a natural salt) (1;2). 
Commonly found in foods as sodium chloride, salt is the key ingredient in taste 
enhancement as well as food preservation. It can also be considered as a major 
food additive since it contributes to approximately 90% source of sodium in 
today’s modern diet (3). 
Historical evolution proposed that human developed a hedonistic taste for salt 
and have been adding it to food since 10,000 years ago. Romans in the first 
century AD consumed large amounts of salt. Gaius Plinus Secundus (Pliny The 
Elder) estimated that an average of 25 g of salt was ingested daily from food as 
it was presented at the table. He also believed that salty foods made people 
slim, whereas sweet foods made them fat (4). Romans used salt as currency 
(“salary”) and considered it synonymous with health (“salus,” “salubritas”) and 
more necessary than gold (5) . The habit of adding salt to meals at the table was 
developed particularly during the Renaissance, when the salt cellar became both 
common usage and art object. For instance, a salt dispenser was presented to 
François I as a gift by Benvenuto Cellini in 1543 (Figure 1-1). It was suspected 
that the French king must have used it excessively because he died of apoplexy 4 
years after receiving the present, at the age of 52 years (5). 
In ancient medical science, salt is mentioned as an essential ingredient in some 
of the oldest medical scripts. The ancient Egyptian papyrus Smith, recommends 
salt for the treatment of an infected chest wound since it was believed that salt 
would dry out and disinfect the lesion. The healing methods of Hippocrates 
denote salt as a powerful expectorant ingredient; therefore mixture of water, 
salt and vinegar has been employed as emetic potion. Hippocrates also 
mentioned inhalation of steam from salt-water which was claimed to provide 
relief from respiratory symptoms. In addition, salt-based remedies have been 
widely prescribed in Greek medicine for various medical conditions such as 
eczema, psoriasis, mycosis, constipation, fever and even for accelerating 
childbirth (6). 
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Figure 1-1. Salt cellar made of gold, enamel, and ebony by Benvenuto Cellini (1500 to 1571) 
 
 
This was presented in 1543 as a gift to Francois I, King of France (1494 to 1547). From (5). 
 
 
Other than its therapeutic value, salt has also been extensively used in 
preservation. It was claimed that the Chinese were the first to discover that salt 
could be used to preserve foods (7).  Preservation was achieved by soaking meat 
in brine, allowing salt to permeate food making bacterial life impossible. Salt 
then became the substance of high economic value as it was possible to preserve 
foods during winter and allowed the development of settled communities. 
The economic value of salt is reflected by the fact that a lot of cities are named 
after salt: Salins in France, Salzburg in Austria, Salzkotten in Prussia, Saltdean in 
England and Saltcoats in Scotland. The ending of the word ‘wich’ also denotes 
that in the past salt had been produced in a saltern in this specific village. The 
Celtic syllable ‘hal’ (for salt) can be found in city names such as Hall/Tirol while 
the German word for salt which is ‘salz’ can also be found in village names such 
as Langensalza and Saltcotes (8). One of the oldest roads in Italy is the Via 
Salaria (Salt Route) over which Roman salt from Ostia was carried into other 
parts of Italy. In fact, cakes of salt were once deemed as highly valuable and had 
been used as money in Ethiopia and elsewhere in Africa and in Tibet (9). 
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During several millions years of evolution, human beings like all other mammals, 
consumed less than 0.25 g of salt per day (3). This was mainly the amount of salt 
naturally present in food to provide enough to regulate the amount of fluid in 
our bodies. Strong mechanisms for conserving salt within our bodies were then 
developed (7). These involved complex interactions of various systems in the 
human body with the kidney having a vital role. 
Human kidneys are programmed to conserve sodium and excrete potassium. 
Prehistoric humans, who consumed a sodium-poor and potassium-rich diet, were 
well served by this mechanism. A typical Palaeolithic diet contains 30 mmol of 
sodium per day so that human physiology evolved over millions of years in a low-
sodium, high potassium environment (Table 1-1). With such a diet, sodium 
excretion is almost negligible and potassium excretion is high, matching total 
potassium consumption. In contrast, today’s modern diet consists of highly 
salted processed foods, which makes the salt-conserving mechanism potentially 
dangerous. Modern humans are ill-equipped to handle the current exposure of 
high sodium diet. As a result, the kidneys fail to adapt with this new diet 
revolution leading to an excess of sodium particularly in hypertensive patients 
(10). 
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Table 1-1. Estimated diet of late Palaeolithic man compared with that of contemporary 
Americans. 
Nutrient Late Paleolithic diet 
(assuming 35% meat)
Current American diet
Protein (% of energy) 30 12
Carbohydrate (% of energy) 45-50 46
Fat (% of energy) 20-25 42
Polyunsaturated-saturated 
fat ratio
1.41 0.44
Fiber (g/d) 86 10 -20
Sodium (mg) 604 3400
Potassium (mg) 6970 2400
Potassium-sodium ratio 12 : 1 0.7 : 1
Calcium (mg) 1520 740
 
 
The essential element of salt as a preservative was no longer relevant with the 
invention of the refrigerator and the deep freezer. Cooling techniques have 
made it possible to gradually reduce the addition of salt to foods. This new 
means of preservation method started in the United States around 1925 and 
became popular in most European countries only after 1950 (11). Along with a 
decrease in consumption of potatoes, bread and cereals, salt intake and sales 
had been declining particularly as observed in Belgium, Switzerland and France. 
Nevertheless, with recent widespread inexpensive commercial access to salt, its 
intake is now increasing again. In developed countries, salt intake is usually 
between 9 to 12 g/day, with many Asian countries having mean intakes over 12 
g/day (12). These values are far greater than the current recommended 
maximum daily intake of salt. The current World Health Organization 
recommendations for adults are to reduce salt intake to 5 g/day or less, and the 
UK and US recommendations are 6 g/day or less (13). 
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1.2 Difference between salt and sodium 
The terms salt and sodium are often used synonymously, however, on a weight 
basis, salt comprises 40% of sodium and 60% chloride. The conversion of different 
units for sodium and salt is summarized in Table 1-2. 
Table 1-2. Equivalent amounts of sodium (in mg and mmol) and salt. 
 
Sodium (mg) Sodium (mmol) Salt (g) 
1200 51 3 
2000 87 5 
2400 104 6 
4000 174 10 
From (14). 
 
1.3 Salt consumption and its sources 
In developed countries up to 80% of salt comes from processed foods. 
Conversely, in Asia and other developing nations, most salt is added during 
cooking or contained in sauces and seasoning. Sodium is naturally present in 
small quantities in unprocessed foods, but is also commonly added to foods 
either during processing, cooking or at the table. The main purpose for addition 
of salt in food processing are for flavour, texture, preservation and to promote 
thirst, hence boost up beverages sales. 
In industrialized countries, most of the sodium ingested is added (as sodium 
chloride) during food production and foods eaten away from home. He and 
MacGregor (3) estimated that approximately 15% of the salt consumed was 
added either at the table or during cooking , 5% was naturally present in the 
foods, and the majority 80%, was added by the food industry in processed, 
canteen, restaurant, and takeaway foods. Table 1-3 lists the differences in salt 
content between processed and unprocessed varieties for selected common 
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foods; tinned salmon, for example, contains five times the sodium content of 
fresh steamed salmon, while smoked salmon contains 16 times as much. 
According to UK National Food Survey data collected in 2000 (15), cereal 
products (including bread, other baked goods and breakfast cereals) accounted 
for the greatest proportion (38%) of household sodium intake in United Kingdom. 
The second largest source (21%) was meat products (including processed meats 
such as ham, bacon, etc.) followed by soups, pickles, sauces, and table spread. 
Similar data are available for the USA (16). Bread, ready-to-eat cereal and 
cakes, dairy products, salad dressings, potato chips, and processed meats are 
the main contributors to dietary salt intake. With regard to restaurant foods, 
various dishes on their own contain over 2.3 g (100 mmol) of sodium, which is 
equivalent to the recommended daily Tolerable Upper Intake Level (UL) for the 
USA (17).  
A different picture with regard to dietary sources of sodium is apparent in some 
Asian countries. In China and Japan, a large proportion of sodium in the diet 
comes from sodium added in the cooking and from various sauces (17). Looking 
at the main sources of sodium in the diets of INTERMAP (18) participants from 
China and Japan, again the predominant source in China was salt added during 
cooking (78%). In Japan, the main sources were soy sauce, fish and other 
seafood, soups and vegetables (66% in total) with a further 10% being 
contributed by salt added during cooking. Some foods commonly consumed in 
Malaysia are also very high in sodium; for example a bowl of Mee curry and a 
bowl of Mee soup available from ‘Hawker’ markets contain about 2.5 g (109 
mmol) and 1.7 g (74 mmol) sodium respectively. Additionally, in many sub-
Saharan African countries, particularly in less urbanized settings, the main 
source of dietary sodium is predominantly from salt added to food for 
preservation, for taste and added in the cooking process (19). 
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Table 1-3. Comparison of sodium content between processed and unprocessed foods. 
 
 
From (12). 
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Figure 1-2. Comparison in sodium sources between United Kingdom and China based on 
INTERMAP data. 
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1.4 Physiology of sodium 
The physiological need for sodium is around 180-230 mg/day (20). A proper 
balance of sodium levels in every part of human body is of vital importance; the 
osmotic pressure of the extracellular fluids of our body is dictated for 90% by 
sodium-ions and their counter-ions, mainly chloride. A tight regulation of the 
sodium levels in our blood plasma and interstitial fluids is crucial for basic 
physiological functions of virtually all cells within a human body since a lot of 
transport processes are dependent on it. Slight deviations from these normal 
parameters can affect the electrical activity of muscle and nerve cells, renal 
function, capillary exchange, cardiac output, and therefore impact blood 
pressure in multiple ways (21).  
Neuronal and hormonal systems have therefore evolved to control salt intake 
behaviour and sodium excretion mechanisms. The hedonic value of salty taste 
and its regulation are an example of the neuronal, while aldosterone and the 
renin/angiotensin system are the most important elements of the hormonal 
mechanisms (Figure 1-3). Hence, it provides the reason why we generally prefer 
salt solutions resembling the extracellular levels in salt concentration, and that 
thirst and human appetite for salt are apparently modulated by physiological 
needs (22). A sodium-deprived state leads to a decreased salty taste response in 
human beings and a variety of animals (23). It is thought that this drives the 
behaviour towards preference of salt-containing food on one hand and protects 
us from ingestion of toxic sodium levels on the other hand. This appears to be 
controlled by mineralocorticoids (i.e. aldosterone) (24). In addition to this 
hormonal regulation there is evidence for an additional central nervous 
regulation (25). Salt craving, a common behaviour of many animals in need of 
sodium, has only incidentally been observed in humans suffering from extreme 
sodium loss (26). 
While these control mechanisms might have evolved to handle scarce sodium 
availability in our ancient diet, they are apparently insufficient to limit our salt 
intake to the physiological needs in today’s modern Western diets. In many 
industrialized countries sodium intake is between 3600–4800 mg/day (20) 
indicating that most people consume excess dietary salt than the amount that is 
required to remain in good physical health (27). Therefore in general the amount 
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of salt eaten in western countries is not driven by a physiological need, but 
rather by taste preference. 
Figure 1-3. Summary of the renin-angiotensin-aldosterone system 
 
 
 
Renin is directly secreted into circulation in response to volume contraction (decreased in 
renal perfusion). Renin cleaves angiotensinogen to angiotensin I which is converted by 
angiotensin-converting enzyme in the lungs to angiotensin II. Angiotensin II triggers various 
cascades leading to: decreased glomerular filtration rate (1), increased NaCl and water 
reabsorption by the proximal tubule and loop of Henle (2), and increased NaCl and water 
reabsorption by the distal tubule and collecting duct by aldosterone (3). ANP, atrial 
natriuretic peptide; BNP, brain natriuretic peptide; ADH, antidiuretic hormone. From (28). 
 
1.5 Sodium and blood pressure 
There are a lot of observational data which support a strong positive association 
between sodium intake and blood pressure within and between populations. 
Epidemiologic studies have shown that dietary sodium intake is directly related 
to cardiovascular mortality and to the increase in blood pressure with aging. 
Long term studies regarding salt intake and blood pressure have demonstrated 
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its adverse prognostic outcome in both hypertensive and normotensive 
populations. 
1.5.1 Epidemiological studies 
Prehistoric populations consuming a low-sodium diet, such as the Alaskan Eskimo 
or the Yanomamo Indians from the Amazon, have an almost negligible 
prevalence of hypertension and their blood pressure does not rise with age 
compared to all westernized, industrialized populations. The Yanomamo Indians, 
who excrete ≈ 1 mmol sodium per day, have an average blood pressure of 96/61 
mmHg. 
The absence of hypertension may be associated with other lifestyle variance, 
but primitive people living under similar environments who consume large 
quantities of sodium develop hypertension. Page et al (29) noted that among the 
prehistoric men of the Qash’qai tribe of Southern Iran, who ingested an average 
of 180 mmol of sodium per day, 18% were hypertensive. 
The INTERSALT study was one of the major global studies on sodium intake using 
standardized method for measuring blood pressure (BP) and 24-hour urinary 
sodium (30). It involved 10 079 individuals from 52 centres around the world, 
with the aim to study communities with a wide range of salt intake from 0.5 to 
25 g/day. Among all the communities recruited into the study, only four had a 
low salt intake (3 g per day or less) whereas the majority lay between 6 and 12 
g/day. None had the high salt intake as initially anticipated.  The results of the 
study revealed a significant positive association between 24-hour urinary sodium 
and BP. Reducing dietary salt intake by 5.8 g was associated with a 3.1 mmHg 
decrease in systolic blood pressure (31). There was also a highly significant 
positive relationship between dietary salt intake and the increase in blood 
pressure with age. The investigators estimated that an increase of 6 g/day in 
salt intake over 30 years would lead to an increase in systolic blood pressure by 
9 mmHg (30). 
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Figure 1-4. Relationship between salt intake and the slope of increase in systolic blood 
pressure with age in 52 centres in the INTERSALT study. 
 
 
From (30). 
 
More recent studies have confirmed these findings and provided more supportive 
evidence on the important role of dietary salt in determining the levels of blood 
pressure in the population. The INTERMAP study (International Study of macro 
and micro-nutrients and blood pressure) showed that a lower dietary salt intake 
and smaller sodium/potassium ratio resulted in lower population blood pressure 
(32). This cross-sectional epidemiologic study recruited 4680 men and women 
aged 40-59 years from 17 diverse population samples from China, Japan, UK and 
USA with the main objective to confirm influences of multiple nutrients on 
systolic and diastolic BP. All participants were assessed regarding blood pressure 
measurement (8 readings), individual intake of 76 nutrients from four 24-hour 
dietary recalls/person accompanied by 2 sets of 24-hour urine collection. The 
results revealed a highly significant positive association of sodium with both 
systolic and diastolic BP measurements. The estimates of association of sodium 
with systolic BP ranged from 0.8 to 3.0 mmHg/100 mmol, while diastolic BP 
corresponding estimates were 0.2 to 1.4 mmHg/100 mmol sodium. 
Another large study, EPIC-Norfolk (the Norfolk Cohort of the European 
Prospective Investigation into Cancer) also confirmed sodium to be an important 
determinant of population blood pressure level (33). This prospective study 
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included ≈25000 men and women aged 45–79 years, unselectively recruited from 
general practice age-sex registers in Norfolk, United Kingdom. Sodium intake 
was assessed based on casual urine specimens (all samples) and in a subset of 
patients, 7 days food diary and 24-hour urine collection were also requested. 
The results showed that systolic and diastolic blood pressure increased as the 
ratio of urinary sodium to creatinine increased, with differences of 7.2 mmHg for 
systolic blood pressure and 3.0 mmHg for diastolic blood pressure (P<0.0001) 
between the top and bottom quintiles. This trend was independent of age, body 
mass index, urinary potassium:creatinine, and smoking and was consistent by sex 
and history of hypertension. 
1.5.2 Migration studies 
Several studies have shown that migration from isolated low-salt societies to an 
urban environment with higher dietary salt intake was associated with an 
increase in blood pressure. In Kenya, a well-controlled migration study of a rural 
tribe (Luo migrants) revealed that upon migration to Nairobi, their sodium 
excretion increased from ≈ 60 to 110 mmol/day , potassium intake reduced, and 
their blood pressure rose significantly over a few months, compared with those 
in a similar control group who remained in the rural environment (34). After 2 
years of followed-up, mean systolic/diastolic BP of the migrants increased from 
117/53 mmHg to 126/66 mmHg in men, and 112/61 mmHg to 119/60 in women. 
In China, Yi farmers living in remote villages were compared against Yi migrants 
in the country (35). The Yi migrants consumed more sodium, less potassium and 
had a higher urinary sodium/potassium ratio. Urinary sodium excretion was 
found to be greater in Yi migrants than in Yi farmers (159.4 mmol/24 hour vs. 
73.9 mmol/24 hour, respectively), reflecting lifestyle changes including dietary 
alterations, resulting in significantly higher blood pressure among Yi migrants. 
Results from the multiple regression analysis revealed that an increase in sodium 
intake of 100 mmol/day corresponded to an increase of 2.3 mmHg systolic blood 
pressure and 1.8 mmHg diastolic pressure. Notably, there were very little 
increments of blood pressure with age among Yi farmers, whereas it increased 
with age in Yi migrants.  
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1.5.3 Population-based intervention studies 
There are a few studies which showed a reduction in population blood pressure 
following a successful restriction of dietary salt intake in a population.  Forte et 
al (36) conducted an intervention study in two similar villages in Portugal. An 
intensive health education concerning salt reduction was introduced, 
emphasizing on avoidance of foods that had previously been identified as the 
major sources of salt in the intervention village. A very substantial 50% reduction 
in salt intake was achieved in the intervention community, resulted in a 
difference of 13/6 mmHg in systolic /diastolic blood pressure after 2 years. A 
recent randomized community-based intervention trial in 2 rural villages in 
north-eastern Japan demonstrated that dietary counselling for one year 
effectively reduced salt intake by 2.3 g/day as measured by 24-hour urinary 
sodium (37). This reduction was accompanied with a decrease of 3.1 mmHg in 
systolic blood pressure.  
Similar studies from developing countries are few; however, in one of the first 
salt reduction trials in Africa, a community-based cluster randomized trial in 
Ghana involving 1013 participants discovered that at 6 months, the intervention 
group achieved a 2.5/3.9 mmHg reduction in systolic/diastolic blood pressure 
(38). A recent community based sodium reduction trial in Pakistan revealed a 
significant 6 mmHg reduction in systolic measurement among participants with 
high normal blood pressure (39).  
1.5.4 Intervention studies 
These observational findings were further supported by various trials of sodium 
reduction in normotensive and hypertensive individuals. Table 1-4 provides a 
summary of results from meta-analyses regarding sodium restriction and blood 
pressure reduction. An overview of 40 trials of sodium reduction confirmed a 
direct relation with BP and found an average decrease in systolic/diastolic 
pressures of 5.2/3.7mmHg and 1.3/1.1mmHg among hypertensive and 
normotensives subjects, respectively (40). A Cochrane review then restricted the 
analysis to studies lasting more than 4 weeks with a modest reduction in urinary 
sodium of at least 40 mmol. The results revealed blood pressure reductions of 
5.0/2.7mmHg (systolic/diastolic) for hypertensives and 2.0/1.0 mmHg among 
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normotensive participants (41). A dose–response relation was established, with a 
fall in BP of 7.1/3.9mmHg among hypertensive and 3.6/1.7mmHg among 
normotensive participants for every 100 mmol reduction in urinary sodium. In 
another meta-analyses, Hooper et. al. (42) restricted trials which lasted 6 
months or longer, including a few trials up to 5 years. In these relatively few 
trials, the degree of sustained sodium reduction was less, hence leading to a 
non-significant degree of blood pressure reduction.  
Table 1-4. Meta-analyses of trials of dietary sodium reduction 
 
Reference No. of 
trials
Duration Reduction in 
24-hour 
sodium 
excretion
Reduction in blood pressure
Normotensive
SBP/DBP
Hypertensive
SBP/DBP
Geleijnse et al., 
2003
40 >2 weeks -77 mmol -1.3/-1.1 -5.2/-3.7
He & MacGregor,
2003
26 >4 weeks -78 mmol -2.0/-1.0 -5.0/-2.7
Hooper et al., 
2002
7 6-12 months -49 mmol -2.5/-1.2
4 13-60 months -35 mmol -1.1/-0.6
 
SBP = systolic blood pressure, DBP = diastolic 
 
The Dietary Approaches to Stop Hypertension (DASH)-Sodium study provides the 
most robust evidence of the short term effects on BP of a well maintained low-
sodium diet (43). Three different levels of salt intake (8, 6 and 4 g/day) were 
studied based on two different diets; the normal American diet and the DASH 
diet, which is rich in fruits, vegetables, and low-fat dairy products (Figure 1-5).  
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Figure 1-5. Food pyramid representing various food groups and portion sizes included in 
DASH diet. 
 
 
 
Both type of diet and sodium reduction were found to be effective in lowering 
BP (Figure 1-6). Comparing the high with low sodium groups, the differences in 
systolic BP were 6.7mmHg among those on the control diet and 3.0mmHg among 
those on the DASH diet, with stronger effects among hypertensive participants. 
The corresponding differences in diastolic BP were 3.5 and 1.6 mmHg 
respectively. Subsequent analyses found that the effect of sodium reduction 
remained among all subgroups defined by demographic characteristics and 
baseline measures including age, body mass index (BMI) and urinary sodium 
excretion (44). Remarkably, sodium reduction was also reported to reduce BP in 
non-hypertensive on both diets though to a lesser degree compared to the 
hypertensive subjects.  
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Figure 1-6. Changes in blood pressure and 24-h urinary sodium excretion with the reduction 
in salt intake in all participants on the normal American diet vs. DASH diet. 
 
 
 
From (45). 
 
There were four long term, well controlled preventive trials which examined the 
effects of combined lifestyle modifications including sodium reduction in 
lowering blood pressure. These trials involved subjects with high-normal blood 
pressure and lasted for at least 1 year of duration. In the Hypertension 
Prevention Trial which randomized healthy men and women aged 25 to 49 years 
to one of four lifestyle interventions, the sodium reduction group achieved a 13% 
decrease in sodium excretion at 6 months and a mean decrease of 1.7mmHg in 
systolic BP (46;46;47;47). Results, however, were not sustained at 3 years. 
Evidence from outcomes trials revealed that a reduction in salt intake results in 
a decrease in cardiovascular disease. A follow-up study of individuals who took 
part in two large randomized salt reduction trials, Trial of hypertension 
prevention (TOHP) I (48)and II (49), has shown a significant effect of dietary salt 
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reduction in relation to cardiovascular disease. More than 3000 participants with 
an average baseline blood pressure of 127/85 mmHg were randomized to a 
reduced-salt group or to a control group.  
In the Trials of Hypertension Prevention (TOHP) Phase I, those randomized to the 
sodium reduction group had lowered their average sodium excretion by 44 
mmol/day resulting in an average decrease of 1.7/0.9mmHg in systolic/diastolic 
BP at 18 months. Subsequently in TOHP Phase II, at 36 months the average 
reduction in sodium was 40 mmol/day, and a significant reduction of 1.2mmHg 
in systolic BP was maintained, along with an 18% reduction in the incidence of 
hypertension. No further advice was offered to the participants after the trials 
were completed. A follow-study at 10-15 years post trial revealed that subjects 
who were originally allocated to the reduced-salt group had a 25% reduction in 
the risk of developing cardiovascular events after adjusting for confounding 
factors. 
The Trial of Nonpharmacologic Interventions in the Elderly (TONE) (50) recruited 
975 men and women aged 60 to 80 years whose hypertension was controlled with 
single antihypertensive drug. Subjects were randomized to weight loss, sodium 
reduction, both interventions or usual care with attempted withdrawal from 
medication. Over the following 30 months, the proportion of patients who 
remained normotensive and drug-free was only 16% in the usual-care group, 
more than 35% in those on one of the two interventions, and 43.6% in those who 
received both interventions. The primary endpoint of hypertension or 
cardiovascular event was also reduced by 32% in the sodium reduction group.  
 
1.6 Dietary sodium restriction as adjunctive therapy of 
hypertension 
Idiopathic, or essential hypertension accounts for more than 95% of cases and 
appears to be caused by a complex interaction between genetic predisposition 
and environmental factors (51). Its pathophysiology is complex, with much 
remaining to be discovered (Figure 1-7). Lifestyle changes including dietary 
modification are recommended by current guidelines as initial treatment for  
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Figure 1-7. Mechanisms linked to increases in blood pressure and the therapeutic effects of 
healthy dietary patterns, sodium reduction, and weight loss. 
 
 
From (52). 
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most hypertensive patients. The triads of dietary treatment of hypertension – a 
healthy dietary pattern (by consuming more fresh fruits and vegetables), 
reduced sodium intake, and reduced body fat – influence the pathophysiology of 
hypertension at many of its points of control.  
Dietary sodium restriction is widely accepted by both the scientific community 
and the general public as a mode of primary prevention for hypertension and an 
effective treatment of established hypertension. For example, patients with 
prehypertension (SBP between 120 and 139 mmHg or DBP between 80 and 89 
mmHg) should adopt healthy lifestyle changes (including sodium reduction), 
given the benefit of dietary therapy at these BP levels (53). Even though drug 
therapy plays an essential role in treating hypertension, they should not be used 
as a substitute against dietary management. Rather, the two forms of treatment 
should be considered complementary (52). 
In a meta-analysis of clinical trials Cutler et al (54) reported a dose-response 
relationship between sodium reduction and BP, such that for every 100 
mmol/day decrease in sodium, BP decreased 5.8/2.5 mmHg in hypertensive 
patients and 2.3/1.4 mmHg in those without hypertension. In the DASH-sodium 
trial, as discussed in great details in Section 1.5.4, it has been shown that 
reducing dietary sodium intake resulted in a significant incremental reduction in 
both systolic and diastolic blood pressure in both groups assigned to either DASH 
diet or control diet. It is also interesting to note that sodium reduction was also 
reported to reduce BP in non-hypertensive on both diets though to a lesser 
degree compared to the hypertensive subjects. 
Patients with resistant hypertension in particular might benefit the most from 
dietary sodium restriction. This is supported by Pimenta et. al. (55) in a study 
looking at the impact of salt reduction in patients treated for resistant 
hypertension. The investigators recruited consecutive patients with resistant 
hypertension where twelve patients with systolic blood pressure (SBP) greater 
than 140 mmHg or diastolic blood pressure (DBP) greater than 90mmHg despite 
the use of at least three antihypertensive medications, completed the study. At 
enrolment, they were receiving an average of 3.4 medications, including at least 
25mg of hydrochlorothiazide (HCTZ) (or equivalent diuretic), with an 
angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker 
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(ARB) medication. The average manually recorded office BP was 145.8±10.8 
/83.9±11.2 mmHg at baseline. Patients were randomized to 1-week treatment 
periods of a low Na (50mmol/day) diet formulated and provided by a research 
kitchen, or the same diet with the addition of 6 g/day NaCl tablets 
(250mmol/day of Na). Compliance to the diets was assessed using 24 hour 
urinary Na measurements. All medications were continued throughout the study. 
On the high-salt diet, office blood pressure averaged 145.6±15.1/84.0±12.1 
mmHg, whereas on the low-salt diet, it was 122.8±14.0/74.9±12.5mmHg, for an 
average reduction in blood pressure of 22.7/9.1. Consistent results were seen 
across daytime, night-time, and average ambulatory blood pressure values. The 
authors claimed that this study was the first to examine the impact of aggressive 
salt restriction in patients identified as resistant to medication, and highlighted 
the effectiveness of aggressive salt restriction in these patients’ population.  
1.7 Factors influencing salt intake 
Individual salt intake varies depending on various factors such as inheritance, 
behaviour and environment (56). 
1.7.1 Genetics 
Genetic endowment plays an important role in determining salt intake. It is 
generally accepted that several genes may contribute to the blood pressure 
levels which reflects a complex network of gene-gene and gene-environment 
interactions. However, in some individuals defects in a single gene cause marked 
abnormalities of blood pressure regulation. Genetic studies of these rare 
Mendelian forms of high and low blood pressure have shown an underlying 
common pathway: the kidney’s ability to excrete or retain sodium (57). The 
monogenic causes of high blood pressure reduce the kidney’s ability to excrete 
sodium and cause high blood pressure when salt is consumed. The monogenic 
causes of low blood pressure result in the kidney being unable to retain sodium, 
thereby causing low blood pressure. In Gitelman’s syndrome for example, loss of 
function mutations of the gene (SLC12A3 gene) encoding sodium-chloride 
cotransport results in a defect in the ability to conserve sodium (58). Those 
whom are affected, either heterozygotes or homozygotes, will have a higher 
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than normal dietary salt intake without being aware of their heightened salt 
appetite. Despite this, blood pressure remains low-normal in these individuals. 
1.7.2 Environment 
Early exposure to sodium intake may have a lasting impact. This is supported in 
a recent study by Stein et. al. (59) who investigated the relationship between 
early sodium exposure and the development of salty taste acceptance. In the 
study, 61 infants were tested at 2 and 6 months old to assess their response to 
0.17 and 0.34 mol NaCl/L in water. Acceptance, calculated as solution intake 
relative to water, was examined as a function of exposure to starchy table 
food—a significant source of sodium. As a control, similar comparisons were 
based on exposure to fruit table food. A subset of 26 subjects returned at 36–48 
months for assessment of salty taste hedonics and preference. Results from the 
study showed that dietary experience was related to salt acceptance, with only 
those infants previously exposed to starchy table foods preferring the salty 
solutions at 6 months old (P = 0.007). Fruit exposure was not associated with 
sodium chloride acceptance. Infants eating starchy table foods at 6 months old 
were more likely to lick salt from the surface of foods at preschool age and were 
more likely to eat plain salt. This study not only suggested an influential role of 
early dietary experience in shaping salty taste responses of infants and young 
children, but also demonstrated that a liking for salt is not intrinsic but rather 
acquired throughout life via exposure to salty foods. 
Much of the increased consumption of convenience foods can also be attributed 
to the ‘de-skilling’ and the ‘de-domestication’ of consumers today. The majority 
of women nowadays work, whilst maintaining the bulk of responsibilities for 
home and family life (60). Therefore there is less time for food preparation and 
family meals. With less time for food preparation, limited cooking skills, and 
diversity in dietary preferences, control over what one eats is diminished and 
somewhat manipulated by the growing power of the retailer, irrespective of the 
high cost of convenience foods. Consequently, home-cooked meals are being 
substituted with convenience foods, such as ready meals which mostly have high 
salt content (61). 
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1.7.3 Behaviour 
There appears to be a high correlation between caloric intake and salt intake, 
mainly due to the fact that most salt is consumed in foods. Thus, people with 
high-energy consumptions presumably have a higher salt intake. Moreover, since 
energy intake (and therefore sodium intake) is likely to reflect energy 
expenditure, individuals who are physically active (e.g. athletes) or those who 
exercise vigorously tend to consume more salt than their sedentary 
counterparts.  
1.7.4 Cultural and ethnic influences 
Due to increased travel and emigration, ethnic influences are now widely 
reflected in consumer’s diet. This is most apparent from the variety of ethnic 
style ready meals currently available. However, the growth and popularity of 
ethnic style ready meals is of considerable concern, given that these products 
are often heavily loaded with salt (62). For example, a recent survey by 
Consensus Action on Salt and Health (CASH) revealed that a leading supermarket 
brand of Indian Chicken Tikka Masala and Pilau Rice contained 5.0g salt per 
portion (63), which is equivalent to the maximum recommended amount of daily 
salt intake as suggested by WHO. 
1.8 Controversies 
Controversies exist surrounding the value of such moderate sodium reduction. 
Advocates insist that the recommendation is justified because sodium reduction 
has been proven to lower blood pressure, hence preventing stroke and 
myocardial infarction. Sceptics argue that modification of this surrogate end 
point does not guarantee a health benefit amid the possibilities of causing harms 
that outweigh its benefits. The alleged hazards associated with sodium reduction 
include the following:  
1.8.1 An increase in myocardial infarction  
Alderman et. al. (64) conducted a cohort investigating the relationship of sodium 
intake to subsequent cardiovascular disease over an average of 3.8 year follow-
up. The 24-hour urinary excretion of electrolytes and plasma renin activity were 
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measured in 2937 hypertensive subjects. The results revealed a 4-fold increase 
in myocardial infarctions in treated hypertensive men with the lowest urinary 
sodium excretion, averaging 65 mmol/day. The investigators however, did not 
find any association for myocardial infarction in women or for stroke in either 
sex. These data have been criticized due to the small number of events, only 46 
out of 1900 men, 22 of which occurring in the 483 in the lowest quartile of 
urinary sodium excretion. Blood pressure measurement appeared to be highest 
in the men in the lowest quintile of sodium intake, possibly reflecting that these 
population represents patients with difficult to control hypertension. The results 
were based only on a single 24-h urine sample and no attempt was made to 
ascertain long term sodium intake. The likely presence of multiple confounding 
factors such as unreported alcohol use and lack of detail information regarding 
the smoking status have also been suggested (65). 
1.8.2 An increase in mortality  
A recent study by Stolarz-Skrzypek et. al (66) claimed that ‘lower sodium 
excretion was associated with higher cardiovascular disease (CVD) mortality’. 
The study which included 3681 subjects without CVD, was conducted to assess 
blood pressure and health outcomes (incidence of mortality and morbidity) 
based on 24-hour urinary sodium excretion. Participants were followed up for an 
average of 7.9 years. The results showed that systolic blood pressure positively 
correlated with 24-hour urinary sodium excretion. Conversely, lower sodium 
excretion predicted higher cardiovascular disease mortality. The investigators 
concluded that the findings from this study ‘did not support the current 
recommendations of a generalized and indiscriminate reduction of salt intake at 
the population level’.  
This study sparked controversies as some media have misleadingly reported that 
these results proved low-salt diet to be ineffective. Advocates on salt restriction 
criticised the study as being small, with low event rates and relatively young 
participants (mean age was 40 years old) (67). Other criticisms of the study 
include unreliable measurement of sodium intake, failure to account for key 
factors that influence sodium intake and heart disease risk (such as differences 
in height, physical activity, and total calories consumption), and missing or 
incomplete urine data from large numbers of participants (68). 
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Taylor et. al. (69) reported a meta-analysis of randomised trials with follow-up 
for at least 6 months on the effect of reducing dietary salt on total mortality and 
cardiovascular mortality and events. The authors investigated seven randomized 
controlled trials, and found that sodium reduction lead to a decrease in urinary 
salt excretion but no evidence of cardiovascular benefit. The investigators 
reported that the relative risks (RRs) for all-cause mortality in normotensives 
(RR: 0.90, 95% confidence interval (CI): 0.58 – 1.40) and hypertensives (RR: 0.96, 
CI: 0.83 – 1.11) showed no strong evidence of any effect of salt reduction. In 
addition, they also suggested that salt restriction increased the risk of all-cause 
mortality in patients with heart failure (RR: 2.59, CI: 1.04 – 6.44). The 
conclusion of the study in plain language, as being disputed by He et. al. (70), 
was ‘cutting down on the amount of salt has no clear benefits in terms of 
likelihood of dying or experiencing cardiovascular disease’. 
The review has been criticised mainly due to small number of studies were 
included (7 studies), and none of them were specifically designed to investigate 
the effects of sodium reduction interventions on cardiovascular events and 
mortality (71). In addition, one of these trials involved a heart failure study, for 
which according to He & MacGregor (70), should have been excluded because 
the participants were severely salt and water depleted due to aggressive 
diuretics therapy, and that salt restriction in these patients were likely to result 
in unfavourable outcomes. He et. al. (70) also suggested that the data should be 
analysed by combining the data for hypertensives and normotensives together 
(instead of separate analysis done by the investigators). By doing so, a 
significant reduction in cardiovascular events by 20% (p<0.05) and a non-
significant reduction in all-cause mortality (5-7%) were demonstrated. 
In other studies involving representative sample of 20,729 U.S. adults surveyed 
in the National Health and Nutrition Examination Surveys (NHANES) I, II and III, 
the data revealed an increased in all-cause mortality as the level of sodium 
intake is reduced (72-74). These data, based on a single-day dietary recall, 
showed increased all-cause mortality in the lower the sodium intake in a 
representative sample of 20,729 U.S. adults. These data also have been 
questioned mainly for the weakness of the measure of sodium intake, resulting 
in a level so low (30 mmol per day) which seemed impossible to achieve in a free 
living population; the presence of known and (likely) unknown confounding 
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factors; and the inability to ascertain long-time sodium intake (75;76). 
Moreover, when these same data were looked at separately for the 6,797 non-
obese  and the 2,688 obese subjects, highly significant direct association 
between increased sodium intake and stroke, coronary  heart disease, and 
cardiovascular and all-cause mortality were found among the obese subjects 
(77). 
1.8.3 Potentially harmful disturbances in various hormonal, lipid, 
and physiologic responses  
Graudal and colleagues have performed a study in collaboration with the Nordic 
Cochrane Centre to estimate the effects of low versus high sodium intake on 
blood pressure, renin, aldosterone, catecholamines, and lipids (78). One 
hundred and sixty seven studies were included. The effects on blood pressure on 
low sodium intake were found to be heterogeneous: in normotensive Caucasians 
blood pressure fell 1.3/0.05 mmHg, in blacks 4/2 mmHg, and Asians 1.3/1.7 
mmHg. The fall in systolic pressure in blacks was significant. In hypertensives, 
the falls were more impressive: Caucasians 5.5/2.8 mmHg, Blacks 6.4/2.4 mmHg 
and Asians 10.2/2.6 mmHg. On the contrary, there were predictable rises in 
plasma renin, aldosterone, catecholamines, and lipids. 
This review has been criticised as the investigators failed to highlight the fact 
that there was no significant increase in cholesterol or LDL cholesterol in those 
studies which lasted four or more weeks. Studies which showed significant 
increases in cholesterol were acute and short term studies which are of no 
relevance to the proposed gradual long term reduction in dietary salt intake. In 
addition, the review in fact supports the wealth of evidence that reducing 
dietary salt intake will result in significant reduction in blood pressure across all 
ethnic groups, which would be greatly beneficial in preventing strokes and other 
cardiovascular complications (79). In addition Kaplan (80) argued that these kind 
of disruptions have usually been noted only when sodium intake has been 
severely restricted (to as low as 10 mmol/day) over short intervals.  
1.8.4 Salt restriction and iodine deficiency 
Tayie et. al. (81) conducted a study to evaluate the association between dietary 
salt intake restriction and iodine deficiency among adults in the United States. 
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The study included 996 men and 960 women from the 2001-2004 waves of the 
National Health and Nutrition Examination Surveys (NHANES). The study revealed 
that 24.96% of men and 40.42% of women were iodine deficient. Compared 
against women who did not restricted salt intake, women who were restricting 
dietary salt were found to have significantly lower urinary iodine concentration 
(p=0.01), and were more likely to be iodine deficient (adjusted odds ratio = 
1.79, p=0.03). 
In a more recent study, Vanderpump et al (82) conducted a cross-sectional 
survey with the aim of assessing current iodine status in 810 schoolgirls aged 14–
15 years attending secondary school in nine UK centres. Urinary iodine 
concentrations and tap water iodine concentrations were measured in June–July, 
2009, and November–December, 2009. Results from the study showed that 
urinary iodine measurements indicative of mild iodine deficiency were present in 
51% (n=379) of participants, moderate deficiency in 16% (n=120), and severe 
deficiency in 1% (n=8). The investigators concluded that these findings have 
great public health importance for the UK since the results indicated that a lot 
of teenage girls in the country were iodine deficient. It was suggested that more 
iodine should be given to the UK population in the form of iodinised salt. 
Although it is undeniable that iodine deficiency is a potentially serious problem, 
the recommendation to iodinise salt presents a conflict in public health issues, 
especially when it is in contrary with the UK’s salt reduction strategy. MacGregor 
(83) suggested that alternative options, such as iodinisation of bread, flour or 
cereals, should be considered as this method has been successfully implemented 
in other countries such as Australia and New Zealand. If iodine must be added to 
salt, it was recommended that all sources of salt should be iodinised in a 
quantity that allows salt intake to be reduced to less than 5-6g per day, as per 
current recommended guideline by UK Food Standard Agency. 
1.9 Proposed mechanisms of salt-induced hypertension 
Dietary salt intake is one of the major regulators of blood pressure. The exact 
mechanisms whereby salt raises blood pressure are not fully understood. The 
existing concepts focus on the tendency for an increase in extracellular fluid 
volume (84). Vliet BV and Montani (85) proposed that salt affects blood pressure 
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in at least two separate ways. One being a relatively acute effect involving days 
or weeks and the other occurring over a much longer period of time, including 
decades in humans. Alternatively, Roberts (7) suggested that the rise in pressure 
in essential hypertension depends on the magnitude of the excess salt intake, 
the type of severity and combination of intrinsic renal abnormalities which 
impair the kidney’s ability to excrete salt, and the duration of existence of these 
abnormalities.  
1.9.1 Role of the kidneys 
The most compelling evidence for the role of the kidney in the pathogenesis of 
hypertension comes from cross transplantation studies between normotensive 
and hypertensive strains of rats. Dahl et. al. (86;87) demonstrated that in young 
bilaterally nephrectomised spontaneously hypertensive rat, a kidney transplant 
from a normotensive rat resulted in no blood pressure increments of the 
hypertensive rats. Conversely, when a kidney from a young hypertensive rat 
(before developing hypertension) was transplanted into a bilaterally 
nephrectomised normotensive rat, the BP of the normotensive rat rose. In 
human, the high blood pressure measurements of patients with essential 
hypertension who developed kidney failure became normal after bilateral 
nephrectomy and transplantation with a kidney from a normotensive donor (88). 
Over a mean follow-up of 4.5 years, mean arterial blood pressure readings in 
these patients were reduced from 168±9 mmHg (before transplant) to 92±1.9 
mmHg (P≤0.001). These findings evidently demonstrate that regardless of any 
functional abnormalities occurring at different sites, renal dysfunction is the 
primary disturbance that initiates the rise in blood pressure. 
1.9.2 Role of extracellular volume 
The traditional concepts regarding the mechanisms for salt-induced hypertension 
involved the impairment of the kidney’s ability to excrete sodium causing 
sodium and water retention. Having a high salt intake therefore can contribute 
to volume expansion and stimulation of various compensatory mechanisms. The 
persistent occurrence of the compensatory mechanisms eventually causes BP to 
rise which in turn assists the kidneys to overcome the difficulties in excreting 
sodium. Based on animal studies, Guyton (89) showed that in 70% 
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nephrectomised dogs given large amounts of saline solution intravenously daily 
for 2 weeks, volume expansion raises BP by the autoregulatory effect on 
resistance vessels. 
1.9.3 Direct role of plasma sodium 
Presently, there is increasing evidence showing dietary salt intake triggers small 
changes in plasma sodium, hence results in changes of blood pressure. A number 
of studies have shown that an alteration in salt intake (either increase or 
decrease) causes parallel changes in plasma sodium in both hypertensive and 
normotensive individuals. For example, when salt intake was reduced from 20 to 
1 g/day for 5 days, plasma sodium decreased by approximately 3 mmol/L (p < 
0.001). In a well-controlled double-blind trial of 1 month, plasma sodium was 
reduced by 0.4 mmol/L (P < 0.05) when salt intake was decreased from 
approximately 10 to 5 g/day in 118 hypertensive. The decrease in plasma sodium 
was weakly but significantly correlated with the fall in systolic BP (84).  
Several epidemiological studies have shown a significant positive association 
between plasma sodium and blood pressure. In a study of 3578 London civil 
servants, a 1 mmol/L increase in plasma sodium was associated with a 1 mmHg 
increase in systolic BP after adjusting for confounding factors (90). In another 
study of a Japanese population (3222 normotensive subjects and 741 patients 
with essential hypertension), serum sodium distribution was shifted by 
approximately 2 mmol/L toward higher values in the hypertensive subjects (91). 
Nevertheless, the Framingham Heart Study showed that serum sodium was not 
associated with BP, with the development of hypertension during 4 years of 
follow-up (92). 
Plasma sodium is a major determinant of extracellular volume, thereby, 
influencing BP. At the same time, small changes in plasma sodium may have a 
direct effect on BP, independent of extracellular volume (93). Using peritoneal 
dialysis in rats, Friedman et. al. (94) were able to change plasma sodium in an 
opposite direction to extracellular volume by altering sodium concentration of 
the dialysis fluid. When plasma sodium was increased by 10 to 15 mmol/L, there 
was a rapid increase in BP despite a reduction in extracellular volume. When 
plasma sodium was decreased, there was a fall in BP despite an increase in 
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extracellular volume. The changes in BP were directly related to the changes of 
intracellular sodium. Friedman et. al. (94) suggested that increases in 
intracellular sodium may affect vascular smooth muscle tension and thereby BP. 
There is also evidence to suggest that small changes in plasma sodium may 
directly affect the hypothalamus' control of BP through the local renin-
angiotensin system (93). 
Tissue culture experiments demonstrated that increasing bath sodium 
concentration within the physiologic range caused marked cellular hypertrophy 
in both arterial smooth muscle and cardiac myocytes (95). In cultured bovine 
endothelial cells, when bath sodium concentration was increased from 137 to 
142 mmol/L, endothelial nitric oxide synthase (eNOS) activity was reduced by 
25%. The decrease in eNOS activity was in a sodium concentration dependent 
manner within the range studied (137-157 mmol/L) (96). Using cultured human 
endothelial cells, Oberleithner et. al. (97) demonstrated that an increase in the 
sodium concentration of the culture medium from 135 to 145 mmol/L stiffened 
endothelium and reduced nitric oxide release.  
Recent studies in humans confirmed that salt intake does affect endothelial 
function. A randomized trial in 29 overweight and obese normotensive 
individuals showed that, when salt intake was reduced from 9.2 to 3.8 g/day for 
2 weeks, there was a significant improvement in endothelial function as 
measured by brachial artery flow-mediated dilatation (98). A study in healthy 
volunteers showed that an increase in salt intake was associated with a blunted 
endothelial response to acetylcholine (99). 
1.10 Salt-sensitivity and salt-resistance 
The term salt-sensitivity was used to classify individuals in whom the percentage 
of change or absolute difference in blood pressures between salt-restricted and 
salt-loaded states reached an arbitrary high level. In humans, the response of 
the blood pressure to an acute change in salt intake, or a diuretic, has been 
used to determine salt-sensitivity. Conversely, individuals in whom a severe 
abrupt change in salt intake or excretion causes the least change in arterial 
pressure are termed salt-resistant (100). Salt-sensitivity of blood pressure may 
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be inherited or acquired – in utero, during early postnatal life, or during adult 
life as a result of a low-potassium diet or uncontrolled hypertension.  
The ‘developmental origins of adult disease’ hypothesis, often called the ‘Barker 
hypothesis’ after one of its leading proponents, states that adverse influences 
early in development, and particularly during intrauterine life, can result in 
permanent changes in physiology and metabolism, which result in increased 
disease risk in adulthood (101;102). The majority of the studies in children, 
adolescents and adults included in a recent, extensive review on this topic 
reported that blood pressure fell with increasing birth weight, the size of the 
effect being approximately 2 mm Hg/kg (103). Skeletal and non-skeletal 
postnatal catch-up growth were positively associated with blood pressure, with 
the highest blood pressures occurring in individuals of low birth weight but high 
rates of growth subsequently (103). The underlying mechanisms that lead to 
these phenomena are still unclear and widely debated. When nutritional 
deficiency occurs in utero at a critical period of development, the resulting 
adaptive changes may be permanent and may lead to long-term changes in 
structure and function (104). Birth weight is also associated with salt sensitivity 
of blood pressure, and this may play a role in the maintenance of elevated blood 
pressure in individuals with a low birth weight (105). Simonetti et. al. reported 
that renal mass is reduced in children born with low birth weight and depends on 
the degree of in utero growth retardation, which then determines lower 
glomerular filtration rate, increased salt sensitivity, and elevated blood pressure 
(106). 
Several methods were used to determine salt-sensitivity, including the salt-
sensitivity index (the ratio of change in mean blood pressure to change in sodium 
excretion during a salt load) proposed by Kimura and Brenner (107) and the 
variability adjusted blood pressure change (difference in blood pressures in study 
periods divided by intraperson standard deviation (SD) of the average of 3 blood 
pressure measurements) described by Flack et al (108). The most accepted 
method to determine salt-sensitivity was introduced by Weinberger et. al.(109) 
as shown in Figure 1-8. 
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Figure 1-8. Proportion of salt sensitive and salt-resistant individuals. 
 
 
Data from Weinberger, who compared blood pressure after infusion of 2L of saline solution 
over 4 hours with blood pressure after salt depletion induced with a salt-restricted (sodium, 
10 mmol/day) diet plus three 40-mg doses of oral furosemide. A difference in mean blood 
pressure between salt loaded and salt-depleted phases of 10 mmHg or greater is defined as 
salt-sensitivity. A blood pressure difference of 5 mmHg or less is defined as salt resistance. 
 
Weinberger et al. (109) defined sodium sensitivity as a 10 mmHg, or greater, fall 
in mean blood pressure from the level recorded after a 4-h infusion of 2 litres 
saline, compared with the level measured after 1 day on a 10 mmol/day sodium 
diet, during which three oral doses of furosemide are given. Those with a 
decrease of 5 mmHg or less (including an increase in pressure) were considered 
sodium-resistant. Subjects with a decrease in BP between 6 and 9 mmHg were 
classified as indeterminate. The responses of the BP were heterogeneous and 
formed a Gaussian distribution in both normotensive and hypertensive groups. It 
was found that 26% of the normotensive subjects were salt-sensitive and 58% 
salt-resistant, whereas in the hypertensive group, 51% were sensitive and 33% 
were resistant. Blacks have been shown consistently to have a greater frequency 
of salt-sensitivity than whites (110). 
Weinberger observed that 73% of black hypertensive patients were salt-sensitive, 
compared with 56% of a white hypertensive group. However, in the normotensive 
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population, the frequency of salt-sensitivity among blacks (36%) was similar to 
that seen among whites (29%). Plasma renin activity (low, normal, high) did not 
predict the sodium response. In both groups, the sodium-sensitive individuals 
were significantly older and had lower baselines of renin values than sodium 
resistant subjects. Subpopulations with increased frequencies of salt-sensitivity 
have been shown to be associated with high-BP, higher age, and African- 
American ethnicity. 
Familial resemblance to acute and chronic salt challenges has been reported, 
but the genetic basis of salt-sensitivity, which is likely to be related to the 
genetics of hypertension, remains poorly known (111). For example, in 44 
families of identical twin children who participated in a sodium restriction 
protocol (less than or equal to 4.3 g/day salt for a period of 12 weeks), mother-
offspring resemblance in blood pressure change with sodium restriction was 
significant both for systolic (r = 0.31, p < 0.001) and diastolic (r = 0.20, p < 0.05) 
pressure (112). Sibling-sibling and twin-twin resemblance was also highly 
significant, thus demonstrating significant familial resemblance in blood pressure 
change with sodium restriction in normotensive persons. 
Multiple mechanisms for sodium sensitivity have been proposed such as a defect 
in renal sodium excretion manifested by renal vasoconstriction, increased 
activity of the sodium-hydrogen exchanger in the proximal tubule, impaired 
natriuretic response to 20-hydroxyeicosatetraeonic acid (20-HETE), a higher 
level of sympathetic nervous system activity, and endothelial dysfunction 
related to a decreased nitric oxide response to sodium loads (113). Various 
numbers of proposed mechanisms for salt-sensitivity highlight the uncertainty 
regarding which exact mechanisms are involved. Regardless of how it occurs, 
greater sodium sensitivity is positively associated with a higher incidence of 
cardiovascular events and mortality (80).  
1.11 Importance of Pressure-Natriuresis 
The domination of the kidneys in the regulation of blood pressure has been 
confirmed by the experimental and conceptual work developed by Guyton (89) 
on the pressure natriuresis and diuresis response. Guyton proposed the 
phenomenon known as pressure-natriuresis, which suggested that when blood 
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pressure rises, renal excretion of sodium and water increases, reducing fluid 
volume and returning the blood pressure to normal. Conversely, when the 
pressure falls below normal, the incoming salt and water overbalance the 
excreted fluid, and the pressure rises. Several systems have been identified 
responsible in regulating blood pressure, which largely differ regarding time 
once the pressure becomes abnormal (80). Some systems based on neural 
receptors react within seconds while others such as the hormonal systems 
respond within minutes. Nevertheless, the system which plays a huge and vital 
role is the kidney-fluid volume system, which reacts within hours or days.  
1.11.1 Resetting of Pressure-Natriuresis 
In patients with essential hypertension, a resetting of the pressure-sodium 
excretion curve prevents the return of blood pressure to normal, hence fluid 
balance is maintained but at the expense of high blood pressure (114). 
Experimental evidence suggested that the resetting plays a key role in causing 
hypertension rather than merely an adaptation to increased blood pressure. This 
resetting mechanism explains why sodium retention occurs when blood pressure 
is lowered by nondiuretic drugs. 
Different types of renal insult are reflected in varying sensitivity to sodium 
(115). As seen in Figure 1-9, either the entire curve can be shifted to the right or 
the slope can be depressed. Salt resistant hypertension is characterized by a 
parallel shift in the pressure-natriuresis curve, whereas salt-sensitive 
hypertension is accompanied by a change in slope, an exaggerated increase or 
decrease in blood pressure with increased or decreased sodium intake, 
respectively. 
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Figure 1-9. Salt resistant mechanism simplified.  
 
 
 
A schematic presentation showing resetting of pressure-natriuresis in hypertension. 
Steady-state relationships between arterial pressures and sodium excretion (equal to 
intake) are shown for both salt-sensitive and salt insensitive essential hypertension. As 
blood pressure increases, natriuresis increases to maintain BP at normal levels. In salt-
sensitive hypertensive individuals, natriuresis increases with increasing BP, but BP does 
not decline to normal levels, while in salt-insensitive individuals, natriuresis does not occur 
until BP crosses a high threshold. From (113). 
 
1.11.2 Mechanisms of resetting 
Pressure-natriuresis, and the resetting that occurs in hypertension, is mediated 
first and foremost by changes in tubular sodium transport with unchanged 
glomerular filtration rate. Extensive rat studies of Cowley (116) identify the 
outer renal medulla as the key site in which pressure-natriuresis occurs.  
The renal medulla is uniquely vulnerable to ischemic insult for several reasons. 
Oxygen extraction is almost near maximal under resting conditions to maintain 
the basal activity of energy-dependent sodium transporters, which are highly 
concentrated in this part of the kidney. With a sudden increase in blood 
pressure, medullary blood flow must increase to match the increased energy 
demands of these transporters. In other words, blood flow to the renal medulla 
must be poorly autoregulated if pressure-natriuresis is to occur. Impaired 
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medullary blood flow regulation impairs pressure-natriuresis and is evident in 
virtually all rat models of hypertension (113). 
1.11.2.1  Intrarenal mechanisms 
The best available evidence so far regarding the intrarenal mechanisms, is the 
presence of imbalance between an overactive Renin-angiotensin-aldosterone 
system (RAAS), which reduces renal medullary blood flow, and a defective nitric 
oxide pathway, which normally maintains medullary blood flow and protects 
against hypertension (117). 
The RAAS is a key mechanism regulating renal sodium handling, producing most 
of its biological effects via AT1 receptors (118). In the kidney, AT1 receptors 
activation causes renal medullary vasoconstriction and increase sodium 
reabsorption, whereas in the brain, they regulate salt appetite, thirst, and 
modulate vasopressin release. In addition, adrenal AT1 receptors enhance 
secretion of aldosterone, the main mineralocorticoid.  
Ang II has been shown repeatedly to cause a rightward shift in the pressure-
natriuresis curve (115). The effect is potent since sodium retention is greatly 
enhanced at the very low Ang II concentrations, even lower than the 
concentration required to cause vasoconstriction. Ang II normally triggers a 
coordinated calcium signal to promote vasoconstriction and causing the release 
of nitric oxide. The latter, is  a potent vasodilator which can offset Ang II-
dependent vasoconstriction (117). The balance between vasoconstrictor and 
vasodilator factors is termed “tubulovascular crosstalk”. Other associated 
vasoconstrictor factors include reactive oxygen species (both superoxide and 
hydrogen peroxide); associated vasodilator factors include cyclooxygenase (COX-
2) and prostaglandins (PGE2) (116). Any imbalance occurring between these 
factors can lead to medullary ischemia, impaired pressure-natriuresis, and salt-
induced hypertension.  
Ang II is selectively concentrated in the kidney hence, emphasizes the reason 
why RAAS is vital in renal sodium handling. Navar et. al. have shown that 
intrarenal concentrations of Ang II are several fold higher than circulating blood 
levels because the kidney actively produces and sequesters Ang II (119). In 
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multiple experimental forms of hypertension, renal Ang II levels are high even 
when plasma levels are normal or low. Thus, selective over activity of the 
intrarenal RAAS may drive hypertension even when extrarenal blood tests 
indicate that systemic RAAS activity is either suppressed or “inappropriately 
normal”. 
While AT1 receptors promote sodium retention, AT2 receptors on the contrary 
promote natriuresis. This is partly mediated by the release of nitric oxide (120). 
The angiotensin receptor blockers, which cause selective AT1 receptor blockade, 
induce natriuresis in rodents by unmasking and activating AT2 receptors in the 
proximal tubule. Despite abundant experimental support, this theory remains 
untested in patients as selective AT2 receptor antagonists are not available for 
use in human subjects. 
1.11.2.2  Extrarenal mechanisms 
The following systemic mechanisms also have been associated in resetting 
pressure natriuresis and have been implicated in causing salt-sensitive 
hypertension: 
Table 1-5. A summary of extra renal involvement in resetting pressure natriuresis. 
 
Mechanisms Summary 
Dysfunction of the natriuretic peptides Studies in humans indicate that 
secretion of ANP may be blunted in 
black salt-sensitive hypertensives in 
response to high salt diets (121). 
Further, a loss of function 
polymorphism of the ANP gene has 
been observed more frequently in 
black salt-sensitive hypertensives, 
compared to normotensives or white 
hypertensives (122). 
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Insulin Insulin promotes sodium reabsorption, 
and hyperinsulinemia, as well as 
obesity. It was also proposed as a 
mechanism of sodium retention and 
hypertension in patients with 
metabolic syndrome (5) 
α-Melanocyte stimulating hormone This particular hormone can cause or 
exacerbate salt-sensitive hypertension 
in rodent models via the central 
melanocortin system and activation of 
sympathetic nerve activity (123). 
Activation of renal sympathetic nerves Activation of the renal sympathetic 
nerves shifts the pressure-natriuresis 
curve and contributes to salt-sensitive 
hypertension in rats. Conversely, renal 
denervation prevents the development, 
attenuates the magnitude, or delays 
the onset of hypertension in multiple 
animal models (124) and may lower 
blood pressure in hypertensive patients 
(125). 
Modified from (113). 
 
1.11.3 Importance of renal inflammation 
Animal studies showed that renal inflammation can act as both the cause and 
the consequence of renal medullary ischemia (126). Renal inflammation is a 
hallmark of both the initiation and progression of experimental salt-sensitive 
hypertension. Eventually, ongoing renal ischemia will kill enough nephrons to 
decrease GFR. 
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1.11.4 Nocturia 
Abnormal pressure-natriuresis can be clinically presented as nocturia. It also  
provides a clue to uncontrolled salt-sensitive hypertension related to aging, 
hypertension, and particularly a blunted or reversed nocturnal dipping pattern in 
blood pressure (127). Nocturnal urine flow accounts for 53% of urine output in 
60- to 80-year-old normotensive individuals compared to 25% in 25- to 35-year-
olds (128). Hypertensives however, have even more nocturia, presumably 
reflecting the resetting of the pressure-natriuresis relationship (129). Fluid 
retained peripherally during the day leads to central volume expansion at night, 
with elevated nocturnal blood pressure driving pressure-natriuresis. 
1.12 Other effects of dietary salt in addition to 
hypertension 
1.12.1 Left ventricular mass 
Left ventricular hypertrophy (LVH) is a frequent and prognostically unfavourable 
finding in patients with essential hypertension. Evidence from human studies 
revealed a link between ventricular mass and cardiovascular mortality and 
morbidity independent of the blood pressure (130;131). In normotensive 
individuals, left ventricular mass and diastolic filling have been found to be 
positively correlated with urinary sodium excretion (132).  In two normotensive 
groups followed up for 3 to 8 years the initial left ventricular mass and wall 
thickness were significantly related to the subsequent development of 
hypertension (130). Gerdts et. al. (133) in a study looking at the effects of 
antihypertensives on blood pressure, albuminuria, and left ventricular mass in 
hypertensive patients with type 1 diabetes, identified dietary sodium intake as 
an independent predictor of left ventricular mass. The study also found no 
significant association between left ventricular mass and the blood pressure. 
Studies in animals revealed almost similar findings. Normotensive rats given 1% 
saline solution for several weeks develop LVH evident by an increase in heart 
weight but without an increase in blood pressure (134). 
The increase in left ventricular mass associated with essential hypertension has 
been shown to be reversible by reducing salt intake. This is evident by results 
from The Treatment of Mild Hypertension Study Research Group (135), which 
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showed a significant correlation between the reduction in salt intake and left 
ventricular mass. In the whole study group reducing salt intake was the only 
factor which was significantly correlated with a reduction in left ventricular 
mass.  
1.12.2 Vessels 
Stiffness of conduit arteries, measured as an increase in pulse wave velocity or 
pulse pressure, is a strong independent predictor of cardiovascular risk (136). 
Studies in both humans and animals have shown that an increase in salt intake 
increases the stiffness of conduit arteries and the reactivity of the small 
resistance vessels and the wall thickness of both (137;138). In a study of two 
Chinese populations, the age-associated increase in pulse wave velocity was 
blunted in the population with a lower salt intake (139). Similarly, the pulse 
wave velocity of a group of normotensive subjects who reduced their salt intake 
for a mean of about 2 years was significantly lower than that of a control group, 
independent of the blood pressure (140). He et. al. in a randomized double-blind 
study shows that a modest reduction in dietary salt intake reduces pulse 
pressure both in individuals with isolated systolic hypertension and in those with 
both raised systolic and diastolic blood pressure, suggesting that salt reduction 
improves arterial distensibility (141). Another recently published paper by Gates 
et al (142) demonstrates that directly measured large elastic artery compliance 
is increased by dietary salt restriction in middle-aged and older men and women 
with stage 1 systolic hypertension. 
1.12.3 Cardiac failure 
Raised blood pressure is major cause of cardiac failure with hypertension 
preceding the development of cardiac failure in almost 90% of patients (53). A 
high dietary salt intake increases blood pressure and the risk of left ventricular 
hypertrophy and left ventricular dysfunction, thereby increasing the risk of 
cardiac failure (Figure 1-10). 
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Figure 1-10. Relationship between salt intake and heart failure. 
 
 
 
From He et. al. (143). 
Predominantly, there is systolic contractile dysfunction due to the salt induced 
hypertension (144). Diastolic dysfunction may occur in some elderly patients 
attributable to impaired ventricular filling, which usually precedes systolic 
dysfunction. This complication occurs as a consequence of the collagen 
deposition and fibrosis of the ventricle which are strongly associated with high 
dietary salt intake. A prospective cohort study which involved 10 352 men and 
women has shown that a higher dietary salt intake was associated with a higher 
risk of developing heart failure over a follow-up period of 19 years. This 
association was found in overweight individuals, but not in those with normal 
body weight (145). Similarly, the administration of drugs which can promote 
sodium and fluid retention (e.g. Non-steroidal anti-inflammatory drugs) have 
been demonstrated to significantly increase the risk of congestive heart failure 
in susceptible patients (146). 
Ahn J et. al. (147) showed that in spontaneously hypertensive rats, dietary salt 
excess increased arterial pressure more than in rats receiving normal salt diets 
and promoted diastolic dysfunction manifested by extended isovolumetric 
relaxation time. These echocardiographically measured ventricular relaxation 
abnormalities were associated with a further increase in left ventricular mass 
and hydroxyproline concentration (an index of ventricular collagen content). 
Moreover, the subgroup of younger salt-loaded spontaneously hypertensive rats 
developed heart failure with impaired systolic and diastolic function associated 
with a greater left ventricular mass myocardial fibrosis. 
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In addition, the salt-induced increase in the size of the cardiac muscle mass and 
the salt-induced thickening of the coronary arteries, impair coronary perfusion 
which can be detected as an inadequate reserve of coronary blood flow 
(148;149). Myocardial function is further impaired by the increase in cardiac 
output, resulting partly from the increase in right auricular pressure secondary 
to salt. Weight gain associated with the salt and water retention that 
accompanies cardiac failure also increases cardiac work load. Hence, the 
mainstay of non-pharmacological therapy for patients with cardiac failure is a 
low salt diet, which has been shown to improve symptoms similar to that which 
occurs with diuretics (150). 
1.12.4 Stroke 
Hypertension is the single most important cause of stroke. According to the 
World Health Organization, 62% of all strokes and 49% of coronary heart disease 
events are attributable to high blood pressure (151). The direct causal relation 
between levels of dietary salt intake and blood pressure at the population level 
has also been recognised. In addition, there is also increasing evidence that salt 
may have a direct effect on strokes, independent of and in addition to the effect 
it has on blood pressure (152). Given the graded causal relation between blood 
pressure and cardiovascular disease, it is reasonable to expect considerable 
benefit on the rate of cardiovascular disease from a reduction in dietary salt 
intake. 
Data from the INTERSALT study (looking at individuals aged 20 to 40 years) and 
from the sex-specific stroke mortality data from 25 countries worldwide  
revealed that there was a significant relationship between stroke mortality and 
sodium excretion in men, and the Na+/K+ ratio in women (153). Strazullo et. al. 
(151) in a recent meta-analysis of 19 independent cohort samples from 13 
studies, with 177,025 participants showed that a high salt intake is associated 
with significantly increased risk of stroke and total cardiovascular disease. The 
authors suggested that reducing current salt intake from 10g to 5g per day, 
would reduce stroke rate by 23% and overall cardiovascular disease by 17%. Such 
measure could potentially prevent 0.25 million deaths from strokes and almost 3 
million deaths from cardiovascular disease each year. In another study, Perry 
and Beevers (154) performed an ecological analysis of the relationship between 
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urinary sodium excretion and stroke mortality in Western Europe. The 
investigators found a significant positive correlation between urinary sodium 
excretion and stroke mortality and this relationship is much stronger than that 
found when urinary sodium is plotted against blood pressure.  
Figure 1-11. Relationship between salt intake and deaths from strokes in 12 European 
countries. 
 
 
From Perry and Beevers (154). 
 
1.12.5 Platelets 
In one study by Gow et. al. (155) which involved normotensive male subjects,  
platelet aggregation induced by adenosine 5´-diphosphate was significantly 
greater when they were on a high-salt diet. Similarly in normotensive women a 
change in salt intake from 10 to 200 mmol/day resulted in a significant increase 
in platelet aggregation (156). In two groups of men with and without a family 
history of hypertension, a high-salt diet increased the blood pressure 
measurement in participants with positive family history, whereas platelet 
aggregation increased in both groups, with more favouring towards those with a 
family history (157). The effect of salt intake on adrenaline-induced platelet 
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aggregation and α-2 adrenergic receptors on platelet membrane fraction has 
been studied in patients with essential hypertension. The response was linked to 
the associated changes in blood pressure. In those in whom there was a rise in 
blood pressure, platelet aggregation also increased as well as the number of α-2 
adrenergic receptors (158).  
1.12.6 Renal function 
There is growing evidence in both animal and human studies associated with 
direct and indirect adverse consequences of high dietary salt on the kidney. 
Models of indirect mechanisms suggest a complex relationship between 
increased sodium load, increased blood pressure and proteinuria. Alternatively, 
direct mechanisms involve elevation of oxidative stress in the mammalian kidney 
by increasing and decreasing the breakdown of reactive oxygen species (159).  
Albuminuria has been well established to be an important and independent risk 
factor for the development and progression of renal disease and also for 
cardiovascular disease in individuals with diabetes, chronic kidney disease, 
hypertension and the general population (3). In addition, the risk appears to 
increase throughout the range of albumin excretion with no threshold. Several 
epidemiological studies have demonstrated a direct association between salt 
intake and urinary albumin excretion, independent of blood pressure. Swift et. 
al. (160) in randomized double-blind trial which involved 40 black hypertensive 
patients demonstrated that a reduction in salt intake from approximately 10 to 5 
g/day reduced 24-hour urinary protein by 19% (p< 0.01). In another more recent 
double-blind trial, a larger number of individuals including 71 whites, 69 blacks, 
and 29 Asians with mildly elevated blood pressure showed that even a smaller 
reduction in dietary salt intake, from an average of 9.7 to 6.5 g/day, 
significantly reduced 24-hour urinary albumin excretion in all 3 ethnic groups 
(161).  
Other studies in patients with proteinuria or diabetes revealed that the 
antiproteinuric effect of an angiotensin-converting enzyme (ACE) inhibitor is 
dependent on salt intake: low salt intake enhances and high salt intake abolishes 
the antiproteinuric effect of ACE inhibitor. Cianciaruso et. al. (162) who 
conducted a retrospective analysis of 57 chronic kidney disease patients with an 
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average observation period of 3 years, showed that a lower salt intake reduced 
proteinuria and slowed down the progression of renal disease. This observation 
occurred despite a similar BP control between the 2 groups on a high and low 
salt intake. Reduction in dietary salt intake would also benefit chronic kidney 
disease patients who are on dialysis, in whom blood pressure management is 
rather challenging. By encouraging a low salt diet, the amount of fluid consumed 
between dialyses will be reduced, resulting in decreased weight gain between 
dialyses, and improved blood pressure control (45). 
1.12.7 Obesity 
Obesity is a major public health burden and is strongly associated with health 
complications such as diabetes, hypertension and cardiovascular disease. 
According to NHS data (163), male obesity in the UK has increased from 13.2% in 
1993 to 23.1% in 2005, while obesity amongst women has increased from 16.4% 
to 24.8% over the same period. Even though there is no direct causal relationship 
between obesity and dietary salt intake, the latter plays a major influencing 
factor through its effect on soft drink consumption.  
Furthermore, the appropriate physiological responses to increased plasma 
sodium levels (i.e., osmolality) are stimulation of vasopressin release and of the 
thirst mechanism. Thirst-induced increased fluid intake would lead, initially, to 
an increased blood volume which would persist for only a short time until urine 
plus sodium excretion returned volume and osmolality to the normal range in 
response to the reduced release of the hormones vasopressin and aldosterone 
(164). 
In adults, it has been shown that a reduction in salt intake reduces fluid 
consumption and would lead to a concomitant reduction in soft drink intake. It 
has been estimated that a reduction in current salt intake from 10 g/day to the 
WHO recommended level of 5 g/day would reduce fluid consumption by ~350 
ml/day (45). A study by Karppanen et. al. (165) which analysed the sales of salt 
and carbonated beverages in the USA between 1985 and 2005 showed a strong 
correlation between the two, including a parallel link with obesity. They were 
also in parallel with the trend of prevalence of obesity. 
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In children, sugar-sweetened soft drinks are an important component of total 
fluid intake. A study by James et. al. (166) revealed that 31% of the fluid 
consumed by 4-18 year olds is sugary soft drinks. Hence, it is a significant source 
of calories in children and is also claimed not to give rise to any feeling of 
satiety. He et. al. (167) who analyzed the data from the National Diet and 
Nutrition Survey for young people in Great Britain in 1997 suggested a reduction 
of 1 g/day in salt intake would reduce the total fluid by 100 g/day and decrease 
sugar sweetened soft drink consumption by 27 g/day per child. This 
demonstrates that a reduction in salt intake might, therefore, be important in 
reducing sugar-sweetened soft drink consumption and, thus reducing childhood 
obesity. 
1.12.8 Osteoporosis 
Osteoporosis affects mainly the older population, with estimated 3 million 
people are suffering from the condition in the United Kingdom. According to the 
National Osteoporosis Society, 1 in 2 women and 1 in 3 men over the age of 50 
have had a fracture at least once, primarily due to brittle bone condition. Since 
1960’s there has been a 7 fold increase in the number of osteoporosis cases, 
costing the NHS approximately 2.3 billion pounds every year (168). 
Urinary sodium excretion, hence dietary sodium intake controls calcium 
excretion in the urine. A high-salt diet therefore contributes to an increase in 
urinary calcium, which over the long term may lead to calcium mobilisation from 
bone (169). Itoh and Suyama (170) conducted a study in 410 healthy men and 
476 healthy women aged between  20 to 79 years old. They discovered that the 
higher the sodium intake, the greater the loss of urinary calcium and the 
excretion of hydroxyproline, which is an indicator of increase in bone resorption. 
An increase in dietary sodium of 100 mmol/day was associated with an increase 
in calcium excretion of 0.6 – 1 mmol. In another study which involved post-
menopausal women, it has been shown that the loss of hip bone density over 2 
years was related to the 24-hour urinary sodium excretion at entry to the study 
and was as strong as that relating to calcium intake (171). Thiazide diuretics, 
through a reduction in extracellular volume, reduce calcium excretion leading to 
a positive calcium balance, increase bone density and reduce bone fractures 
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(172). Salt reduction therefore has been postulated to achieve the same positive 
effects.  
1.12.9 Gastric cancer 
Gastric cancer is the second most common cancer in the world. Of all the 
possible causes linking to its occurrence, the relationship to salt is the strongest 
(173). A high salt diet in both humans and experimental animals has been shown 
to cause gastritis and when coadministered with known gastric carcinogens, it 
promotes their carcinogenic effect (152). One such promoter is Helicobacter 
pylori, which has been proven to be associated with progression of gastritis to 
gastric cancer (174). Prospective studies have shown a positive correlation 
between Helicobacter pylori and gastric cancer amounting to a two-to three-fold 
increase in risk. In addition, a high salt diet also increases Helicobacter pylori 
colonisation (175).  
Joossens et. al. (173) conducted a study looking at mortality associated with 
gastric cancer among 39 populations from 24 countries based on randomly 
selected 24-hour urine collections. Median sodium excretion levels were 
standardised for age and sex between the ages of 20 and 49 years and averaged 
for each country. Based on correlation-regression analyses, the investigators 
found a significant and direct association between sodium excretion levels and 
national gastric cancer mortality rates in both men and women.  Countries with 
high salt intake are more likely to have higher mortality rates due to gastric 
cancer. In Japan for example, where gastric carcinoma is the most common 
cancer, a positive correlation between salt intake and gastric cancer incidence 
in different geographical regions has been found (176). In addition, a higher risk 
of gastric cancer has been discovered in those who prefer salty food including 
salt-preserved meat and fish (177;178). 
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Figure 1-12. Relationship between salt intake and deaths from stomach cancer. 
 
 
Linear regression between stomach cancer mortality per 100 000/year, age adjusted 
between 45—74 years and mmol Na/24-hours. ARG = Argentina; BEL = Belgium; CAN = 
Canada; CHI = P.R. of China; COL = Colombia; DEN = Denmark; E.W = England and Wales; 
FIN = Finland; FRG = Fed. Rep. of Germany; GDR = German Dem. Rep.; HUN = Hungary; ICE 
= Iceland; ITA = Italy; JAP = Japan; KOR = South Korea; MAL = Malta; MEX = Mexico; NET = 
the Netherlands; N.I = Northern Ireland; POL = Poland; POR = Portugal; SPA = Spain; TOB = 
Trinidad and Tobago; USA = United States. From (173). 
 
1.12.10 Asthma 
Regional data from England and Wales have shown that there is a strong 
correlation between the purchase of table salt and asthma occurrence in men 
and children (179). Presently, there are two interventional randomised double-
blind, placebo controlled, crossover trials in men with mild to moderate asthma, 
looking at the effect of altering dietary sodium intake for several weeks.  
Burney et. al. (179) recruited 27 asthmatic patients and assessed the clinical 
severity of the condition whereas in the second study, 36 patients were involved 
whereby the subjects’ airway response to histamine was measured. Results from 
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both of these small trials demonstrated that an increase in dietary sodium, 80 
mmol/day and 204 mmol/day respectively, increased both the severity of the 
asthma and bronchial reactivity. Another observational study on 138 men with 
mild to moderate asthma confirmed that bronchial reactivity was strongly 
related to 24-h urinary sodium excretion, allowing for the effect of age, atopy 
and cigarettes (180). Similarly, a population-based study in children aged 6-7 
years demonstrated that adding salt to food was strongly and independently 
associated with an increased risk of respiratory symptoms which include wheeze 
and asthma (181). Mickleborough et. al. (182) in a double-blind study illustrates 
the mechanism of how a higher salt intake may exacerbate asthma. The authors 
suggested that dietary salt loading enhances airway inflammation, and that 
small salt-dependent changes in vascular volume and microvascular pressure 
might have substantial effects on airway function, secondary to mediator-
induced (post-exercise) increased in vascular permeability. 
 
1.13 The role of the food industry in salt reduction 
In most developed countries, approximately 80% of salt consumption is from the 
processed foods rather than discretionary (183). Salt is added to foods at the 
stage of manufacturing and the consumers have no control over the quantity 
being used. Therefore, to achieve a reduction in population salt intake, it is 
imperative that the food industry reduces the total amount of salt added to all 
foods. In view of the compelling evidence on the benefits of salt reduction, most 
food companies recognize the importance of initiating a salt reduction programs 
and start the initiative to reformulate their products (184). 
Nevertheless, some members of the food industry are still reluctant to oblige 
due to commercial reasons (Figure 1-13). Salt makes cheap, unpalatable food 
edible at no additional cost. With continuous consumption of highly salted foods, 
the salt taste receptors are suppressed. The habituation to salty foods develops, 
together with greater demand for profitable highly salted processed foods. In 
addition, increasing salt concentration in meat products together with other 
water-binding chemicals results in enhanced water-binding capacity, so the 
product weight can be increased by up to 20% with water (45). Salt is also a 
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major determinant of thirst, hence any reduction in salt intake will reduce fluid 
consumption with a subsequent reduction in soft drink and mineral water sales 
(167). 
Figure 1-13. The commercial importance of salt in processed foods. 
 
From He et. al. (45). 
 
Some of the largest snack companies in the world are linked to companies selling 
soft drinks. It is therefore not surprising that the salt industry and some 
members of the food industry are very reluctant to see any reduction in salt 
intake and have been largely responsible for trying to make salt such a 
controversial issue relative to other dietary changes (3). The commercial reasons 
for this opposition need to be acknowledged. Nevertheless, they should not be a 
hindrance factor to pursue salt reduction as this approach will be of major 
benefit to the future health of the whole population, particularly if it is 
combined with other dietary and lifestyle changes such as increasing fruit and 
vegetable consumption, reducing saturated fat intake, regular exercise and 
smoking cessation (185).  
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1.14 Global initiative for salt reduction 
The Global Burden of Disease study identified high blood pressure as the leading  
cause of mortality, attributable to more than 7 million deaths (186).  In 
addition, the WHO World Health Report (187) estimated that globally 62% of 
cerebrovascular disease and 49% of ischaemic heart disease were attributable to 
elevated blood pressure (systolic > 115 mmHg). Heart diseases are the leading 
cause of death for persons over 60 years of age and the second cause of death 
for persons aged 15–59 years. The report proposed strategies to reduce the risks 
associated with CVD and emphasized that in all settings population-wide salt 
reduction strategies were the most cost-effective. 
In 2003, a technical report by WHO and the Food and Agriculture Organization 
(FAO) of the United Nations (UN) recommended a population-wide daily salt 
intake of no more than 5 g (2,000 mg sodium) in adults (188). Subsequently, in 
2007, a report was issued proclaiming the available evidence “conclusive” for 
excess sodium to cause hypertension (20). This report called for worldwide 
reformulation of processed and restaurant foods, to achieve the lowest possible 
sodium content combined with consumer education and creation of an 
environment facilitating choice of low-sodium foods.  
To promote sodium reduction worldwide, World Action on Salt and Health 
(WASH) was established in 2005. This group of experts in hypertension 
encourages multi-national food companies to reduce sodium in their products 
and works with governments in different countries to highlight the need for a 
sodium reduction strategy (189). The overall aim is to achieve reduction in salt 
intake throughout the world by reducing the amount of salt in processed foods as 
well as discretionary. 
Many individual countries around the globe have already taken action against 
reducing population salt intake. Webster et. al. (190) in a recent review 
identified 32 countries around the world with current national salt reduction 
initiatives. These strategies were either led by government, nongovernment 
organizations or industry. Most countries had maximum population salt intake 
targets, ranging from 5 to 8 g per person per day. The average salt intakes level 
documented among these countries were 9 g/person per day. Five countries 
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(United Kingdom, Finland, France, Ireland and Japan) had demonstrated a 
positive impact, either on population salt consumption, salt levels in foods or 
consumer awareness.  
1.14.1 The UK strategy for salt reduction 
The UK is one of the pioneer countries in salt reduction. In 1996, 22 experts on 
salt and BP set up an action group known as Consensus Action on Salt and Health 
(191). Since then, CASH has lead a highly successful campaign to persuade food 
manufacturers and suppliers to universally and gradually reduce the salt content 
of processed foods. They are also involved in educating the public in becoming 
more aware regarding the harmful impact of salt on their health, and translate 
the evidence into public health policy. CASH persuaded the UK Department of 
Health to change its stance on salt, resulting in the Chief Medical Officer 
endorsing the recommendations to reduce national salt intake to less than 6 
g/day in adults, and also ensured that the UK Food Standards Agency (FSA) took 
on the task of reducing salt intake (189).  
A strategy to reduce population salt intake was developed based on the UK’s 
average salt intake of 9.5 g/day (192) as measured by 24-h urinary sodium (Table 
1-6). It was estimated that ≈15% of the salt consumed (i.e., 1.4 g) was added 
either at the table or during cooking, 5% was naturally present in the foods (0.5 
g), and the rest 80% (7.6 g) was added by the food industry in processed, 
canteen, restaurant, and takeaway foods. To reach the target of 6 g, a total 
reduction of 3.5 g (i.e., 40%) was needed. Therefore, the food industry would 
need to reduce the amount of salt added to foods from 7.6 to 4.6 g (40% 
reduction) and the public would need to reduce the amount of salt they add to 
foods themselves from 1.4 to 0.9 g (40% reduction). 
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Table 1-6. UK strategy for reducing salt. 
 
 
In the UK, it was estimated that only ≈15% of foods were eaten outside the home 
i.e. restaurant, canteen, etc. Hence, the main target in the initial phase of salt 
reduction focused on foods that were bought in supermarkets (3). These foods, 
where salt was added, were split into more than 80 categories. The FSA set 
target levels of salt for each food category that the food industry required to 
achieve within a certain time period (193). The aim was to implement a step-
wise reduction in salt added to foods, reducing by 10–20% and repeated at 1–2 
year intervals. Such gradual reductions are not detectable by human salt taste 
receptors and pose neither technical nor safety issues to the relevant foods 
(194). It also poses no risk to manufacturers and is well accepted by the 
consumers. Recently, the salt targets have been revised to ensure that salt 
intake will reach the target of 6 g/day by 2012 (195).  
The UK salt reduction campaigns started around 2003 and have been successful. 
Today, the salt content in many food categories has already been reduced. 
These include a one-third reduction in the average amount of salt in branded, 
prepacked, sliced bread, and a reduction of over 40% in branded breakfast 
cereals (193). Table and cooking salt sales have also been reduced by ≈40–50%. 
The average salt intake, as measured by 24-h urinary sodium, in the general 
adult population in the UK has fallen from the previous 9.5 to 8.6 g/day by May 
2008 (196). This change reverses the previous increasing trend for salt intake 
and marks the beginning of a substantial reduction in salt intake with the food 
industry collaboration. The UK salt reduction campaigns, which cost just £15 
million, led to almost 6000 fewer CVD deaths per year, saving the UK economy 
by £1.5 billion per annum. This cost reflects potential savings from expenditure 
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associated with primary care, outpatient care, Accident and Emergency (A&E) 
admission, inpatient care, medications and productivity losses  (197). 
Clear labelling of the salt content of food is essential for assisting consumers to 
choose products with less salt. A front of pack signpost labelling system has been 
developed in the UK (Figure 1-14), which uses a combination of the ‘traffic light’ 
system, where there is a colour-coding of green, amber, and red for low, 
medium, and high amounts of salt, fat, saturated fat, and sugar present in the 
foods (198). The label also contains the Guideline Daily Amount system where 
the amount of salt per portion is expressed as a percentage of the daily 
recommended maximum. This type of standardised label is already being 
implemented by many supermarkets and is much preferred by consumers, as 
they can see at a glance whether a product has a little or a lot of salt (199). 
 
Figure 1-14. Traffic light system labelling interpretation as suggested by FSA. 
 
 
 
1.14.2 Other countries 
In Ireland, France, and Canada, a national programme aiming for reduced 
sodium levels in foods has been developed in order to reduce the average 
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sodium intake towards the recommended amounts (20). In North America, no 
concrete action plans have been made yet. However, the US Food and Drug 
Administration recently agreed to re-examine the regulatory position on the 
sodium content in foods (21).  
In Finland, the government has worked closely with food companies since the 
late 1970s to decrease the sodium content of products. They also invested in 
educating the physicians and the public regarding the importance of lowering 
sodium intake. Since the 1980s, salt-labelling legislation has been introduced in 
Finland; a mandatory labelling of the salt content and a “highly salted” warning 
if the amount of salt is higher than the set limit, and a voluntary “low or light 
salted” label if the salt content is lower than the set limits. These joint efforts 
between the government, health care sector, media, and industry have led to a 
reduction in sodium intake of 40% (165). 
Following the UK initiatives, the National Heart Foundations of New Zealand and 
Australia also implemented the labelling system. The programme known as “Pick 
the Tick” features a logo that identifies foods that are meeting strict nutritional 
criteria (200).  
1.15 Awareness on salt intake 
Reducing salt in the diet requires knowledge of current salt intake of the 
population, foods that are major contributors of salt and individual’s behaviour 
regarding adding or avoiding salt in their diet. Currently, there are very limited 
studies that have explored people’s knowledge of salt and health and their 
current effort to reduce salt intake. 
1.15.1 Role of CASH  
In United Kingdom, CASH action group is actively involved in raising public 
awareness regarding the harmful effect of excess salt in the diet. Since 2001, 
CASH has been organizing a yearly event of ‘Salt Awareness Week’ to educate 
the public concerning the impact of salt on their health. Each year, a different 
theme is proposed and as for 2012 the programme focused on ‘Reducing salt ; 
preventing stroke’(201). During the week, CASH organizes a reception at the 
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House of Commons. This prestigious event creates the platform to spread the 
message to MPs, food retailers, food manufacturers and other supporters and 
stakeholders. In addition, it provides the food companies an opportunity to 
demonstrate their current efforts in reducing salt in their products. Also as part 
of the activity for the awareness week, other institutions such as hospitals, GP 
surgeries, health charities, schools, universities and the food industry participate 
in supporting events to help raise awareness among the public (201).  
To increase public awareness regarding healthy salt intake, CASH took the 
initiative to conduct surveys among the public from time to time. For example, 
in a recent public survey by CASH (202), it was revealed that 90% of people in 
the UK are aware that excessive salt intake is detrimental to health. However, 
very few realize that it can contribute to other serious complications such as 
stroke (34%), cardiovascular disease (61%) or osteoporosis (4%). Young adults are 
even less likely to realize the damaging effect of salt as they possibly perceived 
it as irrelevant. The survey also indicated that there are differences in 
knowledge across the UK population. Individuals in Scotland are more likely to 
be aware that salt can lead to health complications compared to those in Wales 
(awareness score 70% and 55%, respectively). Social inequalities are also 
evident; people from lower socio-economic groups are over twice as likely not to 
know how salt can damage their health as those in higher socio-economic groups 
(16% vs. 7%). 
1.15.2 Role of Food Standards Agency (FSA) 
In order to raise awareness of salt as a public health issue and educate 
consumers how to reduce their intakes, the FSA has been running a public 
awareness campaign since 2003 with a supporting consumer focused website 
(190). This initiative forms an important part in making healthy eating an easier 
option and reducing diet-related diseases. The FSA ran 4 phases of a public 
awareness campaign to disseminate health issues associated with high salt 
intakes and highlight actions that can be taken to reduce current salt 
consumption (203). This supported product reformulation as it made consumers 
aware of the reason for products content changes and provides an incentive to 
industry to take action as more consumers will be opting for lower salt products.  
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The first phase of the campaign was launched in September 2004, with the key 
aim of ensuring that consumers were aware of why too much salt is bad for their 
health. This is followed by the second phase which was launched in October 
2005, with the main messages focusing on encouraging consumers to check food 
labels for information on the salt content and to raise awareness of the aim to 
eat no more than 6g of salt a day. The FSA launched the third phase of its public 
awareness campaign on March 2007. The theme focused on educating consumers 
that 75% of the salt eaten is already contained in everyday foods as well as 
encouraging and enabling them to choose products with lower levels of salt 
(204). 
All three phases of the campaign have focused on women aged 35-65 in social 
class categories C1 (lower middle class such as supervisory or clerical and junior 
managerial, administrative or professional), C2 (skilled working class comprises 
of skilled manual workers who have served apprenticeships e.g. foremen) and D 
(working class which includes semi-skilled and unskilled manual workers, 
including labourers and people serving apprenticeships e.g. laboratory 
assistants). Although men are more likely to suffer from heart disease and 
stroke, women continue to be the “gatekeepers” with regard to buying and 
preparing food in family households in the UK, hence the focus on this group. A 
range of media have been used to deliver the messages, including TV 
advertising, posters, articles in women’s press and national newspapers and 
news coverage. As well as the salt website, all three phases of the campaign 
have produced materials for consumers, such as leaflets and credit card sized 
prompts, to try and help consumers increase their awareness of the issues and 
the actions they can take. For phases 2 and 3 work was also undertaken by a 
range of stakeholders, both in the food industry and non-governmental 
organisations, to try and get the campaign messages across to a wider audience 
(205). 
Each of the strategy phases was evaluated by an independent company using a 
UK representative survey of 2000 adults. The evaluation of the campaign, which 
was conducted through monitoring changes in consumers’ claimed behaviour, 
suggests that the number of consumers cutting down on salt has increased by 
33%, a 10-fold increase in awareness of the 6g a day message and the number of 
consumers trying to cut down on salt by checking labels has doubled since the 
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campaign was introduced. Of the different methods of advertising, television 
produced the highest awareness level. Internet also plays a vital role as during 
the campaign, traffic to the FSA’s website (www. salt.gov.uk) rose by 44% with 
over 66,000 daily visits (206). 
The fourth phase of consumer awareness programme was launched on 5 October 
2009. The campaign highlights the positive changes that can be attempted by 
consumers to reduce their salt intake. This phase reinforced the previous 
subjects but also introduced a new key message which emphasizes that most of 
the salt we eat is contained in everyday foods. Consumers were encouraged to 
read the foods label, to compare products, and choose foods that are lower in 
salt. All adults should aim to have no more than 6g of salt per day, and children 
under 11 should have considerably less (204).  
Overall the high visibility of all three phases of the campaign has increased 
consumer awareness of the health risks associated with a high salt intake and 
recent consumer research indicates a continued downward trend in the amount 
of salt consumed by people in the UK. The new findings based on 24-hour urine 
sodium excretion indicate that the UK’s average daily salt consumption has 
fallen from 9.5g to 8.6g, which reflects an overall drop of 0.9g since the 
National Nutrition and Diet Survey in 2000/01 (207).  The campaigns also raised 
the profile of salt in the food industry and have encouraged the development of 
partnerships between industry, retailers and other non government 
organizations. Many major retailers and manufacturers have now committed 
themselves to reducing salt in their products and several have already met the 
initial targets set in 2006 (205). 
1.15.3 Role of consumers 
Given the considerable efforts by industry to reduce the salt content of 
manufactured food products for home consumption and initiatives taken by the 
agencies to boost public awareness, it is also necessary to highlight the 
importance of consumers’ role to actively reduce salt in the diet. Consumers can 
help lower their salt intakes towards the recommended population average of 6g 
a day by checking products labels, buying reduced salt products and adding less 
salt to their food. The following guidelines had been suggested by Mahtani 
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(208;208) and Gilbert et. al.  (184) to help consumers in reducing daily salt 
intake. 
1.15.3.1 Reading food label 
Consumers are encouraged to always check the sodium or salt content on 
nutritional labels upon foods purchasing. Where sodium is listed instead of salt, 
consumer should be able to convert the amount of sodium to salt equivalence. 
The use of colour coding in the ‘traffic light system’ is also beneficial for the 
consumer to identify foods with low salt content at a glance.  
Currently, the practice of reading product nutrition label is still minimal. This is 
evident through a study conducted by Grunert et. al. (209) which investigates 
the use of nutrition information on food labels and its understanding among 
consumers in the UK. Data were collected based on in-store observations in 
three major UK retailers, in-store interviews and self-administered 
questionnaire. The study revealed that only 27% of respondents had looked at 
nutrition information on the package before making a selection. 
1.15.3.2 Minimized processed foods intake 
In United Kingdom, it is estimated that 80% of sodium intake comes from food 
processing, 15% is discretionary (half of which is contributed by table salt and 
half by added salt in cooking), and only 5% is naturally occurring in foods (3).  
This so called ‘hidden salt’ is conveniently available in processed foods and they 
are often added to please taste buds which grow ever more dependent upon 
high-salt content foods. For example, a single slice of processed cheese may 
contain more sodium than an entire bag of crisps. A simple way of achieving a 
modest reduction therefore, would be to reduce the consumption of processed 
supermarket, canteen, restaurant, and fast food. 
1.15.3.3 Avoid adding salt to foods 
The simple measure of removing salt from the table and in cooking could cut salt 
consumption significantly. The use of alternative methods for food flavouring 
such as herbs, spices, lemon juice and chillies can be suggested. Seeking low-salt 
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recipes may be another way and the Food Standards Agency offers links to sites 
that can provide such information. For those who cannot bear to go without salt, 
a mineral salt with potassium (e.g. Lo-Salt) could be used. This ‘low-sodium’ salt 
however, is not recommended for patients with kidney problems. 
1.15.3.4 Eating a balanced diet 
As previously discussed, the Dietary Approaches to Stop Hypertension (DASH) 
study revealed that a diet low in saturated fat and cholesterol but high in 
protein, carbohydrate, potassium, calcium, and magnesium resulted in reduced 
blood pressure when compared with a representative average Western diet 
(210). When the DASH diet was combined with a lower sodium intake, the 
reduction of blood pressure was even greater (43). As a result the National 
Institute of Health now recommends the DASH eating plan.  This particular diet 
strategy which consists of potassium-rich foods, such as bananas, avocados, 
dried fruit, seeds, tomato juice, and salad vegetables, together with 
magnesium-rich foods, such as leafy green vegetables, nuts, seeds, and oats, 
may provide additional benefits in reducing blood pressure when combined with 
a low sodium intake. 
1.15.3.5 Take-away and eating outside 
Food can be consumed outside the home through a variety of sources and venues 
– for example restaurants, fast food outlets, coffee shops, in work canteens or in 
leisure venues such as theme parks, sports venues and cinemas. Sixty one 
percent of people aged 18-24 eat out at least once a week; and 22% of people in 
the UK eat a takeaway at least once a week (211).  
Foods offered in these venues have frequently been found to be less healthy 
options (high in fat, saturated fat, salt and sugar). For example, a CASH survey 
on 50 samples of Chicken Tikka Massala with Pilau Rice and 11 samples of 
Chinese chicken dishes with fried rice revealed that many contain more than a 
daily salt limit in a single meal (212). The survey revealed that almost two thirds 
(64%) of the Chinese meals tested contained more than 6g of salt per serving, 
which is the maximum recommended daily intake. Over half (52%) of the Indian 
meal samples contained more than 4g of salt, with one sample containing 7.11g 
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of salt. In addition, a survey by the Food Commission recently found that portion 
sizes in fast food restaurants have also been increasing, hence increasing the 
amount of total salt consumption.  
Whilst the UK has now made progress in implementing better nutritional 
labelling for the food that is bought for consumption at home, consumers 
purchasing food to eat outside the home often have no way of knowing how 
healthy their meal is at the point of purchase. In a recent study by Mackinson et. 
al. (213), over half of the participants (55%) indicated that they would like to 
see information on salt content of menu items at all catering outlets. This study, 
which was based on self-administered questionnaire, was conducted to 
investigate UK consumers’ interest for the provision of nutrition (salt, energy 
and fat) and ingredient information in catering outlets. Out of 786 respondents 
recruited, almost half of the respondents (42%) reported eating at a catering 
outlet at least once a week. Take-away and sandwich outlets were the most 
commonly frequented venues with 17.2% and 16.7%, respectively, of participants 
using these on a weekly basis. 
1.16 Cost-effectiveness of salt reduction 
Population reductions in dietary salt intake are recommended by a variety of 
major scientific and public health organizations. The proposal was made based 
on the available evidence, which has shown that significant population-based 
reductions in salt consumption could lower the blood pressure of enough people 
to produce a substantial public health benefit in both developed and developing 
countries. Indeed, even a modest reduction in the population intake of salt 
worldwide could produce a major improvement in public health. 
Several studies have demonstrated that a reduction in population salt intake is 
very cost-effective. Murray et. al. (214) performed a global analysis, reporting 
estimates of the population health effects and costs of selected interventions to 
reduce the risks associated with high blood pressure and hypercholesterolemia.  
Effect sizes were derived from systematic reviews or meta-analyses, and the 
effect on health outcomes projected over time for populations with differing 
age, sex, and epidemiological profiles. Incidence data  from estimates of burden 
of disease were used to calculate disability-adjusted life years (DALYs) averted 
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and patients treated, while cost incurred were either estimated based on 
previous publication or by local experts. The results revealed that non-personal 
health interventions, including government action to stimulate a reduction in 
the salt content of processed foods, were cost-effective ways to limit CVD and 
could avert over 21 million disability-adjusted life years per year worldwide. 
Furthermore, the combination of personal (such as treatment of individuals with 
high systolic blood pressure) and non-personal health interventions provide 
additional health benefits by reducing the global incidence of cardiovascular 
events by as much as 50%. 
In United Kingdom, Barton et. al. (139) in a recent study indicated that by 
reducing salt intake by 3 g/day might reduce mean population systolic blood 
pressure by approximately 2.5 mmHg, equivalent to a 2% decrease in the risk 
reduction model. This would prevent approximately 4450 deaths from 
cardiovascular disease, with total discounted savings overall of approximately 
£347 million over a decade, representing equivalent annual savings of 
approximately £40 million. Any salt reduction intervention totalling up to £40m a 
year would therefore still be cost saving. 
Other studies in Norway, Canada, and the United States have all demonstrated 
that salt reduction not only saves lives, but also saves money. A recent study in 
the US showed that collaboration with industry that decreases mean population 
sodium intake by 9.5% prevents 513 885 strokes and 480 358 myocardial 
infarctions over the lifetimes of adults aged 40–85 years who are alive today, 
increasing QALYs by 2.1 million and could save more than USD32 billion in 
medical expenses in the US alone (215). 
A simulation study, also from the United States, suggested that achieving a salt 
reduction of 3 g/day in the American diet would be either similar in magnitude 
or greater than those projected for interventions targeting tobacco or obesity, 
interventions involving primary prevention with statins, and the pharmacologic 
treatment of hypertension. The study conducted by Bibbins-Domingo et. al.  
(216) used Markov modelling applied to US residents aged 35 years or older to 
assess the impact of reducing dietary salt by 3 g per day on the annual number 
of new cases of coronary heart disease, stroke, and myocardial infarction and on 
reducing annual deaths from any cause. These researchers found that a 
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regulatory intervention targeting a daily reduction of 3 g of salt would save, on 
an annual basis, 194 000 to 392 000 quality-adjusted life-years (QALYs) and US$ 
10–24 billion in healthcare costs. Such an intervention would save costs even if 
the reduction was just 1 g per day, achieved on a gradual basis between 2010 
and 2019, and it would be more cost-effective than a program of using drugs to 
lower blood pressure in the entire hypertensive population. 
In Canada, Joffres et. al. (217) estimated the impact of dietary sodium reduction 
on the prevalence of hypertension and medical cost savings. The authors 
discovered that sodium reduction of 1840 mg/day might decrease the prevalence 
of hypertension by 30%, translating to a reduction of 1 million hypertensive 
patients in Canada, and it would almost double the rates of treatment and 
control for hypertensive persons. The authors estimated direct cost savings from 
less physician visits and laboratory tests and fewer use of drugs to be about US$ 
430 million annually. They also estimated that the total costs of physician visits 
and laboratory services would decrease by 6.5% and predicted that among 
patients receiving treatment for hypertension, 23% fewer would need drugs to 
control their blood pressure. 
Selmer et. al. (218) from Norway estimated the economic and health 
consequences (reduced risk of myocardial infarction and stroke due to lowered 
blood pressure) of interventions designed to reduce individual daily sodium 
intake in the Norwegian population by 6 g. Health promotion (informational 
campaigns), the development of new recipes for foods by the industry, reporting 
the salt content of foods, and levying taxes on salty food/providing subsidies for 
products with less salt were the possible interventions. The net cost of the 
interventions was minus US$ 118 million indicating cost saving. Thus, the costs of 
population interventions were much lower than the cost savings from fewer 
strokes and heart attacks. 
In developing countries, where the healthcare resources are very limited, a 
reduction in salt intake is one of the most cost-effective interventions to reduce 
CVD. Asaria et. al. (219) estimated the effects and cost of strategies to reduce 
salt intake and to control tobacco use for 23 low- and middle income countries 
that account for 80% of chronic disease burden in the developing world. They 
demonstrated that, over 10 years (from 2006 to 2015), a 15% reduction in 
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population salt intake could prevent 8.5 million CVD deaths while a 20% 
reduction in smoking prevalence could avert 3.1 million CVD deaths. The modest 
reduction in salt intake could be achieved by a voluntary reduction in the salt 
content of processed foods and condiments by manufacturers, together with a 
sustained mass-media campaign aimed to encourage dietary change within 
households and communities. The cost for implementing such salt reduction 
programmes was estimated to be US$0.09 per person per year. The cost for 
tobacco control including both price and non-price measures was US$0.26 per 
person per year (Figure 1-15). These figures clearly suggest that a reduction in 
salt intake is more or at the very least just as cost-effective as tobacco control 
in terms of reducing CVD on its own, which is the leading cause of death and 
disability worldwide. 
 
Figure 1-15. Number of cardiovascular disease deaths averted and financial costs 
associated with implementation of salt reduction and tobacco control. 
 
 
From (219). 
1.17 Methods for measuring dietary sodium intake 
There are various ways of measuring patients’ compliance towards advice to 
reduce dietary salt intake. A number of objective and subjective methods have 
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been used, and each method has its own advantages as well as disadvantages 
(Figure 1-16). Measurement tools have ranged from objective measures such as a 
24-hour urine sodium to subjective measures such as dietary self-report through 
24-hour recall or food diaries. In general, however, the choice of method 
involves a compromise between accuracy and ease-of-use, with relatively 
precise methods being difficult to perform whereas simpler methods being less 
reliable. Moreover, because salt intake is not fixed in each person and 
demonstrates considerable individual variation and daily fluctuations in the same 
individual, its assessment is naturally subject to limitations in accuracy.  
Figure 1-16. General assessment on various methods of salt intake estimation. 
 
 
From (220). 
 
1.17.1 24-hour urine collection 
The “gold standard” method of obtaining data on sodium intake in population 
surveys is the 24-hour urinary sodium excretion (17).  In a healthy individual, 
urine is the major route of sodium excretion.  A 24-hour period is required to 
capture the pattern of sodium excretion since there is marked  diurnal variation 
in sodium, chloride and water excretion (221).  Electrolytes excretion in healthy 
individuals reaches a maximum at or before midday, and a minimum at night 
towards the end of sleep. This cycle of excretion is present regardless of either 
sodium restricted or sodium-supplemented diet and unaffected by moderate 
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activity although severe exercise may produce decreased excretion of sodium 
and chloride (222). Certain circumstances however, may trigger the cycle 
disruption causing reversed pattern of the electrolytes excretions. These include 
healthy individuals taking large doses of cortisone, patients diagnosed with both 
Cushing’s disease and primary aldosteronism, and night workers (223).  
Typically, 24-hour urine sodium excretion can account for ~95% of dietary 
sodium intake. However, the within-person sodium excretion may be varied as 
high as 30% (224). Hence, multiple observations may assist in increasing precision 
in the overall mean for individuals. Since the 24-hour urine collections method 
takes no account of electrolytes loss via other routes other than the kidneys, 
there is possibility that the true sodium intake will be slightly underestimated 
(17). 
Holbrook et. al. (225) in a study revealed that among 28 adults, average urinary 
excretion of sodium from seven consecutive 24-hour urine collections was 86% of 
that estimated from chemical analysis of duplicate diets collected over the same 
seven-day period. In temperate climates it is assumed that skin losses of sodium 
are insignificant. Sodium losses through faeces is considered small under normal 
condition and over wide range of consumption (226). Other losses can be 
regarded as negligible except those from excessive sweating which in certain 
circumstances (as previously stated) can be considerable. 
The 24-hour urine collection offers the main advantage of not being affected by 
subjective reporting of dietary intakes. Nevertheless, it is subjected to a few 
limitations such as high participant burden which may lead to incomplete 
collection or attrition, complete collection must be done with no more than a 
few drops lost or otherwise the excretion estimate will be biased, there is no 
absolute check on completeness; though good survey technique may help to 
minimize the levels of incompleteness, and the collection must be accurately 
timed to avoid over- as well as under-collection (221). 
The 24-hour urine collection may also be used to validate the accuracy of 
dietary assessment methods such as food diary or food frequency questionnaire.  
Validity and reliability are both important in any biochemical measurement as 
both imply that the data are true, unbiased measures of the variable (224). 
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Validity may be difficult to achieve because most biochemical measurements 
involve multiple stages and bias may enter the process at any point in time.  
National quality control schemes have led to improved quality of work in 
laboratories.  This has led to improvement in relative validity between methods 
(224). 
Factors other than laboratory quality control may influence the validity of a 24-
hour urine sodium as a measure of dietary sodium intake.  Partially collected 
urine specimens, heavy perspiration, secretion into breast milk, and chronic 
diarrhoea may interfere with the agreement between 24-hour urine excretion 
and dietary intake (227). 
Completeness of 24-hour urine sampling may be verified by an objective marker 
such as para-aminobenzoic acid (PABA). Bingham and Cummings (228) had 
proposed the use of PABA as an objective biomarker to confirm the 
completeness of 24-hour urine collections, as an alternative to the creatinine 
method. PABA which is a B-complex vitamin, was chosen as it was considered to 
be non-toxic in human. Pharmacokinetically, it is proposed to be absorbed and 
almost entirely excreted within 24-hours and can be quantitatively measured. 
The excretion of PABA in the urine was found to be dose dependent (221). 
Normally, three 80 mg of PABA tablet are taken orally in conjunction with main 
meals on the day of urine collection. At this particular dose, Bingham and 
Cummings (228) discovered that mean PABA recovery over 24-hour period was 
93% ± 4% in 33 individuals. The range between minimum and maximum values 
was 15% of the mean compared with 70% for creatinine excretion. The 
investigators then concluded that in the general population, urine collections 
containing more than 85% (205 mg) of the administered dose can be considered 
complete (with a 5% chance of incorrectly excluding a complete sample). 
Although the use of PABA has proved to be valuable in validation studies, its 
wider use in population surveys may be more challenging. Bingham et. al. (229) 
reported that PABA recovery was lower in patients with renal disease with 
increased creatinine excretion compared to those with normal creatinine 
excretion. Jacobsen et. al. (230) found a gradual decline of PABA recovery with 
age, at a rate of approximately 1% per year from the age of 30 onwards. 
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Consequently, some 24-hour urine collection in older individuals might be falsely 
rejected (false-negative).  
PABA is metabolized in the liver to p-aminohippuric acid (PAHA), and both PAHA 
and PABA are acetylated (221). Hydrolysis of acetylated metabolites of PABA 
occurs in the urine, and the free amine groups become available for detection 
by chemical analysis. A few drugs including sulphonamides, folic acid, 
paracetamol, phenacetin and furosemide contain amine groups or may be 
metabolized to them. As a result, erroneously  high PABA recovery rates might 
therefore be discovered in individuals taking these drugs (228). 
Since the PABA technique requires the participants taking the PABA tablets, 
informed consent and ethics committee approval is required (192). The 
technique relies on the participants taking the tablets as instructed at 
appropriate intervals during the 24-hour period. Non-compliance such as missing 
a dose or taking the tablets at the wrong times, might result in complete urine 
collections being falsely rejected (221). In the 2000-2001 British National Diet 
and Nutrition Survey, the PABA method was initially used to validate the 24-hour 
urine collections. However, during the first wave of data collection, one 
participant exhibited an acute allergic reaction presenting with generalised 
urticaria and periorbital oedema, leading to the procedure being discontinued 
for the remainder of the survey (192). Thus the utility and safety of the PABA 
technique for population surveys have not been established. 
Overall, although PABA verification has proved to be a useful objective marker, 
the 24-hour urine specimens could potentially be unjustly excluded (false-
negative) or included (false positive) depending on confounding factors such as 
non-compliance or variability in pharmacokinetics of PABA.        
1.17.2 Spot urine collection                                                                                                                                                               
Overnight and spot (casual or single) urine collections have been proposed as 
low-burden alternatives to the 24-hour collection (231). In these techniques 
fewer voidings are required and the participant does not have to continue the 
collection during daily activities. 
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A single voiding of the bladder is all that is required for a spot urine collection. 
Sodium concentration and ratios to creatinine and potassium are obtained from 
laboratory analysis. Time of day of the collection should be standardized to 
minimize error introduced by diurnal variation in urinary solute excretion (232). 
The results of Stanbury and Thomson (233) allow estimations of variability in the 
ratios of sodium: potassium (Na:K) and sodium:creatinine (Na:Cr) across 
different urine specimens throughout the day. Large variations are apparent, not 
only between individuals but also within individuals in adjacent time periods.  
Cummins et. al. (234) were sceptical of the use of sodium concentration from 
spot urines as a proxy for sodium excretion. They argued that sodium 
concentration relies not only on the quantity of sodium, but also the volume of 
fluid ingested (which varies greatly throughout the day along with sodium 
consumption), and the amount of water required by the kidneys to excrete a 
given quantity of sodium. The wide variation in Na:K and Na:Cr ratios within 
individuals reflect the fact that both numerator and denominator are dynamic 
variables. 
Nonetheless, Walker et. al. (235) reported significant correlations between 
Na:Cr ratios in spot urine and 24-hour urine collections. For 18 individuals with 
normal blood pressure the correlation coefficient was 0.62 while for 37 
hypertensive individuals the coefficient was 0.56. Moore et. al. (236) reported a 
significant correlation between 24-hour urinary sodium and the Na:Cr ratio of 
the next voided (morning) spot urine (r = 0.84) in eight individuals under 30 
years of age with essential hypertension, but no significant correlations were 
apparent in 18 older people. In another study, Milne et. al. (237) reported on a 
study of 97 men showing significant correlations (r = 0.25 to 0.52) between 
sodium excretion in urine samples at different times of the day and in 24-hour 
collections of urine. They suggested that spot urine specimens might be useful in 
differentiating between individuals with large differences in electrolyte 
excretion.  
Widdowson et. al. (232) collected single specimens of urine to study the 
excretion of urinary electrolytes by young children in Uganda and Cambridge, 
United Kingdom, and concluded that the method was useful for a group, 
although not necessarily for individuals. Dauncey et. al. (238) used single urine 
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specimens to estimate electrolyte excretion in five British towns. In a small 
validation study in 10 men, they found non-significant differences in estimated 
sodium excretion over 24 hours on comparing spot values with those measured in 
24-hour urine collections. Ratios for Na:Cr ranged from 2.1 to 2.9 in four spot 
urine collections over a 24-hour period. 
In an analysis of the 10 079 men and women from 52 population samples of the 
INTERSALT Study, the investigators found the ratio of sodium to creatinine 
assessed by spot urine to be positively correlated with sodium excretion from an 
independent 24-hour collection (r = 0.82 between population samples and r = 
0.37 between individuals) (221). Khaw et. al.(33) reported similar estimates of 
mean sodium excretion based on spot urines and repeated 24-hour urine 
collections. 
The Japanese investigators have been pioneers in developing methods to 
estimate sodium excretion based on spot urine samples. Kawasaki et. al. (239) 
reported a method of estimating 24-hour urinary sodium and potassium 
excretion from second morning voiding urine in adults. The study involved 
analysis of 24-hour urine samples and second morning voiding urine (SMU) 
specimen collected within 4 h after the first voiding upon awakening (but before 
breakfast) in 159 participants. Results from the study revealed a strong, positive 
and significant association between sodium concentration from both estimated 
and measured (r = 0.728, p < 0.001). 
More recently, Tanaka et. al. (240) proposed a method of estimating the 24-hour 
urinary sodium and potassium excretion based on casual spot urine collection. 
The investigators demonstrated that Na:Cr ratio in the casual spot urine samples 
correlates relatively well with the Na:Cr ratio in 24-hour urine sampling            
(r = 0.65, p < 0.01). The estimated sodium excretion calculated based on 
formula incorporating the estimated 24-hour urinary creatinine excretion is also 
reportedly close to the actually measured 24-hour urinary sodium excretion        
(r = 0.54, p < 0.01). It has been suggested that this method of sodium 
assessment, though limited in reliability, is simple enough to be implemented 
and practical in clinical settings (220). 
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1.17.3 Food diary and 24-hour recall 
Food diary is another commonly used method to assess dietary sodium intake. In 
this method, subjects are taught to describe and provide an estimate of the 
portion size or weight of the food eaten.  Information about the weight of food 
consumed may be obtained either by requesting subjects to weigh the food or to 
describe portions of food in terms of household measures, pictures, food models, 
or pack sizes.  Typically, these descriptions are then incorporated into computer 
programs to generate information regarding nutrient intake (224). 
The number of days in which dietary intake is recorded may vary.  The research 
question may play a role in determining the number of days for food intake to be 
recorded.  The ideal number of daily food records will differ according to the 
researcher’s aim of either investigating the mean of a population or an 
individual.  The number of daily food records may also vary depending on 
whether the investigator is interested in a person’s single day’s diet or typical 
eating habits of an individual or population (227). 
An important issue to consider is whether a single day food record estimates 
dietary intake as well as multiple day food records.  Caggiula et. al. (241)     
conducted a study in which single versus multiple-day food records were 
compared for estimates of intake for sodium, potassium, and calories.  For 
sodium, the averages from the one, two, and three days of food records all 
correlated strongly with the six-day average.  Correlations ranged from 0.81 – 
0.93 with the strongest correlation between the three and six-day averages.  
This is an expected finding since each day represented a portion of the 
variability in the six-day mean (227).  As the number of days is increased, more 
of the variability was accounted for and the resulting correlation should be 
improved.  These results indicate that when estimating group averages for 
sodium intake, the one-day record provided a value nearly as close to the six-
day mean as a three-day average. 
The same conclusion however, cannot be applied if the goal is to estimate 
individual intake (241). Absolute differences and mean percent differences were 
calculated between the one, two, and three-day means and the six-day mean.  
The largest absolute difference was obtained with the one-day mean.  This 
89 
[Type text] 
 
difference was decreased by 40-50% when the number of days was increased to 
three.  The three-day record had the smallest mean percent difference from the 
six-day record.  The inability of a one-day food record to closely approximate 
another day or days is largely due to the high degree of intrasubject variability 
between days. 
Measures of daily nutrient intake have low reliability due to the intrasubject 
variability.  A single day dietary record should not be obtained if the goal of the 
investigator is to evaluate whether or not an individual has changed their usual 
diet as a result of an intervention (227). 
Acheson et. al. compared variation of intake among periods of one day and  one, 
two, three, and four weeks (242).  The coefficient of variation improved 
dramatically between one day and one week.  The coefficient of variation did 
not improve significantly for periods longer than one week.  It may be suggested, 
based on these data, that the determination of habitual or usual intake should 
be one week.  However, there are several limitations to this study (227).  First, 
the focus of this study was energy intake.  It was not specific to sodium.  
Second, the sample consisted of only 12 men with a mean age of 24.  Third, the 
study sample was confined to an Antarctic base and the diet was fairly limited, 
consisting mostly of tinned and dehydrated food supplemented by frozen meat 
two to three times a week. 
Another common method to be used in dietary assessment is the 24-hour recall.  
This method may be an interview or written information concerning the previous 
day’s intake.  The actual foods consumed within the previous 24 hours were 
described and information on portion sizes or weights were obtained (227). This 
particular technique provides an ideal method and commonly employed by 
government agencies for national surveys (e.g. US National Health and Nutrition 
Examination Survey). 
Both food diary and 24-hour recall depend on the ability of the participant to 
provide accurate information.  Nelson reported the reliability, or repeatability, 
of 24-hour recalls to generally be good (243).  Other studies have reported 
sodium estimates by dietary recall (r = 0.19 – 0.28) to be less repeatable than by 
urine (r = 0.24 – 0.30) (244;245). Nonetheless, good reliability does not imply 
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validity.  It is therefore necessary to establish the validity of the responses 
obtained.  A valid external measure would be ideal to assess the validity of the 
measurements. A 24-hour urine, if correctly collected, is often used as an 
external measure to assess validity of these measures (241). Another 
consideration is whether dietary recalls and food diaries should include 
weekdays and weekends.  The variability of daily intakes may be high due to 
differing intakes during weekdays and weekends.  Acheson et. al. found a 
significantly higher intake on Saturdays compared to Tuesdays (P<0.05) (242). 
1.17.4 Food Frequency Questionnaire 
Food Frequency Questionnaire (FFQ) is defined as “ A questionnaire in which the 
respondent is presented with a list of foods and is required to indicate how often 
each is eaten in broad terms such as x times per day/per week/per month, etc” 
(246).  Commonly, it is designed to assess nutrient intake including both macro- 
and micro-nutrients, and foods/food groups consumptions. Questionnaires used 
may either be developed from basic principles or adapted from existing 
questionnaires. They may either be interviewer- or self-administered according 
to the need of the study. 
FFQ has been widely used among epidemiologists as a means to characterize the 
‘usual’ dietary pattern of free living individuals. From a statistical perspective, 
FFQ’s are the only dietary intake measure with the potential to minimize the 
very high intra-individual, day-to-day variability in nutrient intake without 
relying on multiple-day assessments of actual foods consumption (e.g. 7-day 
dietary record) (247). The earliest approach to quantifying usual dietary intake 
was the diet history, developed by Burke et. al. (248). These were professionally 
administered, 1½ hour interviews, eliciting descriptions of ‘usual’ meals and 
snacks, portion sizes, frequency of food consumption from broad food groups 
(e.g. meat, fish) and frequency of deviations from usual patterns. These data 
were combined to generate estimates of usual nutrient intake, based on hand-
calculations from food tables.  
Progressing through 1950s and 1960s, nutritionists then started to develop 
questionnaires for the assessment of habitual food intake based on a checklist of 
foods consumed over a set time period. These attempts allowed for 
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standardization of the data collected and reduced both cost and bias when 
collecting these data (247). Later in 1970’s through 1980s, the ‘semi-
quantitative’ FFQ was introduced, in which the standardized list of foods was 
more comprehensive, the nutrient databases were more carefully constructed, 
and portion sizes and seasonability were incorporated into software that 
generated nutrient estimates (249;250). After further refinement, revision and 
appraisal during the 1980’s and 1990’s, FFQ has become one of the key research 
tools in nutrition epidemiology (251). 
The analytic strategy is the same for all FFQs. The frequency of consumption is 
multiplied by portion size and by nutrient density, and these later are summed 
to obtain nutrient totals. Some of the FFQs may include supplementary questions 
such as the types of milk usually consumed and whether chicken is eaten with or 
without skin. Answers to these questions are incorporated into analysis software 
to better refine calculation of nutrient intakes (247).  
In general, a food frequency questionnaire (FFQ) is used in large-scale 
epidemiological studies. FFQs are often used because they are more cost-
effective and easier to administer compared to other methods of dietary 
assessment such as weighed dietary records (WDR) or 24-hour recall (252). Other 
benefits and limitation of FFQs are summarized in Table 1-7. 
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Table 1-7. Summary of comparison between advantages and limitations of FFQs. 
 
Advantages Limitations 
 Suitable for population surveys 
 Relatively inexpensive 
 Most amenable to web-based 
administration 
 Recent improvement include on-line 
and web-based versions (provide 
convenient) 
 Ability to capture intake of all 
nutrients of interest, and can provide 
information on overall dietary 
adequacy 
 Supplementary questions may be 
included 
 
 Typically long in view of the need to be 
comprehensive of common food 
products 
 Should the questionnaire be 
administered by interviewers, an 
extensive training is required to ensure 
data consistency 
 Usually requires validation against food 
diaries or biochemistry analysis in a 
sub-sample of the same population. 
 Depending on the period of 
assessment, may be subjected to recall 
bias (especially when diet is assessed 
over long periods of time e.g. previous 
12 months) 
 
Adapted from WHO (253). 
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1.18 Aims of the thesis: 
The specific aims of this thesis are: 
1) To develop/modify a food frequency questionnaire (FFQ) for sodium 
intake assessment tailored to local UK foods and common portion sizes. 
2) To validate the modified version of the FFQ against corrected spot urine 
for sodium. 
3) To investigate the status of sodium intake among hypertensive patients by 
using modified FFQ as the assessment tool. 
4) To determine patients knowledge, attitude and perception regarding 
dietary sodium intake. 
5) To investigate the impact of sodium consumption (as estimated from the 
modified FFQ and spot urine sodium) on blood pressure control among 
hypertensive patients. 
6) To explore the relationship between serum sodium and mortality. 
 
Hypotheses:  
1) Modified Food Frequency Questionnaire (FFQ) can help assess awareness 
of sodium intake. 
2) Sodium consumption (as estimated from the modified FFQ) will predict 
longitudinal blood pressure control in hypertensive patients. 
3) Serum sodium levels will predict mortality in hypertensive patients due to 
its adverse effect on blood pressure control. 
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2 Materials and methods 
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2.1 Patient recruitment for questionnaires-related study 
All subjects were recruited from the Glasgow Blood Pressure Clinic, Western 
Infirmary, Glasgow. The clinic appointment list for the coming month (containing 
patient’s name, registration number and time of appointment) was obtained 
from the BP clinic’s office. Based on the list provided, the patients’ address was 
traced by using the NHS PAS system. 
2.2 Questionnaires 
2.2.1 Questionnaire to estimate sodium intake 
For the salt consumption assessment, the sodium Food Frequency Questionnaire 
(FFQ) developed by Charlton et. al. (254) was used. The investigators 
constructed the questionnaire based on a cross-sectional validation study in 324 
conveniently sampled men and women. A repeated 24-hour urinary sodium 
values and 24-hour dietary record, obtained on 3 occasions were used to validate 
the questionnaire. Food items consumed by equals or more than 5% of the 
sample and which contributed ≥ 50mg sodium per serving were included in the 
questionnaire in 42 different categories. These included both food sources with 
inherent sodium, such as milk, as well as food items with a high added salt 
content, such as processed meat.  
Patients were instructed to recall their diet for the past seven days, and marked 
each relevant food category with matched frequency. For each food category on 
the list, there is a sodium conversion factor. Total sodium consumption was 
derived based on sodium content of one index food per category multiply by 
frequency of consumption. Results were presented as X g of sodium per day.  
2.2.2 Modification of the original questionnaire  
2.2.2.1 Food elimination 
The food items listed on the original questionnaire were screened and with the 
help of an expert dietician, foods which are not a custom to the locals were 
eliminated. Foods which were eliminated from the original version of the 
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questionnaire include koeksister, biltong/ dry wors, chakalaka, and monkey 
gland.   
2.2.2.2 Category substitution 
The ‘biltong/dry wors/fish biltong’ category from the original questionnaire was 
removed and a category of ‘dried salted meat, beef jerky and smoked fish’ was 
added as a substitute. 
2.2.2.3 Brand substitution and addition 
The following brand substitution and addition were made from the original 
questionnaire; ProVita® were changed to Tac®, Simba® were changed to 
Walkers® and McVitie’s® was added as an example of biscuit brand. 
2.2.2.4 Modification of sodium content in each food category 
Since the original version of the FFQ was constructed based on South African 
MRC Food Composition Table, a modification of sodium content in each food 
category was made based on UK Food Composition Table. The following steps 
were undertaken to convert the sodium content of each food category from the 
original FFQ: 
 Step 1 
For each of the food item listed in the modified version of the FFQ, the 
exact-matched food was searched from the UK Food Composition table. All 
varieties of the particular food were also included. The amount of sodium in 
the UK Food Composition table was listed as mg per 100g serving. The 
average amount of sodium for each food category were then calculated (e.g. 
for white bread, there were 14 varieties of white bread listed in the UK Food 
Composition table. Sodium content for each of the bread ranges from 439mg 
to 710mg (per 100g serving). The total amount of sodium (per 100g serving) 
for all of these white bread were summed up, then later divided by 14, which 
represents the sodium content (per 100g serving) for white bread category). 
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 Step 2 
To estimate average portion size of food consumption, the Food Portion Size 
book (255) was used along with the consultation from the dietician.  
 Step 3 
Sodium content for common portion size for each food category was finally 
calculated based on the following formula (Refer Chapter 3 Table 3-1 for 
detailed listing): 
 
2.2.3 Pilot study  
The modified version of sodium intake questionnaires was then distributed 
among 14 healthy volunteers at the Glasgow Cardiovascular Research Centre for 
a pilot study. Minor changes were made to the questionnaire based on the 
feedbacks given by the participants. These include font sizes and spacing. The 
final version of the questionnaire after the amendment is included in Appendix 
1. 
2.2.4 Questionnaire related to salt intake awareness 
A total of eight questions related to general information on salt were included in 
this section. This questionnaire was adapted based on Consensus Action on Salt 
and Health (CASH) study (256), which covers four main aspects related to sodium 
intake awareness, knowledge, attitude and perception (KAP). For KAP 
questionnaire, patients were requested to select one answer for each question, 
excluding the question on possible complications of hypertension where patients 
may select more than one answer (Appendix 2). 
 
  
Average sodium for each food category      X      Common portion sizes 
  100 gm      (gm) estimated from Step 2 
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2.3 Mailing of the questionnaire 
A cover letter, salt estimation and KAP questionnaires were mailed to the 
patients at pertaining address one week prior to their clinic appointment. In the 
cover letter, all patients were invited to participate in the study. Patients were 
instructed to complete the questionnaires and return to the clinic during their 
appointment. Alternatively, they can return the questionnaires via mail at the 
address as stated. 
2.4 Data entry 
For sodium intake FFQ, each individual response from patients were transferred 
to an excel file where total sodium consumption per day were calculated. This 
result was then transferred to the SPSS program together with the response from 
KAP questionnaire. 
2.5 Questionnaire feedbacks 
All patients were offered feedbacks regarding the questionnaires that had been 
completed. Patients had the options of having a personal session during their 
next clinic visit or being notified via mail. Each patient received a summary of 
personalized daily salt intake status and was offered advice regarding a healthy 
salt intake. A leaflet containing information regarding low-salt diet was also 
distributed to the patients. 
2.6 Laboratory tests 
2.6.1 24-hour urine collection 
A single 24-hour urine sample was collected from sub-sample of the study 
population. Subjects were provided with a plastic container. On the day of the 
collection, patients were instructed to discard their first urine of the day upon 
awakening. The collection was then started from the second time the patient 
passed urine, and continues for the next 24 hours including the first urine of the 
next morning. Patients were instructed to store the container in a cool, dark 
place before returning them to the clinic on the following day. The collected 
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urine was then sent to the Biochemistry laboratory in the Gartnavel General 
Hospital for electrolyte measurements. 
2.6.2 Spot urine samples 
Spot urine samples were obtained from patients upon the collection of the 
completed questionnaire, when they arrived for clinic’s appointment at the 
Glasgow Blood Pressure Clinic. A plastic vial is provided to each patient, and 
they were instructed to collect a midflow sample.  
2.6.3 Urinary electrolyte and creatinine 
Urinary electrolyte (sodium, potassium, urea and chloride) were measured in the 
routine clinical biochemistry laboratory, Gartnavel General Hospital, Glasgow, 
using an Ion specific electrode method. Creatinine was measured using the 
colorimetric method.  
2.7 Data from Glasgow Blood Pressure Clinic Database 
2.7.1 Study setting and study population  
The Glasgow blood pressure clinic (GBPC) provides secondary and tertiary level 
service to individuals with hypertension from the West of Scotland. Data from 
patients attending the clinic are stored in a computerised database, which 
contains information of individuals attending the clinic from the mid 1970s until 
2011.  Record linkage with the office of the Register General for Scotland allows 
identification of all deaths and causes of death in clinic attendees.  
2.7.2 Collection of data and follow up  
All patients were treated at GBPC until they achieve target BP and are 
maintained at that level for at least three months. The frequency of visits to 
GBPC mainly depends on individual patients BP levels and presence of other co-
morbidities. Patients who achieved the target BP level were transferred back to 
the referring physician for ongoing management.  
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2.7.3 Clinical measurements  
Blood pressure measurements were taken manually 3 times, using standardized 
sphygmomanometers at each visit by specialist hypertension nurses; the mean of 
the last 2 measurements is recorded at each visit. Patients attending the clinic 
were advised to take their regular medications as usual. Height and weight of all 
patients were measured using standardized equipment during each visit. Blood 
samples were collected at baseline and at regular intervals for estimation of 
routine haematological and biochemical indices. Estimated glomerular filtration 
rate (eGFR) was calculated from the baseline serum creatinine values using the 
Modification of Diet in Renal Disease Study Group (MDRD) equation (257). A 
structured format was used to assess the presence of existing cardiovascular 
disease, tobacco (any versus none) and alcohol use (any versus none). All data 
were electronically captured and maintained as a large single database.  
 
2.7.4 Outcome assessment  
Records kept by the General Register Office for Scotland ensured notification of 
a subject’s death (provided that it occurred in the United Kingdom) together 
with the primary cause of death according to the International Classification of 
Diseases, 10th Revision, Version for 2007 (ICD-10), codes. We considered 
cardiovascular deaths (CVD mortality; ICD-10 codes I00-I99), ischemic heart 
disease deaths (IHD mortality; ICD-10 codes 120-I25), and stroke deaths (stroke 
mortality; ICD-10 codes I60-I69) in the analysis. Deaths other than due to 
cardiovascular causes are classified as non-CVD deaths. Mortality data were 
collected up to April 2011 allowing a maximum of 35 years for participants who 
had been under follow up for the longest time. 
 
2.8 Statistical analysis 
Statistical Package for the Social Sciences (SPSS. version 18.0) and Data Analysis 
and Statistical Software (STATA Version 12.0) were used for data recording and 
analysis. Details on specific analysis used were described in each chapter under 
the ‘statistical analysis’ section.  
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3 Modification and validation of questionnaire to 
estimate sodium intake  
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3.1 Introduction 
Estimation of salt intake among hypertensive patients is important for accurate 
advice concerning the need for reduction. Daily salt intake may be estimated 
using food consumption data collected from interviews and diaries, spot urine 
collection or from 24 hour urinary sodium excretion. Each method has its own 
advantages and disadvantages, with some relatively more inconvenient to 
perform than the others (227). 
There are various issues concerning the methods for dietary sodium 
measurement. High intra-subject (45%) and inter-subject (45-56%) variability for 
reporting of non-discretionary salt usage may influence reliability of food record 
estimates (258). It has been suggested that 81 days of dietary recording would 
be required to estimate an individual’s intake within 10% of the observed mean. 
For this reason, the gold standard for assessment of salt intake is considered to 
be repeated 24-hour urinary sodium excretion (259). This method, though 
accurate, is not ideal for large community-based studies since it is time-
consuming and inconvenient to the individual performing the collections. 
Incomplete urine collections are also quite common, resulting in under-
estimation.   
A simple method to estimate population mean levels of 24-hour urinary sodium 
excretion from spot urine specimens has been developed by Japanese 
investigators (240). This particular method has been suggested to be more 
convenient and applicable for an out-patient setting. The investigators 
estimated daily salt intake by using formulas comprising of predicted creatinine 
excretion multiply by sodium to creatinine ratio, derived from a “spot” urine 
specimen. The results showed a high correlation between spot urine sodium 
concentration and 24 hour urinary sodium excretion. Despite the reliability of 
the spot urine method in estimating salt consumption has been confirmed in 
population studies, its role in estimating individual salt intake remains uncertain 
(254). 
The food frequency questionnaire (FFQ) has been proposed as a precise measure 
for the evaluation of the intake of nutrients, and has been used extensively for 
various purposes (246). For example, Charlton et. al. (254) developed a short 
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FFQ for dietary salt intake assessment among multi-ethnic, economically active 
South African sample. The questionnaire was constructed based on repeated 24-
hour urinary values and dietary recalls obtained on 3 occasions. Results from the 
study revealed that FFQ performs as well as the dietary recalls against urinary 
sodium excretion and shows an acceptable correlation against the repeated 
dietary recalls.  
In an out-patient hypertension clinic setting, the estimation of salt intake should 
ideally be accomplished for all patients so as to complement patient’s optimum 
hypertensive management. While time constraints in clinics make this difficult, 
short questionnaires such as those previously discussed, suitably adapted to local 
foods, could be used for this purpose. Therefore, the aim of the present study 
was to modify the FFQ for salt intake estimation which has been developed by 
Charlton & colleagues and have it validated against spot urine sodium among 
out-patient hypertensive patients.  
 
3.2 Methods 
Detail methods for this chapter regarding questionnaire modification have been 
previously discussed in Chapter 2 Section 2.1 up to 2.6. In total, 997 
questionnaires we mailed to patients at the Glasgow Blood Pressure Clinic 
between the periods of 1st May 2009 to 30th June 2010. 
3.2.1 Corrected spot urine for sodium concentration 
Biochemistry result for sodium concentration from the spot urine collections 
were corrected based on formula by Tanaka et. al. (240). Detail discussions were 
outlined in Chapter 5, Section 5.2.2. 
3.2.2 Sub-samples for repeat FFQ (Reproducibility test) 
For repeat FFQ assessments, an interval of 1 year was used to administer the 
repeat questionnaires for two reasons. 1) According to Cade et. al. it is not 
recommended to administer a repeated FFQ at a very short interval as 
respondents may still remember, and tend to repeat their previous responses 
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(251), 2)At GBPC, repeat clinic appointments are commonly scheduled at 6 to 
12-monthly interval. Therefore, a one year interval was chosen to address the 
first issue and also to ensure that all subjects were administered the repeat 
questionnaire at approximately similar interval periods.  A total of 62 patients 
completed the questionnaire in May 2009, hence the repeated FFQ were sent to 
all of these patients 12 months later (May 2010). From published literature, 
reproducibility testing of questionnaires is done with around 20-25 samples. In 
this study 62 subjects completed the repeat questionnaires and all of them were 
included to assess reproducibility. 
3.2.3 Sub-samples for 24-hour urine collection 
Patients who returned the questionnaires and provided spot urine samples were 
approached to provide a single 24-hour urine collection. A random sampling 
method has been attempted, however, due to poor patient compliance with this 
procedure, complete 24-hour urine collection were only available for eight 
patients. This is a limitation of the study and other methods to improve patient 
compliance with 24-hour urine collection will need to be explored in future 
studies. 
3.2.4 Data analysis 
Mean, standard deviation, median and range were used to describe the results of 
sodium intake estimation based on FFQ and corrected spot urine. Pearson’s 
correlation was used to investigate the association between FFQ, corrected spot 
urine, and 24-hour urine collection. To test the agreement, kappa analysis was 
performed while paired sample t-test was used to identify any discrepancy 
between the two measurements from the FFQ in the subsample analysis. For 
Kappa analysis, sodium levels were categorized accordingly. For FFQ, patients 
who consumed more than 2.4 g of sodium/day (equivalent to 6g of salt/day) 
were labelled as ‘high’ while those with 2.4 g of sodium/day and below were 
categorized as ‘not high’. Similarly, for corrected spot urine, patients with more 
than 100 mEq of sodium/day (equivalent to 6g of salt /day) were considered as 
‘high’ while those with 100 mEq of sodium/day and below were categorized as 
‘not high’. Sensitivity and specificity analysis were also performed to test the 
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precision of the modified FFQ. All results were analysed using SPSS version 18 
and tables and figures were presented as the followings. 
3.3 Results 
Out of 997 questionnaires being sent throughout the study period, 632 were 
returned to the clinic. Three questionnaires were rejected since the patients did 
not answer the FFQ section at all or replied ‘never’ for all of the foods listed, 
and two questionnaires were returned to the clinic due to unknown address. 
Total FFQ included in the final analysis was 627, providing a response rate of 
63%. With regards to subsample of patients where the FFQ were mailed for a 
second time at 12 months later, thirty one out of sixty two patients replied, 
providing a response rate of 50%. Spot urine samples were collected on 234 
patients, whereas only eight patients agreed to provide 24-hour urine samples. 
Detailed demographic of patients who completed the FFQ were presented in 
Chapter 5 Table 5-2. 
The various food items included in the FFQ, common portion size and average 
sodium content per serving were all listed in Table 3-1. There were 42-
categories of items listed in the questionnaire, mainly consisting of processed 
foods such as meat products, snacks and fast foods. Patients were asked how 
frequently each food category was consumed during the past seven days, with 
options for response ranging from ‘never’ up to ‘three times or more daily’. 
Detail methods on how the FFQ provides estimate for daily sodium consumption 
were discussed in Chapter 2 Section 2.2.1. 
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3.3.1 Determination of average Na content for each food category 
Table 3-1. Various food items, common portion sizes, and sodium content per serving as listed in the modified version of the FFQ. 
 
Food Average sodium  
content (mg) /100g 
Common portion sizes Average sodium content/ 
serving 
White bread/ white bread rolls/ pita /croissants 545.5 2 slices = 72g 392.8 
Brown/ wholewheat bread/ rolls 543.1 2 slices = 72g 391.1 
Breakfast cereal (processed eg. cornflakes,  
rice crispies) 
452.6 30g 135.8 
Breakfast cereal (minimally processed-weetbix,  
muesli, etc.) 
337.4 50g 168.7 
Crackers (Tac, etc.) 650.5 3 pieces = 21g 136.6 
Cookies, biscuits, rusks (McVitie’s, etc.) 314.3 3 pieces = 30g 94.3 
Cake/ scone/ muffin/ puddings/ pancake/  
fruit pie/ tarts 
283.0 60g 169.8 
Roti/ samosa/ spring roll/ doughnut 253.1 130g 329.0 
Pizza 319.6 2 slices = 167g  533.7 
Pasta or noodle dishes with cheese sauces  
(macaroni cheese, lasagne, noodle salad,  
spaghetti bolognaise etc.) 
247.9 230g 570.1 
Popcorn 30.0 75g 22.5 
Crisps (Walkers,etc.) 794.3 40g 317.7 
Beef sausages 1096.7 2 pieces = 80g  877.3 
Processed meat, cooked, smoked or  
canned eg Salami/ bacon/ pork sausages 
1076.9 46g 495.4 
Meat or chicken pies/ sausage rolls 502.3 130g 653.0 
Chicken – battered (KFC, etc.) or chicken burger  405.6 2 pieces =140g  567.8 
Meat and meat dishes (steaks, minced meat,  
cottage pie, mince, meatballs, stew, chicken stew etc.) 
144.2 310g 447.0 
Gravy, made with stock or gravy powder 3395.0 50g 1697.5 
Dried salted meat/ beef jerky/ smoked fish 2127.1 56g 1191.2 
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Food Average sodium  
content (mg) /100g 
Common portion sizes Average sodium content/ 
serving 
Milk (all types, also dairy fruit juice, malted milk,  
milk shakes, chocolate drinks, evaporated & condensed milk) 
130.0 200g 260.1 
Fermented milk/ sour milk 0.01g/65 ml bottle 1 bottle 0.01 
Cheese 693.7 40g 277.5 
Yogurt 82.9 125g 103.7 
Eggs (any preparation) 380.7 50g 190.4 
Tinned fish (tuna, sardines, etc.) 628.6 100g 628.6 
Other fish and seafood (eg battered fish, prawns,  
crabs, mussels) 
244.2 150g 366.3 
Potato chips/ French fries or potato salad 67.7 165g 111.7 
Canned vegetables, including baked beans, tomato paste,  
sweet corn, olives etc. 
359.6 135g 485.5 
Soup (all types) 1263.6 220g 2780.0 
Salad dressing/ mayonnaise 806.9 30g 242.1 
Ice cream (all types) 68.2 75g 51.1 
Margarines, all types, also butter 656.6 14g 91.9 
Worcester sauce/relish/ barbecue or steak sauce 922.1 20g 184.4 
Savoury sauces (mushroom, white, cheese) 766.5 62g 475.2 
Tomato sauce/ Ketchup 985.0 20g 197.0 
Salt (added to cooking or at the table) 38850.0 1g 388.5 
Mustard/ all purpose seasoning mix 2285.0 2g 45.7 
Peanuts (salted/unsalted/raw) 260.6 50g 130.3 
Peanut butter 360.0 25g 90.0 
Marmite/ Bovril 4335.0 9g 390.2 
Chocolate - sweets or sauce 103.5 54g 55.9 
Beer and cider 7.2 1 pint = 574g  41.5 
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3.3.2 Validating the questionnaire 
3.3.2.1 Sodium estimation from FFQ and corrected spot urine for    
sodium 
Table 3-2. Comparison between sodium estimation based on the FFQ and corrected spot 
urine for sodium. 
 
 Spot urine 
(mmol/day) 
Spot urine      
(g/day equivalent) 
 
FFQ (g/day) 
N 234 234 234 
Mean 
Overall 
Men 
Women 
 
                                    
99.08 
103.53 
95.13 
                                                 
2.279 
2.381 
2.188 
 
 
                                
3.779 
4.008 
3.580 
SD 
 
30.938 0.712 1.695 
Median 97.10 2.23 3.60 
Range 33 - 262 0.76 – 6.03 0.6 – 10.6 
 
Sodium estimation based on questionnaire revealed higher results for the overall 
mean, men and women when compared against the results from corrected spot 
urine for sodium. Further analysis showed a significant difference between the 
average sodium intake between men and women based on corrected spot urine 
(p = 0.020), but not according to the FFQ (p = 0.408). 
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3.3.2.2 Correlation between FFQ and corrected spot urine sodium 
Figure 3-1. Scatter plot showing the correlation between FFQ and adjusted spot urine 
sodium (n=234). 
 
 
 
There appears to be little correlation between sodium intake estimation from 
the FFQ and corrected spot urine sodium (r = 0.092, p = 0.155). 
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3.3.2.3 Test of agreement (Kappa) between FFQ and corrected 
spot urine sodium 
 
Table 3-3. Kappa analysis between FFQ and corrected spot urine sodium (n=234). 
 
Symmetric Measures 
 Value Std. Error CI Approx. Sig. 
Measure of Agreement Kappa .056 .052 -0.046 to 0.158 .281 
N of Valid Cases 234    
 
Kappa analysis revealed only slight agreement between the FFQ and corrected 
spot urine for sodium (260). The result however was found to be non-significant 
(p = 0.281). 
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3.3.2.4 Sensitivity and specificity of FFQ 
Table 3-4. Crosstabulation between categories of sodium intake as assessed by FFQ and 
corrected spot urine sodium. 
 
  
Corrected spot urine sodium 
 
 
 
Total 
 
High 
 
Not High 
  F
F
Q
 
High                Count 
 
                 % of total  
 
85 
 
36.3% 
95 
 
40.6% 
180 
 
76.9% 
Not High          Count 
 
                  % of total 
 
21 
 
9.0% 
33 
 
14.1% 
54 
 
23.1% 
                                          Count 
Total 
                                     % of total 
106 
 
45.3% 
128 
 
54.7% 
234 
 
100.0% 
 
 
A sensitivity and specificity values were derived based on the above 
crosstabulation table. The questionnaire was demonstrated to have a sensitivity 
value of 80.2% and specificity of 25.8% against corrected spot urine sodium. 
Positive predictive value was found to be 47.2% and negative predicted value 
was 61.1%. 
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3.3.2.5 Reproducibility test 
Figure 3-2. Scatterplot showing correlation between results of daily sodium intake derived 
from baseline FFQ compared to the same FFQ administered at 12-months later. 
 
 
 
 
Figure 3-2 illustrates the correlation between the results from FFQ administered 
at baseline, and the same FFQ which was administered at 12 months later. The 
correlation between the two results were found to be moderate and significance 
(r = 0.619 and p = 0.000). 
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3.3.2.6 Test of agreement (Kappa) between first FFQ and second 
FFQ 
Table 3-5. Crosstabulation between the results from the first administered FFQ compared 
against the results from the same FFQ administered at 12-months interval. 
 
  
FFQ2 
 
 
 
Total 
 
High 
 
Not High 
  F
F
Q
1
 
High                Count 
 
                 % of total  
 
20 
 
64.5% 
1 
 
3.2% 
21 
 
67.7% 
Not High          Count 
 
                  % of total 
 
5 
 
16.1% 
5 
 
16.1% 
10 
 
32.3% 
                                          Count 
Total 
                                     % of total 
25 
 
80.6% 
6 
 
19.4% 
31 
 
100.0% 
 
 
 
Table 3-6. Kappa analysis between the first FFQ and second FFQ. 
 
Based on the crosstabulation table as demonstrated in Table 3-5, a Kappa 
analysis was computed. The results revealed a moderate and significant 
agreement between the two measurements (K = 0.505, p = 0.003). 
 
 
Symmetric Measures 
 Value Std. Errora CI Approx. Sig. 
Measure of Agreement Kappa .505 .168 0.176 to 0.834 .003 
N of Valid Cases 31    
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3.3.2.7 Paired t-test between baseline FFQ and FFQ administered at 12 months later 
 
Table 3-7. Paired samples t-test result for the first FFQ administered at baseline and second FFQ administered at 12 months later. 
Paired Samples Test 
 
Paired Differences 
t df Sig. (2-tailed) Mean Std. Deviation Std. Error Mean 
95% Confidence Interval of the 
Difference 
Lower Upper 
Pair 1 FFQ 1 and FFQ2 -.1549 1.5109 .2714 -.7091 .3993 -.571 30 .572 
 
 
Paired samples t-test between the results from the first FFQ administered at baseline and second FFQ which was administered at 12 
months later showed no significant difference between the two measurements (p = 0.572). 
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3.3.3 Sub-sample analysis 
3.3.3.1 Correlation between 24-hour urine sodium, spot urine 
sodium and FFQ 
 
Figure 3-3. Scatter plot of sodium intake as estimated according to FFQ compared against 
urine 24-hour urine and corrected spot urine for sodium. 
 
 
 
 
 
Pearson correlation showed a positive, moderate correlation (though non-
significance) between sodium estimation from FFQ and corrected spot urine 
sodium in our sub-sample analysis. Other correlations (FFQ vs. corrected spot 
urine sodium, 24-hour urine sodium vs. corrected spot urine sodium) revealed 
poor, non-significant association. 
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3.3.4 Discussion 
Accurate estimation of sodium intake is challenging due to varied sodium 
distribution in foods, widespread use of sodium chloride in cooking and as table 
salt, and the extensive use of sodium compounds in food processing (254). In 
United Kingdom, the average salt intake as determine from by 24-hour urinary 
sodium was 9.5 g/day (261) which was higher than current recommended value 
of no more than 6 g/day (13). Processed foods are thought to account for as 
much as 80% of total salt intake, followed by discretionary salt usage (15%) and 
naturally presence in foods (5%). 
Determination of salt intake among hypertensive patients is important since 
dietary salt restriction had been proven to improve blood pressure control in 
conjunction with optimum pharmacological management. In order for advice to 
reduce salt intake to be targeted to those with excessive intakes, reliable 
estimations of habitual intake are required. We developed a modified version of 
sodium intake assessment tool based on the original FFQ developed by Charlton 
et. al. (254). This fast and convenient instrument of sodium intake measurement 
may be used as a motivational tool to quantify daily dietary salt intake and to 
set targets for lifestyle changes within out-patient clinic setting.  
Urinary sodium is considered to be the ‘gold-standard’ for estimation of sodium 
intake, although it does not provide information regarding the quantity of 
nutrients consumed, nor what dietary habits are involved. It is therefore of 
limited value in planning educational including diet intervention (262). In this 
study, we use the modified sodium FFQ containing list of foods which were 
mainly high in sodium content. This FFQ was validated against spot urine sodium 
which had been corrected according to Tanaka et. al. (240). This method of 
correction allows the urine sample to be collected at ‘one-off’ point and can be 
performed at any time of day which provides convenient to the patients. 
Results from our study revealed that mean sodium intake as estimated from the 
FFQ was higher compared to mean sodium level based on corrected spot urine 
sodium (3.786 g vs. 2.279 g, respectively). This is in contrary with the findings 
from the original study (254) where mean sodium from FFQ were found to be 
lower than 24-hour urine sodium.  Modification to the original questionnaire by 
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including average sodium content of all foods listed in each category, rather 
than using the exact sodium content based on an index food as a representative 
of the category as per original FFQ, might have contributed to such findings. Men 
were found to have significantly higher sodium consumption compared to women 
as evident by spot urine. This correlates with FSA report which indicated that 
average salt intake in the UK for men as reflected by 24-hour urine collection 
was 166 mmol/day compared to 131 mmol/day in women (263). Reasons being 
men in general had higher caloric intake, leading to higher total sodium 
consumption (264), lack of awareness of good dietary practice, and little 
understanding of the effect of high salt consumption on health status (202). 
Furthermore, gender differences in sensitivity to salt may have contributed to an 
increased use of discretionary salt amongst male (61). 
Our analysis also demonstrated a poor, non-significant correlation between 
reported sodium intakes from the FFQ compared against the corrected spot urine 
for sodium. In addition, Kappa analysis showed very little and non-significant 
agreement exist between the two methods of sodium assessment. The 
discrepancy between the questionnaire estimation of sodium and the urinary 
excretion could possibly be attributable to the time reflective between the two 
measurements. The spot urine samples collected during the clinic appointment 
were most likely suggest the amount of sodium consumed during breakfast, up 
until the period before lunch time. Whereas the questionnaire represents the 
average of daily sodium consumption based on the frequency intake of various 
foods which had been consumed for the past seven days. In addition, our version 
of modified FFQ contained the average amount of sodium content for all of the 
food listed within each category, which would contribute to the higher overall 
sodium estimation as compared to the urinary measure.  
Other similar studies also revealed low correlations between dietary reports and 
urinary estimations of sodium. Sowers et. al. (265)  in a cross-over study, 
provided a diet containing either 2000 or 3500 mg of sodium for 7 days and 
sodium intake was estimated from seven 24-hour urinary sodium collections per 
diet period. Urinary sodium analyses were significantly associated with duplicate 
chemical food analysis (r = 0.61), but not with sodium intake estimated from 
food composition tables (r = 0.05). Thus, even under strictly controlled 
environment, whereby food not provided by the research centre was obtained in 
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duplicate and accounted for, where monitoring of intake and wastage took place 
daily, and where added salt intake was carefully measured, dietary analyses did 
not correlate with urinary sodium excretion. These findings imply that dietary 
assessment methods that rely on food composition tables are unable to 
accurately calculate the sodium content of foods, probably due to the large 
variation in portion sizes and huge range of sodium content in processed foods 
(254). 
Based on the categorisation of sodium intake as represented by Table 3-4, the 
FFQ has a high sensitivity (80.2%) but low specificity (25.8%). Out of 106 urine 
sample that was tested high on sodium content, 80.2% was correctly identified 
by the questionnaire. The negative predictive value indicates that, provided a 
questionnaire result of less or equal to 2.4 g/day (not high category), there is 
61.1% chance than a patient will have a corrected spot urinary sodium 
concentration below 100 mmol/day. The positive predictive value however is 
only moderate, suggesting that those with questionnaire results more than 2.4 
g/day, had a 47.2% probability that the corrected spot urinary sodium 
concentration would be above 100 mmol/day. With a strong sensitivity, and high 
negative predictive value, the questionnaire therefore would be a useful initial 
screening tool to classify patients as having high or desirable sodium intake. 
Patients who were tested low sodium intake from the FFQ, were more likely to 
comply with the sodium restriction, whereas those who score more than 2.4 g 
requires further evaluation such as urinary analyses or screening of food 
consumption pattern from the FFQ. The low Kappa value between the 
questionnaire and corrected spot urine samples further indicates that the FFQ 
needs additional refinement. 
The reproducibility of FFQs has generally been assessed by administering them 
at two points in time to the same group of people and correlation coefficients 
used to assess the association between the two responses. The reproducibility of 
salt intake from repeat FFQ administered at least 12 months apart was moderate 
with r = 0.619 and kappa = 0.505. Paired sample t-test showed no significant 
difference between the 2 measurements. According to Cade et. al. (251) 
correlation coefficients between two administrations of an FFQ of 0.5 to 0.7 are 
quite common. Repeat administration of the FFQ at 1 month or less were more 
likely to results in higher correlation coefficients compared to repeat 
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administrations further apart. The fact that correlations results in this study 
were moderate and comparable with other studies shows that the FFQ provides 
reliable estimates of salt intake in our study. 
There are, however, a few limitations to be considered in the present study. The 
FFQ sodium assessment offers the advantages of being simple, quick, and easy to 
understand and convenient to administer. The questionnaire reflects overall 
sodium intake over the past 7-days period which include weekend days when 
sodium consumption may differ. Nevertheless, we are only measuring a single 
nutrient (sodium) rather than a combination of other micronutrients. The 
current version of the questionnaire, which mainly includes lists of sodium-rich 
foods, does not allow provision for the testing of hypotheses of other nutrients 
such as potassium or calcium (254). Another potential limitation to consider is 
that the FFQ did not take into consideration total energy intake nor did it 
consider sodium intake as a function of estimated energy requirements, as been 
attempted by other studies (265;266). Rationally, the more foods a person 
consumes, the more likely they are to have a higher intake of sodium.  
Due to staff, technique, and time restriction, we were only able to perform 
cross validation against 24-hour urine sample in 8 subjects. Results from the 
analysis revealed a weak positive association with FFQ and a weak negative 
association with corrected spot urine sample. None of the correlations were 
significant due to small sample size. It is recommended for future studies, to 
include more 24-hour urine samples as this would greatly improve the validity of 
the modified questionnaire. In addition, patients own dietary record should be 
incorporated to provide a clear idea on the type of foods consumed together 
with exact portion sizes. As suggested by Ferreira-Sae et. al. (267), the use of 
more than one measure in validating a food frequency questionnaire would 
strengthen its  validity since it is able to capture all different dimensions of the 
actual total intake of sodium. 
Finally, the use of morning spot urine sodium as a method of validation for the 
questionnaire should be given a fair valuation. Previous studies have reported 
that this approach provides a valid estimate of sodium intake in healthy control 
participants (239) and patients taking antihypertensive therapy (268), and has 
been used in previous research (269;270). Nevertheless, Mann et. al. (271) 
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suggested that random urine sample was not significantly correlated with actual 
24-hour sodium excretion. Alternatively, urine samples obtained late 
afternoon/early evening should be used instead as they were found to be 
strongly correlated with actual 24-hour sodium excretion (r = 0.86, p < 0.001). 
In, summary the modified FFQ can be a useful tool for quick assessment of 
sodium intake in hypertensive population. For more accurate estimation of 
sodium consumption, the FFQ should be used in conjunction with other robust 
dietary measure such as serial spot urine measurements or 24-hour urine 
collection. 
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4 Knowledge, attitude and perception study in 
relation to salt intake 
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4.1 Introduction 
High-salt diet has been associated with elevated blood pressure level (30;41). 
Hence, reducing salt intake with the ultimate aim of decreasing chronic illness, 
is an important public health intervention. Strategies to reduce population salt 
consumption should be multi-faceted, with public education being targeted as 
one of the fundamental approach.  
Awareness regarding dietary salt intake is essential among general public, in 
particular individuals with high blood pressure. Optimum pharmacological 
management coupled with strict dietary salt control have been shown to 
improve blood pressure control in hypertensive patients (272). It is therefore 
important to determine the patterns of salt intake, both discretionary and 
consumption of processed foods, being frequently consumed by this specific 
population. Acquiring this data will enable health educators to target advice at 
the relevant patients groups. It can also be used to persuade the government 
and food manufacturers in relation to understanding how to reduce the salt 
content of processed foods frequently consumed by particular groups of 
consumers. 
Findings from a questionnaire by Tilston et. al. (273) suggested concern among 
consumers regarding the impact of high salt intake on health. Despite awareness 
of the potential harmful effects of salt, findings showed a low use of salt 
alternatives and limited awareness of reducing salt consumption. Consumer 
knowledge of the salt content of specific processed foods was assessed revealing 
a poor level of knowledge. The same study also reported high levels of 
awareness of low salt foods, but low levels of purchase.  
A recent study by CASH (202) revealed that whilst as many as 9 out of 10 people 
in the UK knew that too much salt is harmful, very few have any idea how it can 
affect their health. The study, which included all adults aged 16 and over in 
Wales, England and Scotland, was conducted to investigate public awareness 
regarding the danger of high-salt diet. Men, young adults and those from lower 
socio-economic groups appear to be much less aware of the effects of salt on 
their health. Knowledge regarding osteoporosis and stomach cancer is also low 
despite the evidence linking salt intake to both conditions is very compelling. 
123 
[Type text] 
 
The studies available to date provide useful information in relation to awareness 
and salt consumption patterns and related issues among general public. With a 
lack of recent research targeting specific hypertensive population, it was the 
objective of this research study to establish current trends in awareness and 
practice regarding salt consumption among hypertensive patients. 
4.2 Methods 
The detail methods for this chapter have been previously described in Chapter 2, 
Section 2.2.4. Out of 997 KAP questionnaires being sent throughout the study 
period, 632 were returned to the clinic. Five questionnaires were rejected due 
to incomplete response (patient failed to answer at least 5 out of eight 
questions), and two questionnaires were returned to the clinic due to unknown 
address. Total KAP questionnaires included in the final analysis was 625, 
providing a response rate of 63%. Results from the questionnaires collected were 
analysed and presented as follows. 
4.3 Results 
4.3.1 Demographic characteristics 
Details demographic of responders were presented in Chapter 5 Section 5.3.1. 
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4.3.2 Awareness on the harmful effects of high salt intake 
Figure 4-1. Patients’ response regarding the awareness of harmful effects of too much salt 
in the diet. 
 
 
 
 
Majority of patients (92.2%) were aware regarding the harmful effects of having 
too much salt in the diet, while only 18 patients disagreed to the statement.  
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4.3.3 Knowledge of UK salt recommendation 
Figure 4-2. Patients’ knowledge on current recommended level of salt intake. 
 
 
 
A total of 64.5% of respondents knew that that maximum recommended daily 
intake of salt is no more than 6g per day. Twenty five percent indicated that 
they did not know the current recommended value while others thought that 
daily limit of salt intake is more than 6 grams/day. 
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4.3.4 Knowledge on the difference between salt and sodium 
Figure 4-3. Patients’ knowledge regarding the difference between sodium and salt. 
 
 
 
Only 34.2% of patients were able to correctly identify that salt contains sodium. 
About a quarter of respondents did not know the relationship between the two 
entities, while other 38.4% have the wrong perception about salt and sodium. 
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4.3.5 Knowledge on the main source of salt 
Figure 4-4. Patients’ knowledge regarding various sources of sodium in daily diet. 
 
 
 
Most respondents (64%) knew that processed foods contributed as the main 
source of salt in daily diet. Thirty percent chose discretionary salt while only one 
respondent opted for mineral water as the main source of salt. 
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4.3.6 Knowledge on possible complications from high salt diet 
Figure 4-5. Patients’ response regarding all the possible complications arising from high 
salt diet. 
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Majority of patients (83.7%) claimed to know that high salt intake can be 
associated with high blood pressure. This is followed by stroke, myocardial 
infarction, fluid retention and kidney disease. Less than 10% of the respondents 
knew that high salt consumption can also be associated with other conditions 
such as dementia, stomach cancer, osteoporosis and asthma.  
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4.3.7 Attitude regarding salt information on food labels 
 
Figure 4-6. Patients’ attitude regarding reading the food labels. 
 
 
Seventy percent of respondents did not refer to label for salt content upon food 
purchasing.  
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4.3.8 Attitude regarding adding salt in foods 
 
Figure 4-7. Patients’ attitude regarding adding salt during cooking or at the table. 
 
 
 
Only 16% of respondents did not use salt at all either during cooking or at the 
table. Most patients (83.5%) did add salt at one point of food preparation with 
majority (63.5%) had the food tasted before adding them.  
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4.3.9 Perception on low salt diet 
 
Figure 4-8. Patients’ perception regarding low salt diet. 
 
Forty-five percent of patients were concerned regarding the taste of food 
without the addition of salt. This is followed by not having enough information 
about the diet and limited availability of low-salt foods on the market. Only 3% 
of patients indicated that they had no concern over the low salt diet. 
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4.3.10 KAP results in relation to levels of salt intake 
 
Table 4-1. Comparison of KAP variables against high vs. low sodium intake group. 
 
 
 
 
All variables measured from the KAP questionnaire were cross-tabulated against 
the level of salt intake based on the FFQ results. FFQ was chosen as a marker for 
comparison since it estimates sodium consumption for the past 7 days (including 
weekend) which are more likely to represent patients’ habitual dietary pattern. 
Respondents having a sodium intake of more than 2.4 g/day were considered as 
high salt group and those with 2.4 g/day or less were considered as low salt 
group. No significant difference in level of salt intake between genders was 
observed. Awareness and knowledge regarding salt intake between the high- and 
low-salt groups were also non-significant. Nevertheless, there was a significant 
difference with regards to attitude between the groups. Patients with low salt 
intake are more likely to look at the food label for salt content (p = 0.011) while 
those in high-salt group tend to use discretionary salt more often than those in 
the low salt group (p < 0.05). 
 
 
 
 
 
133 
[Type text] 
 
4.4 Discussion 
Published studies related to KAP in hypertensive patients are very limited. 
Assessment on current level of awareness and practice regarding healthy salt 
intake is important as this will encourage patients to take active control over 
their own BP management. In this study, awareness regarding dangers of too 
much salt in the diet appears to be high among hypertensive patients. Nine out 
of ten patients agreed that having a high salt diet is detrimental to their health. 
This is comparable to results from the CASH survey (202) which revealed that 
92% of the Great Britain population were aware of the harmful effects of salt. 
Knowledge concerning the dietary recommendation for salt is crucial for patients 
to engage in low-salt diet. More than half of the respondents in our study knew 
about the 6 gram/day limit and only 1 in 3 respondents indicated that they did 
not know the dietary recommendation for salt. This figure is slightly higher 
compared to the recent survey by CASH (274), which indicated that only 15% of 
the population studied knew 6g as the daily limit of salt intake. The difference 
could possibly be attributed to patients in our sample being closely-monitored at 
the clinic, and therefore they frequently received counselling or advice 
regarding healthy diet including salt intake, from their healthcare professionals.  
Majority of respondents selected processed foods as the main contributor to 
daily salt intake while 1 in 3 patients claimed that they did not know the source. 
It is estimated that 75% of salt consumed contained in processed foods (275). 
Many patients may be unaware that some of the main sources of salt in our diet 
are ‘hidden’ in everyday food items, hence explaining why many did not 
consider salt as a problem in their diet.  For example, a recent survey revealed 
that more than 1 in 4 (28%) loaves of bread contain as much salt, or even more, 
per slice than a packet of crisps (276). The survey was conducted to investigate 
the salt content of 292 fresh and packaged loaves from supermarkets and their 
in-store bakeries as well as chain and independent high street bakeries. These 
findings were disclosed soon after the Department of Health announced that 
bread is the largest contributor of salt to our diet, providing almost a fifth (18%) 
of current daily salt intake among UK populations (207). 
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Despite the high rate of awareness regarding salt, majority of the patients (62%) 
either did not know or had the wrong perception about salt and sodium when 
they were asked regarding the difference between the two elements. This could 
be a potential problem when patients are referring to food labelling, as sodium 
content could easily be interpreted as equivalent to salt. Essentially, this 
highlights the fact that the current method of labelling sodium on foods may 
serve to mislead the public into thinking that they are consuming less salt than 
they actually are. Patients therefore need to be educated regarding the ‘2.5 
conversion factor’ from sodium to salt. Alternatively, they can opt for green 
colouring for salt content from the traffic light labelling system and avoid those 
with red colour, indicating foods with high salt content. 
Although most of the patients knew that salt leads to high blood pressure, they 
did not appear to have made a strong association with other serious 
complications such as stroke, heart or kidney disease. Very few patients 
recognized that salt can be associated with other conditions such as 
osteoporosis, asthma, stomach cancer and dementia. This is in parallel with 
findings from study by Carley et. al. (277) which revealed that general public 
tend to associate excessive salt intake with high blood pressure (88%) compared 
to other health complications, with osteoporosis being the least. Similarly,  
results from CASH survey highlighted that general publics’ knowledge regarding 
osteoporosis and stomach cancer is worryingly low, despite the evidence linking 
salt intake to both conditions is very compelling (202). Other evidence of salt 
and its associated health complications has been well documented. 
Previous study had suggested that the practice of reading food labels for sodium 
content among UK population was satisfactory (278). Grimes et. al. (2009) 
demonstrated that there was a significant association between knowledge of 
some of the health risks of salt intake and salt label usage.  Despite this, our 
findings indicate only 30% of patients referred to label for salt content upon food 
purchasing, with significant higher percentages among patients with low salt 
intake (p<0.05).  Even though similar studies could potentially over estimate 
actual salt label use as measures rely on self-reported behaviour, the fact that 
our results yield a small number should be a major concern. Reading food labels 
for salt content is vital for individual to successfully reduce salt intake 
(278;278). By having a continuous exposure to this habit, patients will have a 
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better understanding and knowledge regarding salt intake status, hence able to 
apply the label information to make inference about the healthiness of the 
product (209).  
Majority of patients surveyed claimed to be adding salt either during cooking or 
at the table, and the difference is significant between the high- and low-salt 
intake groups. This findings correlates with previous study by Grimes et. al. 
(2010), looking at frequency of discretionary salt use among Australian adults. 
The investigators reported that almost 50% of the sample used salt both at the 
table and cooking.  The trend in discretionary salt usage among public could be 
due to lack of awareness of good dietary practice and little understanding of the 
effect of high salt consumption on health status. Shepherd and Farleigh (1989) 
have commented that ‘for many people adding salt to food may be more a habit 
than a conscious decision’. Consequently, habitual use of salt may increase 
tolerance to salt and in turn increase consumption. Since there is positive 
evidence linking the exposure to highly salty foods and an increased in 
preference, a comprehensive salt reduction policy should include both reduction 
in discretionary salt practice and low-salt product reformulation.  
The taste of food without salt was the biggest barrier (45%) to pursuing low salt 
diet according to the patients. This provides a huge area of intervention for 
health care professionals as patients can be advised regarding the alternative 
ways of food seasoning and taste sensory adaptation. Many of us have developed 
a preference for the taste of salt in our diet following years of consuming 
manufactured foods with high salt content and the use of salty seasonings. When 
salt is abruptly removed, the foods can initially taste bland. In spite of this, the 
taste receptors can be re-programmed in two to three weeks to adjust to a diet 
lower in salt content. In addition, there are many alternative ways of adding 
flavours to food such as using spices and natural flavours e.g. lemon juice and 
fresh herbs. Once the taste sensory is adjusted, foods will no longer deemed 
‘tasteless’ and one will begin to appreciate the natural flavours. 
In conclusion, even though reported awareness regarding harmful effects of 
excessive salt seems to be high, patients overall knowledge and practice 
regarding healthy salt intake is still unsatisfactory. Health care professionals, 
community health-workers and public health agencies need to be actively 
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involved in educating hypertensive populations to improve current status of salt 
awareness.  
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5 Dietary sodium intake – Demographics and 
effect on longitudinal patterns of blood pressure 
in a hypertensive cohort 
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5.1 Introduction 
Excessive dietary sodium consumption increases BP, which subsequently 
increases the risk for stroke, coronary heart disease, heart failure, and renal 
disease (279). Importantly, the risk of CVD increases throughout the range of BP, 
beginning at 115/75mmHg  (280). High salt intake, in combination with other 
factors such as low potassium consumption (from fresh fruits and vegetables), 
obesity, excess alcohol intake and sedentary lifestyle have been shown to 
contribute to the development of high BP. Nevertheless, the diversity and 
strength of the evidence is much greater for salt compared to the others. 
The INTERSALT study was one of the landmark international trial which showed a 
significant positive relationship between BP and salt intake (30). The study, 
which used a standardized method for measuring BP and 24-hour urinary sodium, 
was conducted to investigate communities with a wide range of salt 
consumption, varying from 0.5 to 25 g/day. Among all the communities recruited 
into the study, only four had a low salt intake (3 g per day or less) whereas the 
majority lay between 6 and 12 g/day. None had the high salt intake as initially 
anticipated.  Results from the study demonstrated that reducing dietary salt 
intake by 5.8 g was associated with a 3.1 mmHg decrease in systolic blood 
pressure (31). There was also a highly significant positive relationship between 
dietary salt intake and the increase in blood pressure with age.  
Numerous studies have been published since the INTERSALT looking at the 
effects of salt intake and its impact on BP and/or cardiovascular outcomes; all 
with various conflicting results. For example, recently, a study by O’Donnell et. 
al. (281) suggested that a J-shaped association exist between estimated urinary 
sodium excretion and CV events in individual at increased CV risk. Compared to 
those with moderate sodium excretion, the investigators found an association 
between high sodium excretion and CV events. However, they also discovered 
that low sodium excretion was positively linked to CV death (hazard ratio = 1.19 
and 1.37, for sodium excretion = 2-2.99 g/day and <2 g/day, respectively), and 
increased in the rate of hospitalization for patients with congestive heart 
failure. The study had been criticised as patients included in the study already 
had established severe cardiovascular disease and were prescribed with various 
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cardiovascular treatments including Angiotensin Receptor Blockers, ACE 
inhibitors and diuretics which did not reflect the general population (282). 
Due to uncertainty regarding issues related to sodium intake and the outcome, it 
is therefore essential to clarify the pattern of daily intake for sodium, 
particularly in patients who are at risk of CV complications such as hypertensive 
patients. These patients are more likely to be vulnerable to the CV effects of 
high and low sodium intake, and are most likely to receive recommendations 
concerning dietary sodium restriction.  
This chapter reports the association between daily sodium consumption and 
related clinical outcomes in a cohort of hypertensive patients attending the 
Glasgow Blood Pressure Clinic, using FFQ as measure of sodium intake. 
5.2 Methods 
Detail methods for this chapter have been previously discussed in Chapter 2 
Section 2.2 and 2.7. In summary, data obtained from the FFQ for sodium 
estimation and spot urine analysis were merged to the corresponding dataset 
from Glasgow Blood Pressure Clinic database. 
5.2.1 Scottish Index of Multiple Deprivation (SIMD) 
The SIMD is the Scottish Government’s official measure for identifying areas of 
deprivation within Scotland. The SIMD divides Scotland into a few geographical 
areas identified as ‘datazones’ and assigns each datazone with a deprivation 
score. There are 6,505 datazones covering the whole of Scotland, with each 
comprising, on average, populations of between 500 and 1,000 household 
residents. SIMD scores are based on 37 indicators of deprivation across 7 
categories known as ‘domains’ which includes current income, employment, 
health, education, housing, geographic access to services, and crime (283). For 
this particular study, SIMD ranking were presented as quintiles; Quintiles 1 
containing the 20% most deprived datazones, while Quintile 5 containing the 20% 
least deprived datazones in Scotland.  
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5.2.2 Estimation of 24-hour urinary sodium and potassium 
excretion 
The formula developed by Tanaka et. al. (2002) was used to estimate 24-hour 
urinary sodium and potassium excretion from a random spot urine specimen. 
These formulas were based on a similar method reported by Kawasaki et. al., 
except that the second morning voiding urine (SMU) was replaced with casual 
(‘spot’) urine specimen, which were collected during patient’s clinic 
appointment. The collection time of the spot urine ranged from 9.00 am to 
12.00pm. The detail formula for the estimation was shown in Table 5-1. 
Table 5-1. Formula used to estimate 24-hour urinary Na and K excretion. 
 
 
(1) PRCr (mg/day) = -2.04 x age + 14.89 x weight (kg) + 16.14 x height (cm) – 2244.45 
(2) Estimated 24-HUNaV (mEq/day) = 21.98 x XNa
0.392  
 
(3) Estimated 24-HUKV (mEq/day) = 7.59 x XK0.431 
 
PRCr = predicted value of 24-hour urinary creatinine (mg/day) 
SUNa = Na
+
 concentration in the spot voiding urine (mEq/day) 
SUK = K
+
 concentration in the spot voiding urine (mEq/day) 
SUCr = creatinine concentration in the spot voiding urine (mg/dl) 
XNa (or XK) = SUNa (or SUK)/SUCr x PRCr 
Estimated 24-HUNaV = 24-hour urinary sodium 
Estimated 24-HUKV = 24-hour urinary potassium 
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5.2.3 Statistical methods 
Average daily sodium intake was estimated from the dietary survey data using 
FFQ. This dataset was then merged to the corresponding blood pressure clinic 
data. ANOVA was used to assess the difference in demographic characteristics, 
BP pattern and SIMD quintiles, while chi-square was used to determine 
differences in terms of sodium consumption between males and female in the 
samples. The study population was then divided into three groups based on 
tertiles of estimated daily sodium intake. Repeat measurement data (serum 
sodium, serum chloride, serum potassium, systolic blood pressure and diastolic 
blood pressure measured at 0, 3, 6, 12, 24, 36, 48, 60 months and after 60 
months) are then converted from wide format to long format for further 
analysis.  
5.2.3.1 Analysis of longitudinal measures of BP, serum 
electrolytes using generalized estimating equations (GEE)  
GEE were developed by Liang and Zeger (284) as a means of testing hypotheses 
regarding the influence of factors on binary and other exponentially (e.g., 
Poisson, Gamma, negative binomial) distributed response variables collected 
within subjects across time. They are an extension of generalized linear models, 
which allow correlated observations. Often this method account for the 
correlation between observations in generalized linear regression model by use 
of empirical variance estimator.  
GEE also develops a population average or marginal model. Marginal models give 
an average response for observations sharing the same covariates as a function 
of the covariates (285). In other words, for every one-unit increase in a 
covariate across the population, GEE tells the user how much the average 
response would change (286). It also estimates regression coefficients and 
standard errors with sampling distributions that are asymptotically normal can 
be applied to test main effects and interactions, and can be used to evaluate 
categorical or continuous independent variables (284). 
In this study, since there are multiple observations at different time points, it is 
not possible to assume independence among the different measurement 
available on an individual. Ignoring the dependency will result in overestimation 
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of the standard errors of the regression estimates. Therefore, in longitudinal 
repeat measures correlation between observations on a given subject exists and 
need to be accounted for in the regression model. To study the effect of repeat 
measurement outcome variables (systolic blood pressure, diastolic blood 
pressure, serum sodium, serum potassium, and serum chloride) by tertiles of 
sodium intake the generalized estimating equations (GEE) models were 
employed for the different outcome variables with sodium intake in tertiles as 
the principal independent variable and after incorporating all covariates that are 
believed to be confounders. The corresponding regression coefficients for 
sodium intake in tertile 2 and three in comparison to the tertile 1 was used for 
explaining the fixed effect of the sodium intake on the outcome variables. 
5.3 Results 
5.3.1 Overall demographics 
On average, the age of patients being follow-up at the Glasgow Blood Pressure 
Clinic was 62 years old with BMI score more than 25. Both systolic and diastolic 
BP were beyond the ideal target BP of 140/90 mmHg. Mean sodium intake 
estimation based on questionnaire was higher compared to mean urinary sodium 
obtained from spot urine sample (3.8 g vs. 2.0 g, respectively). Other relevant 
demographic details were summarized in Table 5-2.  
5.3.2 Demographic by sodium intake 
Results from univariate analysis comparing all variables against the three tertiles 
of sodium intake revealed significant differences in terms of BMI, amount of 
sodium intake (from FFQ), spot urine Na/K ratio, prevalence of CVD and 
prevalence of LVH across all three tertiles of sodium consumption. Tertile 1 had 
the highest mean BMI (29.72), tertile 2 revealed the highest number of reported 
LVH and CVD cases (41 vs. 55, respectively), and tertile 3 had the highest mean 
for spot urine Na/K ratio. There were significant differences in terms of BMI, 
average daily sodium intake, Na/K ratio, prevalence of CVD and LVH across the 
three tertiles. Details of the analysis were summarized in Table 5-3. 
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5.3.3 Sodium intake by gender 
Based on the FFQ results, male in general had a higher average intake of sodium 
(3.82 g/day) compared to female (3.75 g/day) though the difference was non-
statistically significant. Conversely, corrected spot urine for sodium and 
potassium were found to be significant. Other pertinent variables were found to 
be insignificant when compared against gender, as listed in Table 5-4. 
5.3.4 Sodium intake by SIMD 2009 quintiles 
Patients residing in the area classified in quintile 3 appeared to be consuming 
the highest amount of sodium on average. However, when mean sodium intake 
was compared against all the 5 quintiles, no significant difference were observed 
(Table 5-5). 
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Table 5-2. Overall baseline demographic characteristics. 
 
Variables Mean (SD) 
 
Age (years) 62.09 (13.73) 
BMI (kg/m
2
) 28.89 (5.93) 
Cholesterol (mmol/L) 5.59 (1.12) 
eGFR (mls/min/1.73m
2
) 73.62 (16.90) 
SBP (mmHg) 155.67 (21.42) 
DBP (mmHg) 94.81 (10.72) 
Sodium intake (g/day) 3.79 (1.64) 
U Na (mmol/L) 86.87 (46.07) 
U K (mmol/L) 49.77 (32.50) 
U Cl (mmol/L) 92.95 (52.94) 
U Cr (mg/dL) 9.85 (8.61) 
Na/Cr ratio 12.90 (11.73) 
Na/K ratio 2.75 (3.60) 
Estimated 24-h Na (mmol) 99.08 (30.94) 
Estimated 24-h K (mmol) 37.51 (9.65) 
 Frequencies 
 
Male : Female 337: 349 
Prevalence - IHD IHD – 24 
  MI – 19 
Prevalence- CVA TIA – 15 
  Stroke – 6 
Prevalence -CVD Yes – 142 
  No – 363 
Prevalence -LVH Yes – 100 
  No - 289 
Alcohol status Yes – 369 
  No - 103 
Smoking status Yes – 191 
  No – 310 
 
BMI = body mass index, eGFR = estimated glomerular filtration rate, SBP = systolic blood 
pressure, DBP = diastolic blood pressure, U Na = spot urine sodium, U K = spot urine 
potassium, U Cl = spot urine chloride, U Cr = spot urine creatinine, Na/Cr ratio = 
Sodium/Creatinine ratio, Na/Potassium ratio, IHD = ischemic heart disease, CVA = 
cerebrovascular accident, CVD = cardiovascular disease, LVH = left ventricular hypertrophy 
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Table 5-3. Patients’ demographics by tertiles of sodium intake. 
 
 Tertile 1  
≤ 2.9 
Tertile 2 
3.0 – 4.3 
Tertile 3 
≥ 4.4 
P-value 
 Mean 
(SD) 
% Mean 
(SD) 
% Mean 
(SD) 
% 
N 209 33.3 215 34.3 203 32.4  
Age (years) 61.7 
(13.03) 
 62.2 
(12.78) 
 64.2 
(14.03) 
 0.136 
 
Male : Female 102:107 48.8:51.2 102:113 47.4:52.6 105:98 51.7:48.3 0.672 
BMI (kg/m
2
) 29.72 
(6.99) 
 28  
(5.44) 
 29.14 
(5.42) 
 0.015 
Smoking status 162 77.5 156 72.6 156 76.8 0.438 
Alcohol status 154 73.7 147 68.4 150 73.9 0.414 
Cholesterol  
(mmol/L) 
5.53 
(1.03) 
 5.697 
(1.12) 
 5.501 
(1.21) 
 0.268 
eGFR 
(mls/min/1.73m
2
) 
73.12 
(16.78) 
 74.37 
(16.26) 
 72.69 
(17.44) 
 0.669 
SBP (mmHg) 154.8 
(21.49) 
 155.96 
(20.71) 
 157.06 
(21.58) 
 0.568 
DBP (mmHg) 95.17 
(10.92) 
 94.76 
(10.87) 
 94.84 
(10.53) 
 0.919 
Sodium intake from 
FFQ (g/day) 
2.1  
(0.60) 
 3.6  
(0.41) 
 5.6 
(1.21) 
 0.000 
U Na (mmol/L) 86.82 
(48.29) 
 80.64 
(44.50) 
 91.75 
(44.68) 
 0.303 
U K (mmol/L) 51.14 
(33.75) 
 50.75 
(30.83) 
 42.27 
(25.19) 
 0.108  
U Cl (mmol/L) 92.02 
(54.67) 
 85.87 
(49.55) 
 93.38 
(48.57) 
 0.603 
U Cr (mg/dL) 9.97 
(8.28) 
 9.28 
(6.16) 
 9.76 
(11.80) 
 0.880 
Na/Cr ratio 12.93 
(10.20) 
 11.62 
(7.60) 
 13.24 
(7.59) 
 0.440 
Na/K ratio 2.79 
(3.63) 
 2.10 
(1.62) 
 3.51 
(4.96) 
 0.049 
Estimated 24-h Na 
(mmol) 
99.16 
(33.11) 
 96.08 
(27.82) 
 102.69 
(26.18) 
 0.371 
Estimated 24-h K 
(mmol) 
37.88 
(10.86) 
 38.12  
(8.71) 
 36.29 
(8.82) 
 0.432 
Prevalence - IHD 14 6.7 14 6.5 12 5.9 0.914 
Prevalence - CVA 5 2.4 7 3.3 8 3.9 0.347 
Prevalence -CVD 37 17.7 55 25.6 44 21.7 0.046 
Prevalence -LVH 26 12.4 41 19.1 28 13.8 0.035 
 
BMI = body mass index, eGFR = estimated glomerular filtration rate, SBP = systolic blood 
pressure, DBP = diastolic blood pressure, FFQ = food frequency questionnaire, U Na = spot 
urine sodium, U K = spot urine potassium, U Cl = spot urine chloride, U Cr = spot urine 
creatinine, Na/Cr ratio = Sodium/Creatinine ratio, Na/Potassium ratio, IHD = ischemic heart 
disease, CVA = cerebrovascular accident, CVD = cardiovascular disease, LVH = left 
ventricular hypertrophy 
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Table 5-4. Sodium intake by gender. 
 
Variables Male 
Mean (SD) 
Female 
Mean (SD) 
P-value 
Sodium intake (g/d) 
U Na (mmol/L) 
U K (mmol/L) 
U Cl (mmol/L) 
U Creatinine (mg/dL) 
Na/Cr ratio 
Na/K ratio 
Estimated 24-h Na (mmol) 
Estimated 24-h K (mmol) 
3.82 (1.57) 
96.99 (45.92) 
52.88 (31.17) 
104.81 (54.01) 
11.21 (9.74) 
11.79 (7.86) 
2.70 (3.24) 
103.53 (29.12) 
38.97 (9.41) 
3.75 (1.71) 
78.10 ( 44.63) 
47.13 (33.58) 
82.67 (50.03) 
8.65 (7.34) 
13.90 (14.27) 
2.80 (3.91) 
95.13 (32.14) 
36.22 (9.73) 
0.378 
0.317 
0.495 
0.306 
0.567 
0.490 
0.344 
0.022 
0.014 
Sodium tertiles  
(≤2.9/3.3-4.3/≥4.4) 
102/102/105 107/113/98 0.672 
 
 
Table 5-5. Sodium intake based on SIMD 2009 Quintiles. 
 
SIMD 2009 
Quintiles 
N Mean (SD) Min Max 
1 125 3.80 (1.74) 0.6 10.0 
2 91 3.81 (1.44) 1.1 8.9 
3 67 3.95 (1.72) 0.8 8.6 
4 86 3.48 (1.63) 0.3 9.6 
5 207 3.81 (1.60) 0.4 10.6 
 
* (p = 0.435) 
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5.3.5 Longitudinal BP pattern by sodium intake 
Table 5-6 showed the results of mean BP measurement at 12 months interval 
from baseline up to 5th year of follow-up across all 3 tertiles of sodium 
consumption. Mean systolic blood pressure appears to be different between the 
three tertiles at 12 months of follow-up (p = 0.024). However, after Bonferroni 
adjustment with p = 0.004 (0.05/12), the systolic blood pressure difference were 
insignificant. Mean diastolic blood pressure did not appear to be affected by 
different level of sodium intake throughout the 5 years. 
Complete data for all covariates were available in 439 subjects. Table 5-7 
summarises the results of the Generalised Estimating Equation (GEE) analysis 
between longitudinal measures of BP and serum sodium and tertiles of dietary 
sodium. There is no significant association between serial serum sodium 
measures and dietary sodium intake. 
Serial SBP measurements in treated hypertensive subjects show a significant 
association with tertiles of dietary sodium. Tertile 2 and tertile 3 are 
significantly associated with a 2.28 (95% CI: -4.24;-0.32; p=0.02) and 3.4 (-5.38;-
1.43; p=0.001) mmHg lower SBP during the follow-up period respectively. There 
was no significant association with DBP. 
Spot urine sodium did not show any association with longitudinal SBP or DBP 
measures in this population. 
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Table 5-6. Longitudinal BP pattern by sodium intake at baseline and every 12-month 
interval. 
 
 Tertile 1 
Mean (SD) 
≤ 2.9 
Tertile 2 
Mean (SD) 
3.0 – 4.3 
Tertile 3 
Mean (SD) 
≥ 4.4 
P-value 
N 209 215 203  
SBP 0m (mmHg) 154.80 (21.49) 155.96 (20.71) 157.06 (21.58) 0.568 
SBP 12m (mmHg) 143.93 (20.18) 139.94 (19.14) 137.95 (16.91) 0.024 
SBP 24m (mmHg) 140.78 (17.19) 139.93 (18.42) 138.86 (16.53) 0.715 
SBP 36m  (mmHg) 138.49 (16.99)  137.62 (18.54) 135.09 (13.33) 0.379 
SBP 48m (mmHg) 137.41 (18.07) 136.76 (18.22) 134.77 (14.89) 0.605 
SBP 60m (mmHg) 137.19 (15.53) 135.70 (18.04) 134.50 (12.41) 0.489 
 
DBP 0m (mmHg) 95.17 (10.92) 94.76 (10.87) 94.84 (10.53) 0.919 
DBP 12m (mmHg) 89.65 (10.20) 88.08 (10.71) 87.10 (8.37) 0.088 
DBP 24m (mmHg) 88.28 (9.69) 87.87 (9.96) 87.35 (9.23) 0.773 
DBP 36m (mmHg) 86.24 (9.96) 86.95 (12.18) 86.16 (7.82) 0.853 
DBP 48m (mmHg) 85.57 (9.98) 87.49 (9.75) 87.12 (8.85) 0.434 
DBP 60m (mmHg) 86.66 (8.05) 86.36 (9.79) 86.31 (8.35) 0.956 
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Figure 5-1. Longitudinal change in SBP by tertiles of sodium intake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
150 
[Type text] 
 
Table 5-7. Generalised Estimating Equation (GEE) - Analysis of longitudinal measures of 
blood pressure and serum sodium by tertiles of dietary sodium intake and tertiles of spot 
urine sodium excretion. 
 
Serum Na 
 Coef. Std.Err P>|z| [95%CI]  
FFQ DietNa_Tertile2 (g/day) 0.11 0.23 0.642 -0.34 0.56 
Obs 
2621 
Groups 
437 
Min 
1 
Max 
5 
FFQ DietNa_Tertile3 (g/day) 0.23 0.23 0.302 -0.21 0.68 
Sex -1.03 0.20 <0.0001 -1.42 -0.65 
Baseline SBP (mmHg) -0.01 0.00 0.174 -0.01 0.00 
Age_first_visit (years) -0.03 0.01 <0.0001 -0.05 -0.01 
BMI (kg/m
2
) 0.00 0.01 0.84 -0.02 0.03 
Smoking_status -0.05 0.19 0.809 -0.42 0.33 
eGFR_0m (mls/min/1.73m
2
) -0.01 0.01 0.059 -0.02 0.00 
        
SBP 
 Coef. Std.Err P>|z| [95%CI]  
FFQ DietNa_Tertile2 (g/day) -2.28 1.00 0.023 -4.24 -0.32 Obs 
2128 
Groups 
439 
Min 
1 
Max 
7 
FFQ DietNa_Tertile3 (g/day) -3.40 1.01 0.001 -5.38 -1.43 
Sex 4.00 0.85 <0.0001 2.34 5.65 
Age_first_visit (years) 0.28 0.04 <0.0001 0.21 0.36 
BMI (kg/m
2
) -0.13 0.07 0.06 -0.26 0.01 
Smoking_status 0.75 0.84 0.374 -0.90 2.40 
eGFR_0m (mls/min/1.73m
2
) 0.09 0.03 0.001 0.04 0.15 
        
DBP 
 Coef. Std.Err P>|z| [95%CI]  
FFQ DietNa_Tertile2 (g/day) -0.55 0.51 0.282 -1.55 0.45 Obs 
2128 
Groups 
439 
Min 
1 
Max 
7 
FFQ DietNa_Tertile3 (g/day) -0.42 0.51 0.411 -1.43 0.58 
Sex -1.29 0.43 0.003 -2.13 -0.44 
Age_first_visit (years) -0.24 0.02 <0.0001 -0.28 -0.20 
BMI (kg/m
2
) 0.02 0.03 0.634 -0.05 0.08 
Smoking_status 0.33 0.43 0.445 -0.51 1.17 
eGFR_0m (mls/min/1.73m
2
) 0.04 0.01 0.003 0.01 0.07 
        
SBP 
 Coef. Std.Err P>|z| [95%CI]  
UrineNa_Tertile2 (mmol/L) -0.07 1.63 0.966 -3.27 3.13 Obs 
811 
Groups 
168 
Min 
1 
Max 
7 
UrineNa_Tertile3 (mmol/L) 1.43 1.71 0.404 -1.93 4.79 
Sex 2.39 1.39 0.085 -0.33 5.12 
Age_first_visit (years) 0.36 0.06 <0.0001 0.24 0.48 
BMI (kg/m
2
) -0.19 0.10 0.057 -0.38 0.01 
Smoking_status -0.67 1.35 0.621 -3.32 1.98 
eGFR_0m (mls/min/1.73m
2
) 0.11 0.04 0.011 0.03 0.20 
        
DBP 
 Coef. Std.Err P>|z| [95%CI]  
UrineNa_Tertile2 (mmol/L) 2.00 0.84 0.017 0.36 3.64 Obs 
811 
Groups 
168 
Min 
1 
Max 
7 
UrineNa_Tertile3 (mmol/L) 0.95 0.88 0.28 -0.77 2.67 
Sex -1.94 0.71 0.006 -3.34 -0.54 
Age_first_visit (years) -0.20 0.03 <0.0001 -0.26 -0.14 
BMI (kg/m
2
) -0.02 0.05 0.677 -0.12 0.08 
Smoking_status 0.54 0.69 0.437 -0.82 1.90 
eGFR_0m (mls/min/1.73m
2
) 0.06 0.02 0.015 0.01 0.10 
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5.4 Discussion 
The role of dietary sodium chloride in the regulation of blood pressure has been 
difficult to elucidate for several reasons. Population science is limited by the 
narrow range of dietary sodium intake by most populations and individuals and 
the multiple confounders in those populations at the extremes of intake. For 
example in isolated hunter-gatherer populations in Africa, the Americas, Asia 
and the Pacific region, blood pressure raised little or not at all with age and 
hypertension was distinctly uncommon. These communities have a low-salt 
intake, usually less than 40 mEq/day and when these individuals migrated to an  
urban environment blood pressure increased(287). However, Hollenberg et. 
al.(288) showed the Kuna Indian tribe which demonstrated low BP and low salt 
intake in the original studies, have acculturated in-situ, enjoying a very-high salt 
intake while living in their original island homes. Despite the high salt intake 
among the Kuna, BP remains low and does not rise with age(288). This raises the 
question that the rise in BP seen on migration to the urban environment may not 
be due to salt alone as migration involves far more changes than just a change in 
salt intake.  
 
Results from clinical trials have been rather challenging to interpret because of 
the difficulty in maintaining a given level of sodium intake over a period of time 
sufficient for study. In 167 controlled, randomized trials in which the effect of a 
reduction in salt intake on blood pressure in subjects with hypertension and 
normotension was assessed, in hypertensive subjects (whites), the mean 
reduction was 5.5/2.8 mmHg and the mean reductions in normotensive subjects 
(whites) were smaller or 1.3/0.1 mmHg(78). In addition they showed that salt 
restriction resulted in significant increases in renin and aldosterone levels as 
well as increases in catecholamines and lipids(78).  
 
The relationship between sodium intake and cardiovascular outcomes is still 
controversial (69;70;78;281). Furthermore, basic science studies have been 
challenged by identification of appropriate models that mimic salt-sensitive 
hypertension in humans. The relationship between renal handling of sodium and 
blood pressure is apparently influenced by a complex combination of factors 
152 
[Type text] 
 
including nutritional, environmental, genetic, neurohormonal, and metabolic 
factors.  
 
In this analysis of hypertensive adults with detailed diet estimates of sodium 
intake, there were no significant differences in sodium intake by deprivation 
scores. However, corrected urine sodium and potassium excretion were found to 
be statistically significant between genders with males appeared to have higher 
sodium excretion. This could be attributed to lack of awareness of good dietary 
practice and little understanding on the effect of high salt consumption on 
health status. Furthermore, gender differences in salt preference may have 
contributed to an increased use of discretionary salt amongst males in general. 
This suggestion is supported by findings from other study which indicated that 
male respondents were more inclined to add salt to their food before even 
tasting it. 
Analysing BP control during follow-up, a significant reduction of 3.4 mmHg in the 
highest tertile of sodium intake was observed compared to the lowest tertile of 
intake.  Hypertensives subjects who are in the highest tertile of salt intake 
based on FFQ show the highest early drop in SBP and the lowest BP over time. 
Table 5-6 shows similar starting BP in all three tertiles of sodium intake, 
indicating that the observed difference in longitudinal SBP cannot be due to 
differences in initial BP between groups. However, the highest tertile of sodium 
intake is also associated with a significantly higher prevalence of cardiovascular 
disease and LVH. This would imply that the greater reduction in BP seen in those 
in the highest tertile of sodium intake is likely to be due to more aggressive 
management of BP in these individuals given their associated risk factors.  
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As this is an observational study, it is impossible to attribute causality to the 
higher prevalence of CVD in the highest tertile of sodium intake. Nevertheless, 
in real-life treated hypertensive patients, at least in the Glasgow cohort, it 
appears that sodium intake may not be a major factor in resistance to 
antihypertensive treatment. Additionally, FFQ was administered at only one 
point during follow-up and it may not be representative of sodium intake during 
the entire period of follow-up. An important future analysis will be to analyse 
anti-hypertensive prescriptions to see if there are differences in prescribing 
diuretics among the different groups. Major limitation of this study is the 
observational nature of the cohort which can be confounding. Randomised 
control studies are needed to further validate these findings. 
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6 Serum sodium levels and long-term mortality:  
35 year follow-up study in a treated hypertensive 
population in Glasgow  
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6.1 Introduction  
Worldwide, hypertension and elevated blood pressure together attribute to 7.6 
million premature deaths annually. While the available anti-hypertensive agents 
reduce the blood pressure and curtail the risk of cardiovascular complications, 
the mortality burden remains relatively high in hypertensive population. Risk 
stratification and identification of factors associated with mortality outcomes 
are therefore important strategies for delaying the mortality events in 
hypertensive population.  
The normal serum sodium distribution in healthy individuals is between 135-145 
mmol/L. Both renal and extra-renal mechanisms play important role in 
maintenance of sodium content in body fluids. A surplus of sodium, the main 
extracellular cation, increases arterial blood pressure and cited as an important 
mechanisms associated with pathogenesis of hypertension. A relative excess or 
deficiency of total body water content to sodium is often seen in hypertensive 
population either as a consequence of hypertension or due to the effect of anti-
hypertensive medication especially the diuretics.   
While hyponatremia is associated with increased mortality outcomes in heart 
failure patients and also in adult hospitalized patients, serum sodium and its 
association with mortality outcomes are not studied in detail in hypertensive 
population. We therefore studied this association in an uncontrolled 
hypertensive cohort of nearly 15,000 adults in Glasgow, United Kingdom.  
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6.2 Methods  
6.2.1 Study settings  
The Glasgow blood pressure clinic (GBPC) provides secondary and tertiary level 
service to individuals with hypertension from the West of Scotland. Data from 
patients attending the clinic are stored in a computerized database, which 
contains information of individuals attending the clinic from the mid 1970s until 
2011.  Record linkage with the office of the Register General for Scotland allows 
identification of all deaths and causes of death in clinic attendees.  
6.2.2 Collection of data and follow up  
All patients were treated at GBPC until they achieve target BP and are 
maintained at that level for at least three months. The frequency of visits to 
GBPC mainly depends on individual patients BP levels and presence of other co-
morbidities. Patients who achieved the target BP level were transferred back to 
the referring physician for ongoing management.  
6.2.3 Clinical measurements  
Blood pressure measurements were taken manually 3 times, using standardized 
sphygmomanometers at each visit by specialist hypertension nurses; the mean of 
the last 2 measurements is recorded at each visit.  
Patients attending the clinic were advised to take their regular medications as 
usual. Height and weight of all patients were measured using standardized 
equipment during each visit. Blood samples were collected at baseline and at 
regular intervals for estimation of routine haematological and biochemical 
indices. Estimated glomerular filtration rate (eGFR) was calculated from the 
baseline serum creatinine values using the Modification of Diet in Renal Disease 
Study Group (MDRD) equation (289).  
A structured format was used to measure tobacco (any versus none) and alcohol 
use (quantity and frequency of consumption). All data were electronically 
captured and maintained as a large single database.   
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6.2.4 Outcome assessment  
Records kept by the General Register Office for Scotland ensured notification of 
a subject’s death (provided that it occurred in the United Kingdom) together 
with the primary cause of death according to the International Classification of 
Diseases, 10th Revision, Version for 2007 (ICD-10), codes. We considered 
cardiovascular deaths (CVD mortality; ICD-10 codes I00-I99), ischemic heart 
disease deaths (IHD mortality; ICD-10 codes 120-I25), and stroke deaths (stroke 
mortality; ICD-10 codes I60-I69) in the analysis. Deaths other than due to 
cardiovascular causes are classified as non-CVD deaths. Mortality data were 
collected up to April 2011 allowing a maximum of 35 years for participants who 
had been under follow up for the longest time.  
6.2.5 Statistical analysis  
The normal serum sodium range is 135-145 mmol/L. The study population was 
divided into four groups based on baseline serum sodium levels (quartiles). The 
approximately equal sample sizes in each cohort will allow reliable risk 
estimates to be calculated in survival analyses. The baseline characteristics of 
study subjects in different sodium quartiles were compared using one way 
analysis of variance (ANOVA) for continuous variables and Chi-Square test for 
categorical variables. Kaplan-Meir (KM) curves were generated to plot the time 
to mortality outcomes across serum sodium quartiles. A log-rank test for 
multiple groups was employed to determine whether the KM curves for groups 
based on serum sodium quartiles are statistically equivalent. The cause-specific 
mortality event rates per 1000 person-years of follow-up and their 95% 
confidence interval were also estimated.   
Cox proportional hazards models were set up to analyse the influence of 
baseline sodium on all-cause, CVD, ischaemic heart disease (IHD), stroke and 
non-CVD mortality. The covariates included were baseline age, gender, body 
mass index (BMI), smoking status, systolic and diastolic blood pressure (SBP and 
DBP), alcohol use, tobacco use, eGFR, and cardiovascular co-morbidity. A 
variable on year of first visit strata (epochs) was used to adjust the secular trend 
in mortality and was divided into three categories (first visit 1986 or before, 
between years 1987-1996, 1997 and after). Hazard ratios were then generated.  
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Initially, hazard rate of second, third and fourth sodium quartiles were 
generated in comparison to the first quartile after adjustment for the above 
mentioned baseline variables (Model 1).  A second model was generated (Model 
2) after incorporating baseline total cholesterol also in the model. Baseline 
serum chloride, potassium and bicarbonate were also incorporated in the model 
1 and generated a new model (Model 3). Finally, baseline total cholesterol was 
also incorporated in the model 3 and generated the model 4. Since concomitant 
diuretic use can influence serum sodium levels, all the above models were 
repeated after stratifying for baseline diuretic use. 
The proportional hazard (PH) assumption is tested by comparing the estimated –
ln(-ln) survivor curves of groups based on serum sodium in quartiles and also by 
the goodness-of-fit (GOF) tests. The coefficient of variation (CoV) of serum 
sodium levels in the initial five years was estimated for each individual based on 
available data at the following time points; 3 months, 6 months, 12 months, 24 
months, 36 months, 48 months, 60 months and above 60 months.  The 
population was then divided into three categories based on the CoV of serum 
sodium (<50th percentile, 50th-75th percentile, >75th percentile). This variable 
was replaced with the baseline sodium variable in model 4 and the 
corresponding HRs were generated (Model 5). All analysis for this section was 
performed using STATA Software (Version 12.0, Statacorp, Texas, USA). 
6.3 Results  
A total of 13,380 patients with baseline serum sodium values were included in 
the current analysis. The full demographic and clinical characteristics for men 
and women are given in Table 6-1. The mean age of the study population was 
50.6 years (range 14-93). More than half of the study patients were females 
(52.3%, n=6996). The population was overweight (mean BMI 27.53 (5.68)), 
hypertensive with baseline BP >166/98 mmHg and eGFR>70 mL/min per 1.73 m2. 
There were 5911 smokers (45%) and 7756 people (61%) drank alcohol. 
There were 3470 all-cause deaths in 202,114 person-years of follow-up. Of 
these, 2030 were cardiovascular deaths (IHD deaths=1138; stroke deaths=488) 
and 1440 were non-cardiovascular deaths. Survival analysis was performed after 
grouping the population into serum sodium quartiles. Univariate analysis was 
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performed by calculating deaths per 1000 person-years and with Kaplan Meier 
analysis. Univariate analysis showed a U-shaped pattern in all-cause, 
cardiovascular and non-cardiovascular mortality (Table 6-2, Figure 6.1 to 6.5). 
Multivariate adjusted survival analysis was performed used Cox-proportional 
hazards model. Five different models were employed of which two models were 
essentially replicates by the addition of baseline cholesterol which was available 
in only a subset of subjects. Model 1 (3470 all-cause deaths) was adjusted for 
conventional cardiovascular covariates and model 2 (2874 all-cause deaths) was 
the same as model 1 but including serum cholesterol. Model 3 (3337 all-cause 
deaths) included all conventional cardiovascular covariates but also included 
other serum electrolytes – potassium, chloride, bicarbonate (as serum potassium 
levels can be artefactually elevated by haemolysis from delay in analyses, we 
excluded all serum potassium>6). Model 4 (2750 all-cause deaths) was the same 
as model 3 but including cholesterol. Finally we were able to assess the 
longitudinal variability in serum sodium which would reflect on how 
representative our analysis based on baseline sodium could be generalisable to 
hypertensive patients. We classified patients based on the coefficient of 
variation of serial sodium measurements (minimum 3 sodium in the first 5 years 
of follow-up at-least a year apart) and tested whether the level of variability in 
serum sodium had an impact on survival (model 5 – 2750 all-cause deaths). 
Models 1 and 2 showed decrease in mortality with each increasing quartile of 
serum sodium (Table 6-3). However this association completely disappeared 
when adjusted for other electrolytes (models 3 and 4). Potassium and 
bicarbonate independently predicted mortality in models 3 and 4 unsurprisingly. 
Finally in model 5, variability in longitudinal sodium levels did not predict 
mortality in the hypertensive population. Repeating the analyses after stratifying 
by diuretic use did not substantially change the results. 
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Table 6-1. Baseline characteristics stratified by serum sodium in quartiles. 
 
Variables  
 
Total (N=13380) Na<=138 (N=3385) Na=139-140 (N=4050) Na=141-142 (N=3767) Na>=143 (N=2178) P Value  
Age at first visit (years), mean (SD) 
 
50.62 (14.24) 51.23 (14.94) 48.86 (14.31) 50.59 (13.77) 53.02 (13.33) <0.001 
Men, n(%)  
 
6384 (47.71)  1437 (42.45)  1945 (48.02)  1848 (49.06)  1154 (52.98)  <0.001  
BMI (Kg/m2), mean (SD) 
 
27.53 (5.68) 27.46 (6.02) 27.40 (5.56) 27.69 (5.70) 27.59 (5.34) 0.12 
SBP (mmHg), mean (SD) 166.26 (29.13) 166.40 (28.98)  164.62 (28.69) 166.34 (28.80) 168.97 (30.53) <0.001 
DBP (mmHg), mean (SD) 98.41 (15.06) 97.54 (14.99) 97.54 (14.99) 98.73 (14.88) 99.49 (15.73) <0.001 
Total cholesterol (mmol/l), mean (SD) 5.95 (1.46) 6.02 (1.50) 5.93 (1.28) 5.90 (1.24) 5.94 (1.95) 0.01  
eGFR (mL/min per 1.73 m2), mean (SD) 73.82 (32.96) 74.91 (31.29) 74.97(21.98) 73.08 (36.95) 71.19 (43.65) <0.001 
eGFR <60 mL/min per 1.73 m2, n(%) 
 
2227 (17.62)  659 (20.56)  777 (20.16)  558 (15.69)  233 (11.50)  <0.001 
Alcohol Use, n (%) 
 
7756 (61.04)  1901 (59.46) 2449 (63.54) 2165 (60.32) 1241 (60.04) 0.002 
Tobacco Use, n (%) 
 
5911 (45.08)  1515 (45.90) 1806 (45.47) 1641 (44.45) 949 (44.20) <0.001 
CVD, n (%) 
 
2424 (18.12) 608 (17.96) 657 (16.22) 710 (18.85) 449 (20.62) 0.50 
Year of first visit  
 
     
First visit <= Year 1987, n (%) 
 
6260 (46.88) 1391 (41.17) 1880 (46.50) 1901 (50.59) 1088 (50.07)  
First visit between years 1988 - 1997, n (%) 
 
3351 (25.10)  1086 (32.14) 1118 (27.65) 761 (20.25) 386 (17.76)  
First visit >=  Year 1998, n (%) 
 
3742 (28.20)  902 (26.69) 1045 (25.85) 1096 (29.16) 699 (32.17) <0.001 
Serum Chloride, mean (SD)   102.74 (3.53) 100.71 (3.77)  102.59 (3.11) 103.63 (3.02) 104.50 (3.16)  <0.001 
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Variables  
 
Total (N=13380) Na<=138 (N=3385) Na=139-140 (N=4050) Na=141-142 (N=3767) Na>=143 (N=2178) P Value  
Serum Potassium, mean (SD) 4.11 (0.46)  4.09 (0.49)  4.11 (0.44) 4.10 (0.44) 4.13 (0.47) 0.01 
Serum Bi-carbonate, mean (SD)   26.02 (3.08)  25.69 (3.14)  25.86 (3.02)  26.16 (2.98) 26.65 (3.19)  0.002  
 
BMI=body mass index, SBP=systolic blood pressure, DBP=diastolic blood pressure, eGFR=estimated glomerular filtration rate based on MDRD equation, 
Baseline CVD=prevalent cardiovascular disease at baseline, SD=standard deviation 
 
 
 
Table 6-2. Person years of follow-up and mortality event rates. 
 
Follow-up and event rates  Na+<=138 (N=3385) Na+=139-140 (N=4050) Na+=141-142 (N=3767) Na+>=143 (N=2178) Total (N=13380) 
Person years of follow-up (p-y) 48740.84 62359.80 58613.16 32400.33 202114.14 
IHD mortality, n/1000 p-y (95% CI) 7.16 (6.45-7.95) 6.54 (5.94-7.21) 6.40 (5.78-7.08) 7.35 (6.47-8.34) 6.78 (6.43-7.15) 
Stroke mortality, n/1000 p-y (95% CI) 3.06 (2.60-3.59) 2.87 (2.48-3.32) 3.09 (2.67-3.57) 3.95 (3.32-4.70) 3.15 (2.92-3.41) 
CVD mortality, n/1000 p-y (95% CI) 12.88 (11.92-13.93) 11.63 (10.81-12.50) 12.15 (11.29-13.07) 13.67 (14.46-15.01) 12.41 (11.93-12.90) 
Non-CVD mortality, n/1000 p-y (95% CI) 9.23 (8.42-10.13) 7.94 (7.27-8.67) 7.85 (7.16-8.60) 9.01 (8.04-10.11) 8.40 (8.01-8.81) 
All-cause mortality, n/1000 p-y (95% CI) 22.12 (20.84-23.48) 19.56 (18.50-20.69) 20.00 (18.88-21.17) 22.69 (21.10-24.39) 20.81 (20.19-21.44) 
 
 
CVD=Cardiovascular disease and IHD=Ischemic heart disease 
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Table 6-3. Cox regression analysis for the association between serum sodium and mortality. 
 
Cox-PH Models  All-cause mortality CVD mortality IHD mortality Stroke Mortality Non-CVD mortality 
 
 
N=3470/11288 N=2030/11288 N=1138/11288 N=488/11288 N=1440/11288 
Baseline Serum Sodium (Model 1) HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
Na<=138 1  1  1  1  1  
Na=139-140 0.87* 0.79-0.95 0.88* 0.78-0.99 0.88 0.76-1.04 0.89 0.70-1.15 0.86* 0.75-0.99 
Na=141-142 0.80* 0.73-0.88 0.83* 0.74-0.94 0.81* 0.69-0.95 0.88 0.68-1.13 0.76* 0.66-0.87 
Na>=143 0.80* 0.72-0.89 0.80* 0.70-0.92 0.76* 0.63-0.92 1.05 0.80-1.37 0.80* 0.68-0.95 
Baseline Serum Sodium (Model 2) N=2874/10009 N=1646/10009 N=911/10009 N=409/10009 N=1228/10009 
Na<=138 1  1  1  1  1  
Na=139-140 0.90* 0.82-0.99 0.91 0.80-1.04 0.94 0.79-1.12 0.93 0.71-1.22 0.89 0.77-1.04 
Na=141-142 0.84* 0.76-0.93 0.89 0.78-1.02 0.87 0.73-1.04 0.97 0.74-1.27 0.78* 0.67-0.91 
Na>=143 0.85* 0.75-0.95 0.87 0.75-1.01 0.82 0.67-1.01 1.15 0.86-1.54 0.82* 0.69-0.97 
Baseline Serum Sodium (Model 3) N=3337/8939 N=1971/8939 N=1108/8939 N=473/8939 N=1366/8939 
Na<=138 1  1  1  1  1  
Na=139-140 1.02 0.93-1.12 1.06 0.93-1.20 1.06 0.89-1.25 1.06 0.82-1.39 0.96 0.83-1.12 
Na=141-142 1.05 0.95-1.16 1.15* 1.01-1.31 1.16 0.97-1.38 1.09 0.83-1.44 0.92 0.78-1.08 
Na>=143 1.11 0.99-1.25 1.20* 1.03-1.40 1.16 0.94-1.43 1.41* 1.03-1.92 0.99 0.83-1.20 
Baseline Serum Sodium (Model 4) N=2750/7822 N=1589/7822 N=883/7822 N=396/7822 N=1161/7822 
Na<=138 1  1  1  1  1  
Na=139-140 1.02 0.92-1.13 1.05 0.91-1.20 1.06 0.88-1.27 1.06 0.80-1.42 0.98 0.84-1.15 
Na=141-142 1.02 0.91-1.14 1.12 0.96-1.29 1.10 0.91-1.34 1.12 0.82-1.51 0.89 0.74-1.05 
Na>=143 1.08 0.95-1.24 1.17 0.98-1.39 1.11 0.88-1.40 1.41* 1.01-1.97 0.97 0.80-1.19 
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Cox-PH Models  All-cause mortality CVD mortality IHD mortality Stroke Mortality Non-CVD mortality 
 N=2750/7822 N=1589/7822 N=883/7822 N=396/7822 N=1161/7822 
Coefficient of Variation of Serum Sodium 
(Model 5) HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
<50th percentile 1.06 0.98-1.17 1.11 0.99-1.25 1.09 0.93-1.28 0.97 0.77-1.22 1.01 0.88-1.16 
50th-75th Percentile 0.96 0.86-1.06 0.99 0.87-1.14 1.04 0.87-1.24 0.80 0.61-1.05 0.90 0.77-1.06 
>75th Percentile 1   1  1  1  1  
 
*p value <0.05, Model 1 is adjusted for age at first visit, gender, BMI=body mass index, baseline cardiovascular disease, CKD=Chronic kidney disease, 
tobacco smoking, alcohol use, year of first visit (epochs), SBP=systolic blood pressure, and DBP=diastolic blood pressure. Model 2 is adjusted all 
variables in model 1 and total cholesterol. Model 3 is adjusted for all variables in model 1 and serum chloride, serum potassium and serum bi-carbonate. 
Model 4 is adjusted for all variables in model 3 and total cholesterol. In Model 5 baseline sodium in quartiles as in the Model 4 is replaced by categories 
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Figure 6-1. Kaplan Meier Plot serum Sodium quartiles and all-cause mortality. 
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Figure 6-2. Kaplan Meier Plot serum Sodium quartiles and cardiovascular mortality. 
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Figure 6-3. Kaplan Meier Plot serum Sodium quartiles and ischaemic heart disease 
mortality. 
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Figure 6-4. Kaplan Meier Plot serum Sodium quartiles and non-cardiovascular mortality. 
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Figure 6-5. Kaplan Meier Plot serum Sodium quartiles and stroke mortality. 
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6.4 Discussion 
The primary finding from this study is that among treated hypertensive patients, 
lower serum sodium is associated with a higher mortality risk which disappears 
when adjusted for other serum electrolytes. The univariate results from Kaplan 
Meier analysis and event-rates by serum sodium quartiles show a U shaped 
relationship which disappears after multivariate adjustment. In the multivariate 
analysis, the long ascertainment period was adjusted for by using a time-
covariate and after accounting for other factors that affect mortality the 
adjusted hazard estimates reflect the true relationship between serum sodium 
and mortality. The results show that hyponatremia is associated with higher risk, 
which is not novel.  
Previous studies have shown that hyponatremia is a significant predictor of 
mortality in hospitalised patients (290), patients with heart failure and renal 
failure. In a prospective cohort study of 98,411 adults hospitalized between 2000 
and 2003 at 2 teaching hospitals in Boston, Massachusetts, Waikar et. al.(290) 
showed that patients with hyponatremia had higher in-hospital, 1-year, and 5-
year mortality rates than patients without hyponatremia. They only adjusted for 
age, sex and co-morbidities only and did not adjust for other serum electrolytes. 
As all the subjects were hospitalised, they categorised patients into categories 
based on change in serum sodium between the first and final measurement and 
showed that mortality was highest in those with persistent or acquired 
hyponatremia. In this study, after adjustment for other electrolytes and 
stratifying by diuretic use, the relationship between sodium and mortality 
disappears, indicating that perhaps serum sodium is not a sensitive nor 
independent marker of risk. 
In the current study of Glasgow hypertensive subjects, despite the use of 
diuretics as an antihypertensive agent, the prevalence of hyponatremia defined 
as serum sodium<135 was 2.8% (n=386) which is much lower than 13% as 
reported by Waikar et. al.(290). However this is similar to the prevalence of 
hyponatremia found in hospitalised patients (0.97% to 2.48%)(291). Wald et. 
al.(292) estimated the prevalence of community-acquired hyponatremia, defined 
as serum sodium <138, to be 37.9% which is comparable to 30% in the Glasgow 
hypertensive population using the same definition which corresponds to quartile 
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1. Thus our analysis reflects the spectrum of serum sodium in the general 
population albeit in a high cardiovascular risk group.  
Hyperglycemia can result in misclassification of hyponatremia(293), however the 
hypertensive subjects in this cohort  had a very low prevalence of diabetes. Also, 
as glucose data was not available in all the subjects it was not possible to adjust 
for it. Waikar et. al.(290) found only a minor level of miss-classification of 
hyponatremia due to hyperglycemia and this had no effect on the association 
between hyponatremia and mortality.  It is unlikely that the results in this study 
will be confounded by glycemia because of the low prevalence of hyponatremia 
in the hypertensive cohort. The relationship between serum sodium and 
mortality in hospitalised patients is not valid across all diagnosis. There is clear 
evidence that hyponatremia is associated with increased mortality in patients 
with heart failure (294-296) and possibly in liver disease (297-300).   
Although 135 to 145 mEq/L is frequently used as the reference range for serum 
sodium, Wald et. al.(292) showed an increase in mortality as serum sodium 
values declined below 138 mEq/L or rose above 142 mEq/L. The definition of 
serum sodium quartiles in this study reflected this definition, though it was 
selected primarily based on the distribution of serum sodium in this cohort. 
None of the studies which analysed mortality outcomes in relation to serum 
sodium have adjusted for other serum electrolytes. The rationale for adjusting 
for serum electrolytes in the hypertensive population is related to the 
interconnectedness of the pathways that affect these electrolytes. For example, 
diuretics can decrease Na and K but can also increase bicarbonate. Potassium 
sparing diuretics can increase potassium in the presence of ACEI or ARBs. 
Aldosterone is a key hormone in sodium balance and primarily works through 
exchanging sodium for potassium in the distal tubules. Serum potassium and 
acidosis have been independently associated with mortality. In the hypertensive 
population we show that after correction for other serum electrolytes, serum 
sodium loses any effect on mortality. This is a novel finding from this study. It 
raises the question of interactions with other dietary or environmental factors. 
There is compelling evidence of an interaction between alcohol intake, 
potassium and magnesium, saturated or polyunsaturated, calcium, dietary fibre, 
and the accompanying anion, and salt-sensitivity of blood pressure.  
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Kurtz et. al. showed that in salt-sensitive individuals, replacement of sodium 
chloride with equimolal sodium bicarbonate (administered as sodium citrate) did 
not replicate the blood pressure influence of sodium chloride. When bicarbonate 
was the anion, sodium was much less likely to influence blood pressure (301). 
Moreover, the pressor response to norepinephrine and catecholamines were 
similar with dietary sodium chloride or sodium citrate indicating that increased 
pressor responsiveness alone cannot account for the sodium chloride-induced 
rise in resting blood pressure (302). Hence, this can be a possible explanation for 
the lack of association between serum sodium and mortality in the presence of 
other electrolytes. Further studies are needed to disentangle these effects. 
There are several strengths and limitations to this study. The strengths include 
the large cohort with long follow-up and high event rates. The limitations are 
that this is a hypertensive cohort and hence the results may not be 
generalisable. The GBPC database only captures medication related to 
hypertension. Therefore, data pertaining to other concomitant drugs usage 
which may cause hyponatremia (such as selective serotonin reuptake inhibitors 
and antiepileptic drugs e.g. carbamazepine) are not available. We did not have 
diet information on all the subjects nor did we have measurements of renin 
aldosterone. 
In summary, low serum sodium is associated with mortality in hypertensive 
patients, which is explained by the effect of other electrolytes. Thus this limits 
the prognostic value of serum sodium in hypertensive patients.
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7 Conclusion 
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The issues regarding sodium intake and its relationship to blood pressure still 
continues to be a subject of controversy with some countries implementing 
regulatory interventions to reduce salt-intake on a population wide level. The 
evidence-base for sodium and blood pressure comes from epidemiological 
studies and randomised controlled trials of salt intervention. Estimates of 
sodium intake were done using diet questionnaires, food diaries, urinary sodium 
excretion (both spot urine and 24 hour urine) and combinations of these. Not all 
of the observational studies found an association between sodium intake and 
blood pressure. Observational studies showed that a 100 mmol rise in sodium 
intake led to a rather modest rise in systolic blood pressure in the range of 1–3 
mmHg and diastolic blood pressure of 0–2 mmHg (303). A Cochrane review of 167 
studies(78) of salt intervention showed a heterogenous effect on BP: in 
normotensive Caucasians blood pressure fell 1.3/0.05 mmHg, in blacks 4/2 
mmHg, and Asians 1.3/1.7 mmHg. The fall in systolic pressure in blacks was 
significant. In hypertensives the falls were more impressive: Caucasians 5.5/2.8 
mmHg, Blacks 6.4/2.4 mmHg and Asians 10.2/2.6 mmHg. There were predictable 
rises in plasma, renin, aldosterone, catecholamines, and lipids. The relationship 
between sodium intake and cardiovascular events appear to be J-shaped with 
higher risk with urinary sodium excretion of >7g/day or <3g/day. 
 
In this project I have studied dietary sodium intake using a food frequency 
questionnaire that was adapted for use in UK. Though food frequency 
questionnaire alone is not reliable for estimating sodium intake, it is useful in 
assessing sodium intake in treated hypertensive patients both as a tool to create 
awareness and facilitate healthy diet. The application of this questionnaire, 
when used in conjunction with other dietary measures such as serial spot urine 
measurement or 24-hour urine collection, can be extremely helpful in 
monitoring excessive dietary salt intake among hypertensive patients.  
 
The knowledge and understanding of health risks associated with salt was 
unsatisfactory despite the population being a high cardiovascular risk 
hypertensive population attending a specialist hypertension clinic. The findings 
from our study indicate that there is a need for increased education and 
awareness campaigns to increase patients understanding of the health risks 
associated with high-salt diet and how excessive intake could potentially 
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jeopardizing their health.  Health care professionals, community health-workers 
and public health agencies need to actively inform the public regarding the 
recommended salt intake and the importance of reading food labels to identify 
for salt contents. As with other lifestyle interventions, problems can be 
anticipated from patients pertaining to the adjustment in taste to a lower salt 
diet and compliance with it. Nevertheless, with greater awareness from the 
media, and sensible advice from healthcare professionals, salt reduction may 
prove to be a readily accessible, non-pharmacological intervention, as well as a 
significant way of reducing public health concern in the long term. 
 
Dietary sodium intake did not appear to have a significant effect on longitudinal 
blood pressure during follow-up in the hypertensive population. The decreased 
SBP during follow-up in the highest tertile of sodium intake was confounded by 
the greater prevalence of LVH and cardiovascular disease in this group. There 
appeared to be no association between dietary sodium intake and serum sodium 
(both single-point measurement and serial measurements). In multivariate 
adjusted survival analysis, serum sodium showed an inverse relationship to 
mortality with hyponatremia associated with increased risk. However, after 
adjusting for other electrolytes serum sodium was no longer a predictor of 
mortality. This is a novel finding and raises the prospect that other electrolytes 
may have an impact on blood pressure and cardiovascular risk – not sodium in 
isolation.  
 
Whilst the current study is observational it has raised interesting insights into 
sodium and blood pressure which can inform future studies. A priority would be 
to correlate food questionnaire with a more robust estimation of dietary sodium 
intake such as 24 hour urinary sodium estimation, in a serial measurements. The 
effect of drugs especially diuretics on sodium balance and outcomes need to be 
studied. This will inform whether population based interventions for salt 
reduction will be beneficial over focussed diuretic based intervention in higher 
risk hypertensive individuals. Issues pertaining to confounding factors can be 
addressed through randomised control studies. Randomised controlled sodium 
intervention studies are feasible, although large sample sizes of ~15,000–20,000 
are needed to detect benefits in the magnitude of 12–15% over 5 years.  
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8 Appendices 
8.1 Appendix 1: Modified FFQ for sodium assessment 
 
SALT INTAKE QUESTIONNAIRE 
. 
 
During the PAST 7 days (1 week) did you eat any of the following? Please put a tick (√) in the appropriate box 
 
 
Food Item 
 
 
NEVER 
NOT EVERY DAY EVERY DAY 
1-3 
times/week 
4-6 
times/ 
week 
1 time 
a day 
2 times 
a day 
3+ times 
a day 
White bread/ white bread rolls/ pita /croissants       
Brown/ wholewheat bread/ rolls       
Breakfast cereal (processed eg. cornflakes, rice 
crispies) 
      
Breakfast cereal (minimally processed-weetbix, 
muesli, etc.) 
      
Crackers (Tac, etc.)       
Cookies, biscuits, rusks (McVitie’s, etc.)       
Cake/ scone/ muffin/ puddings/ pancake/ fruit pie/ 
tarts 
      
Roti/ samosa/ spring roll/ doughnut       
Pizza       
Pasta or noodle dishes with cheese sauces 
(macaroni cheese, lasagne, noodle salad, spaghetti 
bolognaise etc.) 
      
Popcorn       
Crisps (Walkers,etc.)       
Beef sausages       
Processed meat, cooked, smoked or canned eg 
Salami/ bacon/ pork sausages 
      
Meat or chicken pies/ sausage rolls       
Chicken – battered (KFC, etc.) or chicken burger        
Meat and meat dishes (steaks, minced meat, 
cottage pie, mince, meatballs, stew, chicken stew 
etc.) 
      
Gravy, made with stock or gravy powder       
Dried salted meat/ beef jerky/ smoked fish       
Milk (all types, also dairy fruit juice, malted milk, milk 
shakes, chocolate drinks, evaporated & condensed 
milk) 
      
Fermented milk/ sour milk       
Cheese       
Yogurt       
Eggs (any preparation)       
Tinned fish (tuna, sardines, etc.)       
Other fish and seafood (eg battered fish, prawns, 
crabs, mussels) 
      
Potato chips/ French fries or potato salad       
Canned vegetables, including baked beans, tomato 
paste, sweet corn, olives etc. 
      
Soup (all types)       
Salad dressing/ mayonnaise       
Ice cream (all types)       
Margarines, all types, also butter       
Worcester sauce/relish/ barbecue or steak sauce       
Savoury sauces (mushroom, white, cheese)       
Tomato sauce/ Ketchup       
Salt (added to cooking or at the table)       
Mustard/ all purpose seasoning mix       
Peanuts (salted/unsalted/raw)       
Peanut butter       
Marmite/ Bovril       
Chocolate - sweets or sauce       
Beer and cider       
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8.2 Appendix 2: KAP Questionnaire 
 
1. Do you think eating too much salt affects your health? 
 
Yes [  ]   No [  ]   I don’t know [  ] 
 
 
2. A high salt intake can cause (you may choose more than one answer) 
 
High blood pressure  [  ] Kidney disease   [  ]  
Stroke    [  ] Memory/concentration problems [  ] 
Osteoporosis   [  ] Asthma    [  ] 
Fluid retention  [  ] Heart attacks    [  ]  
Stomach cancer  [  ] I don’t know    [  ] 
 
 
3. What is the maximum recommended daily amount of salt for an adult in 
the UK? 
 
6 grams (1 teaspoonful)  [  ] 15 grams (2 ½ teaspoons) [  ] 
9 grams  (1 ½ teaspoons) [  ]  I don’t know    [  ] 
12 grams (2 teaspoons) [  ]  
 
4. What is the main source of salt in the diet of an average person? 
 
Salt added during cooking and at the table    [  ] 
Salt in processed foods (including takeaway, fast food, catered food) [  ] 
Salt in mineral water       [  ] 
I don’t know         [  ] 
 
 
5. Do you add salt to food before tasting them? 
 
Yes [  ] No [  ]   I don’t add salt at the table or in cooking    [  ]  
 
 
 
6. Which of these statements best describes the relationship between salt 
and sodium? 
 
Exactly the same  [  ] Sodium contains salt   [  ] 
Salt contains sodium  [  ] No idea about the relationship [  ] 
 
 
7. Do you look for the sodium content of the product when shopping? 
 
Yes [  ]  No [  ] 
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8. What is your greatest concern related to low salt diet? 
 
The taste of food without salt      [  ] 
Don’t have enough information on low salt diet    [  ] 
Worry that low salt diet would interfere with your daily lifestyle    [  ] 
Limited low salt food choices on the market    [  ] 
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8.3 Appendix 3: Cover letter  
 
 
Glasgow Blood Pressure Clinic     
Western Infirmary 
Glasgow 
G11 6NT 
 
Dear Sir/Madam 
 
I am writing to you with regard to your next appointment at the Glasgow 
Blood Pressure Clinic in the Western Infirmary. Enclosed with this letter is 
a questionnaire related to salt consumption. Many individuals are not 
aware of their daily salt intake. Studies have shown that high salt diet is 
related to poor blood pressure control and may affect how well the blood 
pressure medicine works. The purpose of this questionnaire is to find out 
the average daily salt intake amongst patients attending the Glasgow 
Blood Pressure Clinic. Your participation in this questionnaire, when 
combined with the others, could help, leading to the development of 
methods to help promote healthier living in people with high blood 
pressure.  
 
The questionnaire will take approximately 10 minutes to read and answer 
the questions. Do not worry if you make a mistake, simply cross it out and 
tick your new answer. All the information provided will be kept 
confidential. Kindly be informed that a urine sample will also be 
requested upon your next appointment at the clinic.  
 
The completed questionnaire can be returned to the clinic during your 
next appointment. Otherwise it can be mailed to the following address: 
 
Adyani Md. Redzuan 
Room 416 
BHF Glasgow Cardiovascular Research Centre,  
University of Glasgow,  
Glasgow 
G12 8TA 
 
I would be happy to inform you personally regarding the result of your 
average daily salt intake, upon the completion of the study. This can 
either be discussed during clinic time or by mail. Should you have any 
questions regarding the questionnaire, please call me (Adyani Redzuan) at 
0141-330-5074. I really appreciate your time in reading this letter and look 
forward to your participation. 
 
Thank you. 
 
Yours sincerely, 
 
Adyani Redzuan 
 
For Dr Sandosh Padmanabhan 
Consultant,  
Glasgow Blood Pressure Clinic 
Western Infirmary 
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